Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048731 | 0.00000 | 3.18638 | 134 | 289 | 4638 | system development |
| GO:0032502 | 0.00000 | 2.99939 | 176 | 339 | 6097 | developmental process |
| GO:0007275 | 0.00000 | 2.98553 | 150 | 304 | 5227 | multicellular organism development |
| GO:0048856 | 0.00000 | 2.90295 | 164 | 319 | 5712 | anatomical structure development |
| GO:0051239 | 0.00000 | 3.07211 | 91 | 212 | 3173 | regulation of multicellular organismal process |
| GO:0009653 | 0.00000 | 3.16433 | 76 | 187 | 2652 | anatomical structure morphogenesis |
| GO:0048869 | 0.00000 | 2.73704 | 125 | 252 | 4334 | cellular developmental process |
| GO:0030154 | 0.00000 | 2.76467 | 119 | 244 | 4125 | cell differentiation |
| GO:0048513 | 0.00000 | 2.83046 | 99 | 214 | 3430 | animal organ development |
| GO:0050793 | 0.00000 | 3.00155 | 77 | 182 | 2681 | regulation of developmental process |
| GO:0032501 | 0.00000 | 2.40756 | 232 | 371 | 8064 | multicellular organismal process |
| GO:0007399 | 0.00000 | 3.09580 | 65 | 161 | 2257 | nervous system development |
| GO:0048518 | 0.00000 | 2.40272 | 174 | 301 | 6033 | positive regulation of biological process |
| GO:0007155 | 0.00000 | 3.57949 | 37 | 109 | 1273 | cell adhesion |
| GO:0022610 | 0.00000 | 3.54098 | 37 | 109 | 1285 | biological adhesion |
| GO:0045595 | 0.00000 | 3.05839 | 54 | 136 | 1874 | regulation of cell differentiation |
| GO:0009888 | 0.00000 | 3.04112 | 55 | 137 | 1899 | tissue development |
| GO:0007166 | 0.00000 | 2.77697 | 71 | 161 | 2473 | cell surface receptor signaling pathway |
| GO:0065007 | 0.00000 | 2.28498 | 345 | 471 | 11983 | biological regulation |
| GO:0042127 | 0.00000 | 3.16877 | 47 | 124 | 1636 | regulation of cell proliferation |
| GO:0048522 | 0.00000 | 2.30042 | 154 | 268 | 5349 | positive regulation of cellular process |
| GO:2000026 | 0.00000 | 2.88698 | 61 | 146 | 2136 | regulation of multicellular organismal development |
| GO:0048468 | 0.00000 | 2.77757 | 67 | 153 | 2330 | cell development |
| GO:0050789 | 0.00000 | 2.19255 | 327 | 450 | 11369 | regulation of biological process |
| GO:0008283 | 0.00000 | 2.86622 | 57 | 136 | 1981 | cell proliferation |
| GO:0040007 | 0.00000 | 3.52930 | 32 | 95 | 1106 | growth |
| GO:0032879 | 0.00000 | 2.57529 | 79 | 167 | 2749 | regulation of localization |
| GO:0022008 | 0.00000 | 2.97451 | 49 | 123 | 1712 | neurogenesis |
| GO:0048519 | 0.00000 | 2.20333 | 149 | 255 | 5186 | negative regulation of biological process |
| GO:0048523 | 0.00000 | 2.23972 | 133 | 234 | 4605 | negative regulation of cellular process |
| GO:0051094 | 0.00000 | 2.99661 | 44 | 111 | 1516 | positive regulation of developmental process |
| GO:0048583 | 0.00000 | 2.29801 | 108 | 201 | 3755 | regulation of response to stimulus |
| GO:0000902 | 0.00000 | 3.43189 | 30 | 88 | 1042 | cell morphogenesis |
| GO:0016043 | 0.00000 | 2.10165 | 171 | 276 | 5929 | cellular component organization |
| GO:0048589 | 0.00000 | 3.87238 | 22 | 73 | 765 | developmental growth |
| GO:0051179 | 0.00000 | 2.10164 | 167 | 271 | 5794 | localization |
| GO:0051241 | 0.00000 | 3.11604 | 38 | 100 | 1305 | negative regulation of multicellular organismal process |
| GO:0048699 | 0.00000 | 2.88732 | 46 | 114 | 1613 | generation of neurons |
| GO:0032989 | 0.00000 | 3.26787 | 33 | 92 | 1142 | cellular component morphogenesis |
| GO:0009987 | 0.00000 | 2.32994 | 449 | 551 | 15608 | cellular process |
| GO:0001503 | 0.00000 | 5.49521 | 11 | 49 | 369 | ossification |
| GO:0009966 | 0.00000 | 2.44442 | 78 | 159 | 2712 | regulation of signal transduction |
| GO:0001655 | 0.00000 | 5.59448 | 10 | 46 | 340 | urogenital system development |
| GO:0048666 | 0.00000 | 3.14513 | 34 | 92 | 1181 | neuron development |
| GO:0010646 | 0.00000 | 2.29576 | 94 | 178 | 3256 | regulation of cell communication |
| GO:0071840 | 0.00000 | 2.03416 | 175 | 277 | 6096 | cellular component organization or biogenesis |
| GO:0051240 | 0.00000 | 2.65707 | 54 | 123 | 1887 | positive regulation of multicellular organismal process |
| GO:0023051 | 0.00000 | 2.27775 | 94 | 178 | 3277 | regulation of signaling |
| GO:0016477 | 0.00000 | 2.91889 | 40 | 101 | 1397 | cell migration |
| GO:0050794 | 0.00000 | 1.96909 | 307 | 415 | 10650 | regulation of cellular process |
| GO:0030182 | 0.00000 | 2.87402 | 42 | 103 | 1447 | neuron differentiation |
| GO:0035295 | 0.00000 | 3.16473 | 32 | 87 | 1105 | tube development |
| GO:0000904 | 0.00000 | 3.66188 | 22 | 70 | 768 | cell morphogenesis involved in differentiation |
| GO:0120036 | 0.00000 | 2.82424 | 43 | 104 | 1485 | plasma membrane bounded cell projection organization |
| GO:0031175 | 0.00000 | 3.17796 | 30 | 83 | 1046 | neuron projection development |
| GO:0006928 | 0.00000 | 2.55812 | 56 | 122 | 1932 | movement of cell or subcellular component |
| GO:0051270 | 0.00000 | 3.22183 | 29 | 80 | 993 | regulation of cellular component movement |
| GO:0065008 | 0.00000 | 2.12085 | 114 | 199 | 3955 | regulation of biological quality |
| GO:0009887 | 0.00000 | 3.12416 | 30 | 82 | 1048 | animal organ morphogenesis |
| GO:0050767 | 0.00000 | 3.27892 | 27 | 76 | 925 | regulation of neurogenesis |
| GO:0007167 | 0.00000 | 3.36798 | 25 | 73 | 865 | enzyme linked receptor protein signaling pathway |
| GO:0030030 | 0.00000 | 2.72727 | 44 | 104 | 1531 | cell projection organization |
| GO:0022603 | 0.00000 | 3.10401 | 30 | 82 | 1054 | regulation of anatomical structure morphogenesis |
| GO:0035239 | 0.00000 | 3.30720 | 26 | 74 | 892 | tube morphogenesis |
| GO:0051960 | 0.00000 | 3.11448 | 30 | 81 | 1037 | regulation of nervous system development |
| GO:0060284 | 0.00000 | 3.08741 | 30 | 82 | 1059 | regulation of cell development |
| GO:0009967 | 0.00000 | 2.73673 | 43 | 101 | 1478 | positive regulation of signal transduction |
| GO:0072001 | 0.00000 | 5.52121 | 9 | 40 | 297 | renal system development |
| GO:0030334 | 0.00000 | 3.31628 | 25 | 72 | 864 | regulation of cell migration |
| GO:0040011 | 0.00000 | 2.57975 | 50 | 112 | 1744 | locomotion |
| GO:0048870 | 0.00000 | 2.68022 | 44 | 103 | 1538 | cell motility |
| GO:0051674 | 0.00000 | 2.68022 | 44 | 103 | 1538 | localization of cell |
| GO:0045597 | 0.00000 | 3.01950 | 31 | 82 | 1080 | positive regulation of cell differentiation |
| GO:2000145 | 0.00000 | 3.18427 | 26 | 73 | 909 | regulation of cell motility |
| GO:0030155 | 0.00000 | 3.58301 | 19 | 60 | 664 | regulation of cell adhesion |
| GO:0040012 | 0.00000 | 3.05053 | 28 | 76 | 986 | regulation of locomotion |
| GO:0001822 | 0.00000 | 5.49333 | 8 | 37 | 275 | kidney development |
| GO:0043062 | 0.00000 | 5.29099 | 8 | 38 | 292 | extracellular structure organization |
| GO:0023052 | 0.00000 | 1.87124 | 189 | 280 | 6550 | signaling |
| GO:0051093 | 0.00000 | 2.94846 | 30 | 78 | 1045 | negative regulation of developmental process |
| GO:0051128 | 0.00000 | 2.23112 | 72 | 139 | 2513 | regulation of cellular component organization |
| GO:0035556 | 0.00000 | 2.21329 | 74 | 141 | 2571 | intracellular signal transduction |
| GO:0007165 | 0.00000 | 1.87172 | 173 | 261 | 6010 | signal transduction |
| GO:0007154 | 0.00000 | 1.84506 | 190 | 280 | 6614 | cell communication |
| GO:0048584 | 0.00000 | 2.27925 | 64 | 127 | 2231 | positive regulation of response to stimulus |
| GO:0030198 | 0.00000 | 5.59352 | 7 | 34 | 248 | extracellular matrix organization |
| GO:0072359 | 0.00000 | 2.82605 | 32 | 80 | 1115 | circulatory system development |
| GO:0060429 | 0.00000 | 2.78506 | 33 | 82 | 1160 | epithelium development |
| GO:0045596 | 0.00000 | 3.22416 | 22 | 64 | 781 | negative regulation of cell differentiation |
| GO:0010647 | 0.00000 | 2.40353 | 52 | 110 | 1818 | positive regulation of cell communication |
| GO:0023056 | 0.00000 | 2.39442 | 53 | 110 | 1824 | positive regulation of signaling |
| GO:0048729 | 0.00000 | 3.41735 | 19 | 58 | 668 | tissue morphogenesis |
| GO:0050673 | 0.00000 | 4.24734 | 12 | 44 | 412 | epithelial cell proliferation |
| GO:0048514 | 0.00000 | 3.52714 | 18 | 55 | 614 | blood vessel morphogenesis |
| GO:0030278 | 0.00000 | 5.79417 | 7 | 32 | 226 | regulation of ossification |
| GO:0008285 | 0.00000 | 3.38314 | 19 | 58 | 674 | negative regulation of cell proliferation |
| GO:0031589 | 0.00000 | 4.72572 | 9 | 38 | 322 | cell-substrate adhesion |
| GO:0001568 | 0.00000 | 3.25658 | 20 | 59 | 710 | blood vessel development |
| GO:0045664 | 0.00000 | 3.15784 | 22 | 61 | 756 | regulation of neuron differentiation |
| GO:0040008 | 0.00000 | 3.17636 | 21 | 60 | 739 | regulation of growth |
| GO:0050896 | 0.00000 | 1.75552 | 271 | 361 | 9397 | response to stimulus |
| GO:0042221 | 0.00000 | 1.92688 | 116 | 190 | 4043 | response to chemical |
| GO:0008284 | 0.00000 | 2.84884 | 28 | 71 | 974 | positive regulation of cell proliferation |
| GO:0071363 | 0.00000 | 3.45136 | 17 | 52 | 590 | cellular response to growth factor stimulus |
| GO:0048585 | 0.00000 | 2.40657 | 45 | 96 | 1565 | negative regulation of response to stimulus |
| GO:0001944 | 0.00000 | 3.09947 | 21 | 59 | 742 | vasculature development |
| GO:0070848 | 0.00000 | 3.36168 | 17 | 52 | 604 | response to growth factor |
| GO:0072006 | 0.00000 | 7.14069 | 4 | 24 | 141 | nephron development |
| GO:0050678 | 0.00000 | 4.31022 | 10 | 38 | 349 | regulation of epithelial cell proliferation |
| GO:0035265 | 0.00000 | 5.63637 | 6 | 29 | 209 | organ growth |
| GO:0070887 | 0.00000 | 2.01806 | 84 | 148 | 2933 | cellular response to chemical stimulus |
| GO:0019220 | 0.00000 | 2.32954 | 48 | 99 | 1665 | regulation of phosphate metabolic process |
| GO:0051174 | 0.00000 | 2.32794 | 48 | 99 | 1666 | regulation of phosphorus metabolic process |
| GO:0072358 | 0.00000 | 3.03977 | 22 | 59 | 755 | cardiovascular system development |
| GO:0061448 | 0.00000 | 4.78731 | 8 | 33 | 275 | connective tissue development |
| GO:0120039 | 0.00000 | 3.17703 | 19 | 54 | 661 | plasma membrane bounded cell projection morphogenesis |
| GO:0048858 | 0.00000 | 3.16098 | 19 | 54 | 664 | cell projection morphogenesis |
| GO:0120035 | 0.00000 | 3.01463 | 22 | 58 | 747 | regulation of plasma membrane bounded cell projection organization |
| GO:0032990 | 0.00000 | 3.11445 | 20 | 55 | 686 | cell part morphogenesis |
| GO:0001501 | 0.00000 | 3.51773 | 15 | 46 | 510 | skeletal system development |
| GO:0051216 | 0.00000 | 5.49507 | 6 | 28 | 206 | cartilage development |
| GO:0010648 | 0.00000 | 2.45525 | 38 | 83 | 1314 | negative regulation of cell communication |
| GO:0031344 | 0.00000 | 2.97454 | 22 | 58 | 756 | regulation of cell projection organization |
| GO:0009719 | 0.00000 | 2.40960 | 40 | 86 | 1388 | response to endogenous stimulus |
| GO:0023057 | 0.00000 | 2.44684 | 38 | 83 | 1318 | negative regulation of signaling |
| GO:0048646 | 0.00000 | 2.56218 | 33 | 75 | 1135 | anatomical structure formation involved in morphogenesis |
| GO:0071495 | 0.00000 | 2.50645 | 35 | 78 | 1207 | cellular response to endogenous stimulus |
| GO:0051049 | 0.00000 | 2.19101 | 54 | 106 | 1892 | regulation of transport |
| GO:0001525 | 0.00000 | 3.45857 | 15 | 45 | 506 | angiogenesis |
| GO:0051716 | 0.00000 | 1.69645 | 222 | 303 | 7705 | cellular response to stimulus |
| GO:0060350 | 0.00000 | 10.29816 | 2 | 17 | 74 | endochondral bone morphogenesis |
| GO:0048812 | 0.00000 | 3.11265 | 19 | 52 | 647 | neuron projection morphogenesis |
| GO:0042325 | 0.00000 | 2.31867 | 43 | 90 | 1508 | regulation of phosphorylation |
| GO:0009893 | 0.00000 | 1.88741 | 98 | 161 | 3406 | positive regulation of metabolic process |
| GO:0009968 | 0.00000 | 2.48015 | 34 | 76 | 1185 | negative regulation of signal transduction |
| GO:0007417 | 0.00000 | 2.78062 | 24 | 61 | 847 | central nervous system development |
| GO:0042063 | 0.00000 | 4.30159 | 9 | 33 | 302 | gliogenesis |
| GO:0048667 | 0.00000 | 3.15828 | 17 | 49 | 600 | cell morphogenesis involved in neuron differentiation |
| GO:0001763 | 0.00000 | 4.82470 | 7 | 29 | 239 | morphogenesis of a branching structure |
| GO:0002009 | 0.00000 | 3.25913 | 16 | 46 | 546 | morphogenesis of an epithelium |
| GO:0031325 | 0.00000 | 1.90142 | 90 | 150 | 3128 | positive regulation of cellular metabolic process |
| GO:0061326 | 0.00000 | 7.82480 | 3 | 19 | 103 | renal tubule development |
| GO:0060349 | 0.00000 | 7.21430 | 3 | 20 | 116 | bone morphogenesis |
| GO:0008219 | 0.00000 | 2.08550 | 59 | 110 | 2056 | cell death |
| GO:0000165 | 0.00000 | 2.78090 | 23 | 58 | 803 | MAPK cascade |
| GO:0072073 | 0.00000 | 6.30856 | 4 | 22 | 143 | kidney epithelium development |
| GO:0060828 | 0.00000 | 4.98020 | 6 | 27 | 216 | regulation of canonical Wnt signaling pathway |
| GO:0080090 | 0.00000 | 1.72999 | 148 | 218 | 5147 | regulation of primary metabolic process |
| GO:0043408 | 0.00000 | 2.83624 | 21 | 55 | 746 | regulation of MAPK cascade |
| GO:0007267 | 0.00000 | 2.22629 | 45 | 90 | 1563 | cell-cell signaling |
| GO:0051130 | 0.00000 | 2.37687 | 36 | 77 | 1248 | positive regulation of cellular component organization |
| GO:0010975 | 0.00000 | 3.11219 | 17 | 47 | 582 | regulation of neuron projection development |
| GO:0060348 | 0.00000 | 4.87611 | 6 | 27 | 220 | bone development |
| GO:0061138 | 0.00000 | 4.87611 | 6 | 27 | 220 | morphogenesis of a branching epithelium |
| GO:0051173 | 0.00000 | 1.89330 | 86 | 144 | 3000 | positive regulation of nitrogen compound metabolic process |
| GO:0060485 | 0.00000 | 4.38663 | 8 | 30 | 269 | mesenchyme development |
| GO:0030335 | 0.00000 | 3.22613 | 15 | 44 | 526 | positive regulation of cell migration |
| GO:0072009 | 0.00000 | 7.30120 | 3 | 19 | 109 | nephron epithelium development |
| GO:0072080 | 0.00000 | 7.87178 | 3 | 18 | 97 | nephron tubule development |
| GO:1905114 | 0.00000 | 3.26536 | 15 | 43 | 508 | cell surface receptor signaling pathway involved in cell-cell signaling |
| GO:0051962 | 0.00000 | 2.99641 | 18 | 49 | 629 | positive regulation of nervous system development |
| GO:0023014 | 0.00000 | 2.71305 | 24 | 58 | 821 | signal transduction by protein phosphorylation |
| GO:0010941 | 0.00000 | 2.16735 | 48 | 94 | 1677 | regulation of cell death |
| GO:0007169 | 0.00000 | 3.19900 | 15 | 44 | 530 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0006915 | 0.00000 | 2.10378 | 54 | 101 | 1860 | apoptotic process |
| GO:1902531 | 0.00000 | 2.15272 | 49 | 94 | 1687 | regulation of intracellular signal transduction |
| GO:0051271 | 0.00000 | 4.04296 | 9 | 32 | 309 | negative regulation of cellular component movement |
| GO:0042981 | 0.00000 | 2.21814 | 44 | 87 | 1512 | regulation of apoptotic process |
| GO:0010720 | 0.00000 | 2.95974 | 18 | 49 | 636 | positive regulation of cell development |
| GO:0050768 | 0.00000 | 3.93140 | 9 | 33 | 327 | negative regulation of neurogenesis |
| GO:0010562 | 0.00000 | 2.42905 | 32 | 70 | 1106 | positive regulation of phosphorus metabolic process |
| GO:0045937 | 0.00000 | 2.42905 | 32 | 70 | 1106 | positive regulation of phosphate metabolic process |
| GO:0090092 | 0.00000 | 4.68036 | 7 | 27 | 228 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0048762 | 0.00000 | 4.83993 | 6 | 26 | 213 | mesenchymal cell differentiation |
| GO:0065009 | 0.00000 | 1.95143 | 70 | 122 | 2437 | regulation of molecular function |
| GO:0050769 | 0.00000 | 3.08223 | 16 | 45 | 561 | positive regulation of neurogenesis |
| GO:0051272 | 0.00000 | 3.08223 | 16 | 45 | 561 | positive regulation of cellular component movement |
| GO:0007178 | 0.00000 | 3.77074 | 10 | 34 | 350 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0051961 | 0.00000 | 3.77074 | 10 | 34 | 350 | negative regulation of nervous system development |
| GO:0061564 | 0.00000 | 3.26847 | 14 | 41 | 483 | axon development |
| GO:0009790 | 0.00000 | 2.36130 | 34 | 73 | 1186 | embryo development |
| GO:0090287 | 0.00000 | 4.28818 | 8 | 29 | 265 | regulation of cellular response to growth factor stimulus |
| GO:0043067 | 0.00000 | 2.18699 | 44 | 87 | 1531 | regulation of programmed cell death |
| GO:2000147 | 0.00000 | 3.10111 | 16 | 44 | 545 | positive regulation of cell motility |
| GO:0030111 | 0.00000 | 4.14129 | 8 | 30 | 283 | regulation of Wnt signaling pathway |
| GO:0071310 | 0.00000 | 1.95111 | 68 | 119 | 2372 | cellular response to organic substance |
| GO:0051234 | 0.00000 | 1.72894 | 127 | 191 | 4428 | establishment of localization |
| GO:0048638 | 0.00000 | 3.54875 | 11 | 36 | 392 | regulation of developmental growth |
| GO:0010604 | 0.00000 | 1.83562 | 91 | 147 | 3149 | positive regulation of macromolecule metabolic process |
| GO:0012501 | 0.00000 | 2.05553 | 55 | 101 | 1898 | programmed cell death |
| GO:0010721 | 0.00000 | 3.60944 | 11 | 35 | 375 | negative regulation of cell development |
| GO:0001932 | 0.00000 | 2.22660 | 40 | 81 | 1396 | regulation of protein phosphorylation |
| GO:0006468 | 0.00000 | 2.07656 | 52 | 97 | 1801 | protein phosphorylation |
| GO:0016310 | 0.00000 | 1.98676 | 62 | 110 | 2144 | phosphorylation |
| GO:0060070 | 0.00000 | 4.16334 | 8 | 29 | 272 | canonical Wnt signaling pathway |
| GO:0006793 | 0.00000 | 1.85310 | 84 | 138 | 2914 | phosphorus metabolic process |
| GO:0040017 | 0.00000 | 2.98737 | 17 | 45 | 577 | positive regulation of locomotion |
| GO:0046903 | 0.00000 | 2.32725 | 34 | 72 | 1184 | secretion |
| GO:0019222 | 0.00000 | 1.65283 | 168 | 236 | 5833 | regulation of metabolic process |
| GO:0030282 | 0.00000 | 6.90630 | 3 | 18 | 108 | bone mineralization |
| GO:0006796 | 0.00000 | 1.85141 | 83 | 137 | 2893 | phosphate-containing compound metabolic process |
| GO:0098609 | 0.00000 | 2.75676 | 20 | 51 | 707 | cell-cell adhesion |
| GO:0045926 | 0.00000 | 4.09519 | 8 | 29 | 276 | negative regulation of growth |
| GO:0001667 | 0.00000 | 3.44068 | 12 | 36 | 403 | ameboidal-type cell migration |
| GO:0051050 | 0.00000 | 2.40362 | 30 | 66 | 1049 | positive regulation of transport |
| GO:0061333 | 0.00000 | 7.99023 | 2 | 16 | 85 | renal tubule morphogenesis |
| GO:0006810 | 0.00000 | 1.71526 | 124 | 185 | 4298 | transport |
| GO:0060993 | 0.00000 | 7.23913 | 3 | 17 | 98 | kidney morphogenesis |
| GO:0048608 | 0.00000 | 3.27935 | 13 | 38 | 445 | reproductive structure development |
| GO:0048732 | 0.00000 | 3.21020 | 13 | 39 | 466 | gland development |
| GO:0048754 | 0.00000 | 4.98675 | 5 | 23 | 183 | branching morphogenesis of an epithelial tube |
| GO:0007409 | 0.00000 | 3.25492 | 13 | 38 | 448 | axonogenesis |
| GO:0033002 | 0.00000 | 4.41141 | 7 | 26 | 231 | muscle cell proliferation |
| GO:0050790 | 0.00000 | 2.04875 | 51 | 95 | 1782 | regulation of catalytic activity |
| GO:0042327 | 0.00000 | 2.39124 | 30 | 65 | 1037 | positive regulation of phosphorylation |
| GO:0061458 | 0.00000 | 3.24685 | 13 | 38 | 449 | reproductive system development |
| GO:0060322 | 0.00000 | 2.76135 | 19 | 49 | 677 | head development |
| GO:0007423 | 0.00000 | 2.89263 | 17 | 45 | 594 | sensory organ development |
| GO:0045444 | 0.00000 | 4.32621 | 7 | 26 | 235 | fat cell differentiation |
| GO:0014013 | 0.00000 | 5.62391 | 4 | 20 | 143 | regulation of gliogenesis |
| GO:0016055 | 0.00000 | 3.30334 | 12 | 36 | 418 | Wnt signaling pathway |
| GO:0010001 | 0.00000 | 4.43141 | 6 | 25 | 221 | glial cell differentiation |
| GO:0010810 | 0.00000 | 4.60265 | 6 | 24 | 205 | regulation of cell-substrate adhesion |
| GO:0031323 | 0.00000 | 1.64416 | 152 | 216 | 5290 | regulation of cellular metabolic process |
| GO:0198738 | 0.00000 | 3.28584 | 12 | 36 | 420 | cell-cell signaling by wnt |
| GO:0040013 | 0.00000 | 3.66891 | 9 | 31 | 326 | negative regulation of locomotion |
| GO:0010942 | 0.00000 | 2.71844 | 19 | 48 | 672 | positive regulation of cell death |
| GO:0048598 | 0.00000 | 2.78463 | 18 | 46 | 629 | embryonic morphogenesis |
| GO:0007162 | 0.00000 | 3.93171 | 8 | 28 | 276 | negative regulation of cell adhesion |
| GO:0043065 | 0.00000 | 2.80867 | 18 | 45 | 610 | positive regulation of apoptotic process |
| GO:0051171 | 0.00000 | 1.64628 | 144 | 206 | 5008 | regulation of nitrogen compound metabolic process |
| GO:0030029 | 0.00000 | 2.64027 | 21 | 50 | 720 | actin filament-based process |
| GO:0044237 | 0.00000 | 1.56047 | 265 | 336 | 9199 | cellular metabolic process |
| GO:0010033 | 0.00000 | 1.78603 | 87 | 138 | 3005 | response to organic substance |
| GO:0008152 | 0.00000 | 1.55502 | 298 | 369 | 10337 | metabolic process |
| GO:0043068 | 0.00000 | 2.77840 | 18 | 45 | 616 | positive regulation of programmed cell death |
| GO:0031214 | 0.00000 | 5.31943 | 4 | 20 | 150 | biomineral tissue development |
| GO:0061061 | 0.00000 | 2.67435 | 20 | 48 | 682 | muscle structure development |
| GO:0090066 | 0.00000 | 2.88588 | 16 | 42 | 554 | regulation of anatomical structure size |
| GO:0044238 | 0.00000 | 1.55167 | 268 | 338 | 9296 | primary metabolic process |
| GO:0032535 | 0.00000 | 3.29403 | 11 | 34 | 395 | regulation of cellular component size |
| GO:0030177 | 0.00000 | 5.85966 | 4 | 18 | 124 | positive regulation of Wnt signaling pathway |
| GO:0031399 | 0.00000 | 2.00137 | 50 | 91 | 1737 | regulation of protein modification process |
| GO:0097435 | 0.00000 | 2.67073 | 19 | 47 | 668 | supramolecular fiber organization |
| GO:0060537 | 0.00000 | 3.06520 | 13 | 37 | 460 | muscle tissue development |
| GO:1902533 | 0.00000 | 2.31635 | 29 | 61 | 998 | positive regulation of intracellular signal transduction |
| GO:0060255 | 0.00000 | 1.60478 | 155 | 216 | 5386 | regulation of macromolecule metabolic process |
| GO:0022604 | 0.00000 | 2.91084 | 15 | 39 | 509 | regulation of cell morphogenesis |
| GO:0060536 | 0.00000 | 17.08485 | 1 | 9 | 27 | cartilage morphogenesis |
| GO:0031401 | 0.00000 | 2.17586 | 35 | 69 | 1202 | positive regulation of protein modification process |
| GO:0001649 | 0.00000 | 4.48041 | 6 | 22 | 192 | osteoblast differentiation |
| GO:0048705 | 0.00000 | 3.85969 | 7 | 26 | 260 | skeletal system morphogenesis |
| GO:0070167 | 0.00000 | 6.87920 | 3 | 15 | 90 | regulation of biomineral tissue development |
| GO:0051246 | 0.00000 | 1.79317 | 76 | 123 | 2642 | regulation of protein metabolic process |
| GO:0031328 | 0.00000 | 1.94012 | 53 | 94 | 1848 | positive regulation of cellular biosynthetic process |
| GO:0016049 | 0.00000 | 2.88575 | 15 | 39 | 513 | cell growth |
| GO:0043410 | 0.00000 | 2.84186 | 15 | 40 | 534 | positive regulation of MAPK cascade |
| GO:0044057 | 0.00000 | 2.75893 | 17 | 42 | 577 | regulation of system process |
| GO:0001934 | 0.00000 | 2.29507 | 28 | 60 | 989 | positive regulation of protein phosphorylation |
| GO:0051247 | 0.00000 | 2.00012 | 47 | 85 | 1616 | positive regulation of protein metabolic process |
| GO:0032270 | 0.00000 | 2.03343 | 44 | 81 | 1513 | positive regulation of cellular protein metabolic process |
| GO:0060562 | 0.00000 | 3.25535 | 11 | 32 | 375 | epithelial tube morphogenesis |
| GO:0007420 | 0.00000 | 2.66913 | 18 | 44 | 624 | brain development |
| GO:0072078 | 0.00000 | 7.40035 | 2 | 14 | 79 | nephron tubule morphogenesis |
| GO:0009605 | 0.00000 | 1.81710 | 70 | 115 | 2429 | response to external stimulus |
| GO:0050679 | 0.00000 | 4.40212 | 6 | 22 | 195 | positive regulation of epithelial cell proliferation |
| GO:0009891 | 0.00000 | 1.91669 | 54 | 95 | 1889 | positive regulation of biosynthetic process |
| GO:0001823 | 0.00000 | 6.12013 | 3 | 16 | 106 | mesonephros development |
| GO:0010463 | 0.00000 | 9.14257 | 2 | 12 | 57 | mesenchymal cell proliferation |
| GO:0090263 | 0.00000 | 6.61374 | 3 | 15 | 93 | positive regulation of canonical Wnt signaling pathway |
| GO:0072088 | 0.00000 | 7.17881 | 2 | 14 | 81 | nephron epithelium morphogenesis |
| GO:0048709 | 0.00000 | 6.52973 | 3 | 15 | 94 | oligodendrocyte differentiation |
| GO:0032835 | 0.00000 | 8.94342 | 2 | 12 | 58 | glomerulus development |
| GO:1990845 | 0.00000 | 4.93121 | 4 | 19 | 152 | adaptive thermogenesis |
| GO:0072028 | 0.00000 | 7.07292 | 2 | 14 | 82 | nephron morphogenesis |
| GO:0071704 | 0.00000 | 1.51251 | 283 | 350 | 9839 | organic substance metabolic process |
| GO:0032268 | 0.00000 | 1.79546 | 71 | 115 | 2454 | regulation of cellular protein metabolic process |
| GO:0048568 | 0.00000 | 2.87127 | 14 | 37 | 488 | embryonic organ development |
| GO:0030036 | 0.00000 | 2.59559 | 18 | 44 | 640 | actin cytoskeleton organization |
| GO:0045665 | 0.00000 | 3.77059 | 7 | 25 | 255 | negative regulation of neuron differentiation |
| GO:0110110 | 0.00000 | 6.21394 | 3 | 15 | 98 | positive regulation of animal organ morphogenesis |
| GO:0106106 | 0.00000 | 5.04597 | 4 | 18 | 141 | cold-induced thermogenesis |
| GO:0120161 | 0.00000 | 5.04597 | 4 | 18 | 141 | regulation of cold-induced thermogenesis |
| GO:2000027 | 0.00000 | 4.13692 | 6 | 22 | 206 | regulation of animal organ morphogenesis |
| GO:0051046 | 0.00000 | 2.31724 | 25 | 54 | 878 | regulation of secretion |
| GO:0031346 | 0.00000 | 2.91849 | 13 | 35 | 454 | positive regulation of cell projection organization |
| GO:0030336 | 0.00000 | 3.67374 | 8 | 25 | 261 | negative regulation of cell migration |
| GO:0072132 | 0.00000 | 9.41603 | 1 | 11 | 51 | mesenchyme morphogenesis |
| GO:0007015 | 0.00000 | 3.06464 | 11 | 32 | 396 | actin filament organization |
| GO:0042592 | 0.00000 | 1.87947 | 53 | 92 | 1857 | homeostatic process |
| GO:0030500 | 0.00000 | 7.19424 | 2 | 13 | 75 | regulation of bone mineralization |
| GO:0007507 | 0.00000 | 2.59007 | 18 | 42 | 611 | heart development |
| GO:0003198 | 0.00000 | 23.85498 | 0 | 7 | 17 | epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:0030855 | 0.00000 | 2.57152 | 18 | 42 | 615 | epithelial cell differentiation |
| GO:0006935 | 0.00000 | 2.63941 | 16 | 40 | 571 | chemotaxis |
| GO:0009892 | 0.00000 | 1.71843 | 80 | 125 | 2787 | negative regulation of metabolic process |
| GO:0001657 | 0.00000 | 5.85957 | 3 | 15 | 103 | ureteric bud development |
| GO:0072163 | 0.00000 | 5.85957 | 3 | 15 | 103 | mesonephric epithelium development |
| GO:0072164 | 0.00000 | 5.85957 | 3 | 15 | 103 | mesonephric tubule development |
| GO:0030850 | 0.00000 | 8.96685 | 2 | 11 | 53 | prostate gland development |
| GO:0044281 | 0.00000 | 1.90512 | 49 | 86 | 1708 | small molecule metabolic process |
| GO:0042330 | 0.00000 | 2.62927 | 16 | 40 | 573 | taxis |
| GO:0050808 | 0.00000 | 2.94322 | 12 | 33 | 424 | synapse organization |
| GO:0007160 | 0.00000 | 4.09999 | 6 | 21 | 198 | cell-matrix adhesion |
| GO:0021700 | 0.00000 | 3.33590 | 9 | 27 | 308 | developmental maturation |
| GO:0048588 | 0.00000 | 3.64619 | 7 | 24 | 252 | developmental cell growth |
| GO:0030097 | 0.00000 | 2.25193 | 26 | 54 | 901 | hemopoiesis |
| GO:0030324 | 0.00000 | 3.90164 | 6 | 22 | 217 | lung development |
| GO:0048738 | 0.00000 | 3.63010 | 7 | 24 | 253 | cardiac muscle tissue development |
| GO:0035567 | 0.00000 | 8.55851 | 2 | 11 | 55 | non-canonical Wnt signaling pathway |
| GO:0002683 | 0.00000 | 2.82377 | 13 | 34 | 454 | negative regulation of immune system process |
| GO:0030323 | 0.00000 | 3.84201 | 6 | 22 | 220 | respiratory tube development |
| GO:0045935 | 0.00000 | 1.86417 | 51 | 88 | 1784 | positive regulation of nucleobase-containing compound metabolic process |
| GO:2000146 | 0.00000 | 3.46584 | 8 | 25 | 275 | negative regulation of cell motility |
| GO:1990138 | 0.00000 | 4.15913 | 5 | 20 | 186 | neuron projection extension |
| GO:0010769 | 0.00000 | 3.18877 | 10 | 28 | 333 | regulation of cell morphogenesis involved in differentiation |
| GO:0006629 | 0.00000 | 2.04118 | 36 | 67 | 1234 | lipid metabolic process |
| GO:0051254 | 0.00000 | 1.91042 | 46 | 81 | 1599 | positive regulation of RNA metabolic process |
| GO:0031324 | 0.00000 | 1.74521 | 69 | 110 | 2397 | negative regulation of cellular metabolic process |
| GO:0090100 | 0.00000 | 5.48409 | 3 | 15 | 109 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0014706 | 0.00000 | 2.83256 | 13 | 33 | 439 | striated muscle tissue development |
| GO:0045893 | 0.00000 | 1.93002 | 43 | 77 | 1502 | positive regulation of transcription, DNA-templated |
| GO:0045667 | 0.00000 | 4.75833 | 4 | 17 | 140 | regulation of osteoblast differentiation |
| GO:1903508 | 0.00000 | 1.92569 | 43 | 77 | 1505 | positive regulation of nucleic acid-templated transcription |
| GO:0045785 | 0.00000 | 2.93147 | 11 | 31 | 399 | positive regulation of cell adhesion |
| GO:1902680 | 0.00000 | 1.92425 | 43 | 77 | 1506 | positive regulation of RNA biosynthetic process |
| GO:0060560 | 0.00000 | 3.49142 | 8 | 24 | 262 | developmental growth involved in morphogenesis |
| GO:0060675 | 0.00000 | 7.08928 | 2 | 12 | 70 | ureteric bud morphogenesis |
| GO:0010557 | 0.00000 | 1.85091 | 50 | 86 | 1752 | positive regulation of macromolecule biosynthetic process |
| GO:0072171 | 0.00000 | 6.96881 | 2 | 12 | 71 | mesonephric tubule morphogenesis |
| GO:0048534 | 0.00000 | 2.16432 | 27 | 55 | 952 | hematopoietic or lymphoid organ development |
| GO:0045778 | 0.00000 | 5.72163 | 3 | 14 | 98 | positive regulation of ossification |
| GO:0044087 | 0.00000 | 2.17965 | 27 | 54 | 928 | regulation of cellular component biogenesis |
| GO:0045666 | 0.00000 | 2.77682 | 13 | 33 | 447 | positive regulation of neuron differentiation |
| GO:0019216 | 0.00000 | 3.15392 | 9 | 27 | 324 | regulation of lipid metabolic process |
| GO:0001659 | 0.00000 | 4.14633 | 5 | 19 | 177 | temperature homeostasis |
| GO:0031326 | 0.00000 | 1.62020 | 97 | 143 | 3386 | regulation of cellular biosynthetic process |
| GO:0060541 | 0.00000 | 3.52004 | 7 | 23 | 249 | respiratory system development |
| GO:0022612 | 0.00000 | 4.53580 | 4 | 17 | 146 | gland morphogenesis |
| GO:0048871 | 0.00000 | 2.69924 | 14 | 34 | 473 | multicellular organismal homeostasis |
| GO:0001958 | 0.00000 | 12.99561 | 1 | 8 | 29 | endochondral ossification |
| GO:0036075 | 0.00000 | 12.99561 | 1 | 8 | 29 | replacement ossification |
| GO:0009889 | 0.00000 | 1.60958 | 99 | 145 | 3456 | regulation of biosynthetic process |
| GO:0071695 | 0.00000 | 4.06852 | 5 | 19 | 180 | anatomical structure maturation |
| GO:0032101 | 0.00000 | 2.31796 | 21 | 45 | 726 | regulation of response to external stimulus |
| GO:0003014 | 0.00000 | 5.46058 | 3 | 14 | 102 | renal system process |
| GO:0002376 | 0.00000 | 1.68692 | 75 | 115 | 2588 | immune system process |
| GO:0080134 | 0.00000 | 1.98229 | 36 | 66 | 1247 | regulation of response to stress |
| GO:0051172 | 0.00000 | 1.73530 | 64 | 102 | 2222 | negative regulation of nitrogen compound metabolic process |
| GO:0014855 | 0.00000 | 6.52519 | 2 | 12 | 75 | striated muscle cell proliferation |
| GO:0045598 | 0.00000 | 4.70214 | 4 | 16 | 133 | regulation of fat cell differentiation |
| GO:0060317 | 0.00000 | 12.40435 | 1 | 8 | 30 | cardiac epithelial to mesenchymal transition |
| GO:0060415 | 0.00000 | 5.86533 | 3 | 13 | 89 | muscle tissue morphogenesis |
| GO:0043583 | 0.00000 | 3.53553 | 7 | 22 | 237 | ear development |
| GO:0060351 | 0.00000 | 8.33821 | 1 | 10 | 51 | cartilage development involved in endochondral bone morphogenesis |
| GO:0009880 | 0.00000 | 7.23924 | 2 | 11 | 63 | embryonic pattern specification |
| GO:0055008 | 0.00000 | 6.42295 | 2 | 12 | 76 | cardiac muscle tissue morphogenesis |
| GO:0014031 | 0.00000 | 5.78890 | 3 | 13 | 90 | mesenchymal cell development |
| GO:0032940 | 0.00000 | 2.07175 | 30 | 57 | 1028 | secretion by cell |
| GO:0051153 | 0.00000 | 4.90716 | 3 | 15 | 120 | regulation of striated muscle cell differentiation |
| GO:0032970 | 0.00000 | 2.88507 | 11 | 29 | 378 | regulation of actin filament-based process |
| GO:0001658 | 0.00000 | 7.10234 | 2 | 11 | 64 | branching involved in ureteric bud morphogenesis |
| GO:0006464 | 0.00000 | 1.59718 | 98 | 142 | 3400 | cellular protein modification process |
| GO:0036211 | 0.00000 | 1.59718 | 98 | 142 | 3400 | protein modification process |
| GO:1901564 | 0.00000 | 1.48029 | 176 | 230 | 6130 | organonitrogen compound metabolic process |
| GO:0032102 | 0.00000 | 3.07434 | 9 | 26 | 319 | negative regulation of response to external stimulus |
| GO:0001666 | 0.00000 | 3.72881 | 6 | 20 | 205 | response to hypoxia |
| GO:0060341 | 0.00000 | 2.11566 | 27 | 53 | 935 | regulation of cellular localization |
| GO:0033043 | 0.00000 | 1.97036 | 35 | 64 | 1214 | regulation of organelle organization |
| GO:0048640 | 0.00000 | 4.81501 | 4 | 15 | 122 | negative regulation of developmental growth |
| GO:0033036 | 0.00000 | 1.64206 | 81 | 122 | 2821 | macromolecule localization |
| GO:0010605 | 0.00000 | 1.67348 | 73 | 112 | 2533 | negative regulation of macromolecule metabolic process |
| GO:0006357 | 0.00000 | 1.76332 | 56 | 91 | 1941 | regulation of transcription by RNA polymerase II |
| GO:0006355 | 0.00000 | 1.64964 | 79 | 119 | 2736 | regulation of transcription, DNA-templated |
| GO:0071456 | 0.00000 | 5.57107 | 3 | 13 | 93 | cellular response to hypoxia |
| GO:0000122 | 0.00000 | 2.17035 | 24 | 49 | 842 | negative regulation of transcription by RNA polymerase II |
| GO:1903506 | 0.00000 | 1.64537 | 79 | 119 | 2742 | regulation of nucleic acid-templated transcription |
| GO:0010556 | 0.00000 | 1.59898 | 93 | 136 | 3242 | regulation of macromolecule biosynthetic process |
| GO:0010811 | 0.00000 | 4.72624 | 4 | 15 | 124 | positive regulation of cell-substrate adhesion |
| GO:0050680 | 0.00000 | 4.43531 | 4 | 16 | 140 | negative regulation of epithelial cell proliferation |
| GO:2000112 | 0.00000 | 1.60446 | 91 | 133 | 3156 | regulation of cellular macromolecule biosynthetic process |
| GO:0003416 | 0.00000 | 9.03850 | 1 | 9 | 43 | endochondral bone growth |
| GO:0055085 | 0.00000 | 1.94208 | 36 | 65 | 1250 | transmembrane transport |
| GO:0010628 | 0.00000 | 1.75643 | 55 | 90 | 1925 | positive regulation of gene expression |
| GO:2001141 | 0.00000 | 1.63971 | 79 | 119 | 2750 | regulation of RNA biosynthetic process |
| GO:0051493 | 0.00000 | 2.51913 | 15 | 35 | 519 | regulation of cytoskeleton organization |
| GO:0050922 | 0.00000 | 7.59568 | 2 | 10 | 55 | negative regulation of chemotaxis |
| GO:0060740 | 0.00000 | 10.91437 | 1 | 8 | 33 | prostate gland epithelium morphogenesis |
| GO:0060419 | 0.00000 | 5.00375 | 3 | 14 | 110 | heart growth |
| GO:0006082 | 0.00000 | 2.08368 | 27 | 53 | 948 | organic acid metabolic process |
| GO:0043436 | 0.00000 | 2.09711 | 27 | 52 | 924 | oxoacid metabolic process |
| GO:0048878 | 0.00000 | 1.97522 | 33 | 61 | 1152 | chemical homeostasis |
| GO:0003272 | 0.00000 | 14.02799 | 1 | 7 | 24 | endocardial cushion formation |
| GO:0035264 | 0.00000 | 3.57297 | 6 | 20 | 213 | multicellular organism growth |
| GO:0009611 | 0.00000 | 2.57386 | 14 | 33 | 479 | response to wounding |
| GO:0006811 | 0.00000 | 1.83773 | 44 | 75 | 1526 | ion transport |
| GO:0003006 | 0.00000 | 2.19041 | 23 | 46 | 782 | developmental process involved in reproduction |
| GO:0048644 | 0.00000 | 5.30484 | 3 | 13 | 97 | muscle organ morphogenesis |
| GO:0003203 | 0.00000 | 10.49412 | 1 | 8 | 34 | endocardial cushion morphogenesis |
| GO:0060512 | 0.00000 | 10.49412 | 1 | 8 | 34 | prostate gland morphogenesis |
| GO:0002520 | 0.00000 | 2.03410 | 29 | 55 | 1007 | immune system development |
| GO:0098868 | 0.00000 | 8.53561 | 1 | 9 | 45 | bone growth |
| GO:0006950 | 0.00000 | 1.56379 | 101 | 144 | 3512 | response to stress |
| GO:0019752 | 0.00000 | 2.10782 | 25 | 50 | 883 | carboxylic acid metabolic process |
| GO:0044260 | 0.00000 | 1.44360 | 201 | 254 | 6974 | cellular macromolecule metabolic process |
| GO:0043085 | 0.00000 | 2.01258 | 30 | 56 | 1036 | positive regulation of catalytic activity |
| GO:0045807 | 0.00001 | 4.00462 | 5 | 17 | 163 | positive regulation of endocytosis |
| GO:0007517 | 0.00001 | 2.67702 | 12 | 30 | 419 | muscle organ development |
| GO:0003422 | 0.00001 | 18.55944 | 0 | 6 | 17 | growth plate cartilage morphogenesis |
| GO:0048713 | 0.00001 | 8.30455 | 1 | 9 | 46 | regulation of oligodendrocyte differentiation |
| GO:0044093 | 0.00001 | 1.85441 | 41 | 70 | 1408 | positive regulation of molecular function |
| GO:0051336 | 0.00001 | 2.03858 | 28 | 53 | 967 | regulation of hydrolase activity |
| GO:0048645 | 0.00001 | 6.16869 | 2 | 11 | 72 | animal organ formation |
| GO:0045685 | 0.00001 | 5.55251 | 2 | 12 | 86 | regulation of glial cell differentiation |
| GO:0055017 | 0.00001 | 5.06281 | 3 | 13 | 101 | cardiac muscle tissue growth |
| GO:0001702 | 0.00001 | 9.74368 | 1 | 8 | 36 | gastrulation with mouth forming second |
| GO:0003417 | 0.00001 | 9.74368 | 1 | 8 | 36 | growth plate cartilage development |
| GO:0007010 | 0.00001 | 1.88983 | 37 | 65 | 1281 | cytoskeleton organization |
| GO:0048659 | 0.00001 | 3.89714 | 5 | 17 | 167 | smooth muscle cell proliferation |
| GO:0002062 | 0.00001 | 4.66224 | 3 | 14 | 117 | chondrocyte differentiation |
| GO:0006351 | 0.00001 | 1.60453 | 81 | 120 | 2826 | transcription, DNA-templated |
| GO:0043412 | 0.00001 | 1.54626 | 103 | 145 | 3571 | macromolecule modification |
| GO:0045892 | 0.00001 | 1.93592 | 33 | 60 | 1153 | negative regulation of transcription, DNA-templated |
| GO:0048844 | 0.00001 | 6.06893 | 2 | 11 | 73 | artery morphogenesis |
| GO:0060038 | 0.00001 | 6.83460 | 2 | 10 | 60 | cardiac muscle cell proliferation |
| GO:0019219 | 0.00001 | 1.56378 | 94 | 135 | 3276 | regulation of nucleobase-containing compound metabolic process |
| GO:0045834 | 0.00001 | 4.07192 | 4 | 16 | 151 | positive regulation of lipid metabolic process |
| GO:0007411 | 0.00001 | 3.39545 | 6 | 20 | 223 | axon guidance |
| GO:0048863 | 0.00001 | 3.39545 | 6 | 20 | 223 | stem cell differentiation |
| GO:0097659 | 0.00001 | 1.60050 | 82 | 120 | 2832 | nucleic acid-templated transcription |
| GO:1903507 | 0.00001 | 1.93035 | 33 | 60 | 1156 | negative regulation of nucleic acid-templated transcription |
| GO:0022414 | 0.00001 | 1.82732 | 42 | 71 | 1448 | reproductive process |
| GO:1902679 | 0.00001 | 1.92850 | 33 | 60 | 1157 | negative regulation of RNA biosynthetic process |
| GO:0034762 | 0.00001 | 2.40720 | 16 | 35 | 541 | regulation of transmembrane transport |
| GO:0000003 | 0.00001 | 1.82591 | 42 | 71 | 1449 | reproduction |
| GO:0006812 | 0.00001 | 1.96171 | 31 | 57 | 1080 | cation transport |
| GO:0097485 | 0.00001 | 3.37865 | 6 | 20 | 224 | neuron projection guidance |
| GO:0048846 | 0.00001 | 9.40727 | 1 | 8 | 37 | axon extension involved in axon guidance |
| GO:1902284 | 0.00001 | 9.40727 | 1 | 8 | 37 | neuron projection extension involved in neuron projection guidance |
| GO:0006366 | 0.00001 | 1.70298 | 58 | 91 | 2001 | transcription by RNA polymerase II |
| GO:0051347 | 0.00001 | 2.40235 | 16 | 35 | 542 | positive regulation of transferase activity |
| GO:0061311 | 0.00001 | 11.92221 | 1 | 7 | 27 | cell surface receptor signaling pathway involved in heart development |
| GO:0032147 | 0.00001 | 3.24757 | 7 | 21 | 244 | activation of protein kinase activity |
| GO:0032774 | 0.00001 | 1.59248 | 82 | 120 | 2844 | RNA biosynthetic process |
| GO:0044249 | 0.00001 | 1.47743 | 139 | 185 | 4824 | cellular biosynthetic process |
| GO:0019538 | 0.00001 | 1.46183 | 152 | 199 | 5268 | protein metabolic process |
| GO:0003229 | 0.00001 | 6.57115 | 2 | 10 | 62 | ventricular cardiac muscle tissue development |
| GO:0002573 | 0.00001 | 3.44308 | 6 | 19 | 209 | myeloid leukocyte differentiation |
| GO:0003413 | 0.00001 | 11.35398 | 1 | 7 | 28 | chondrocyte differentiation involved in endochondral bone morphogenesis |
| GO:0014014 | 0.00001 | 7.49302 | 1 | 9 | 50 | negative regulation of gliogenesis |
| GO:0010976 | 0.00001 | 2.77632 | 10 | 26 | 350 | positive regulation of neuron projection development |
| GO:0090288 | 0.00001 | 4.15175 | 4 | 15 | 139 | negative regulation of cellular response to growth factor stimulus |
| GO:0044255 | 0.00001 | 2.02686 | 26 | 50 | 915 | cellular lipid metabolic process |
| GO:0036293 | 0.00001 | 3.28124 | 7 | 20 | 230 | response to decreased oxygen levels |
| GO:0009058 | 0.00001 | 1.46459 | 144 | 190 | 5000 | biosynthetic process |
| GO:0002682 | 0.00001 | 1.81478 | 41 | 69 | 1414 | regulation of immune system process |
| GO:0014033 | 0.00001 | 5.13470 | 3 | 12 | 92 | neural crest cell differentiation |
| GO:0071772 | 0.00001 | 3.69849 | 5 | 17 | 175 | response to BMP |
| GO:0071773 | 0.00001 | 3.69849 | 5 | 17 | 175 | cellular response to BMP stimulus |
| GO:0007389 | 0.00001 | 2.49587 | 13 | 31 | 462 | pattern specification process |
| GO:0060412 | 0.00001 | 7.31429 | 1 | 9 | 51 | ventricular septum morphogenesis |
| GO:0032956 | 0.00001 | 2.81514 | 10 | 25 | 332 | regulation of actin cytoskeleton organization |
| GO:1901700 | 0.00001 | 1.77227 | 45 | 74 | 1554 | response to oxygen-containing compound |
| GO:0051147 | 0.00002 | 3.84275 | 5 | 16 | 159 | regulation of muscle cell differentiation |
| GO:0006807 | 0.00002 | 1.39593 | 252 | 305 | 8771 | nitrogen compound metabolic process |
| GO:1904705 | 0.00002 | 7.14387 | 1 | 9 | 52 | regulation of vascular smooth muscle cell proliferation |
| GO:1990874 | 0.00002 | 7.14387 | 1 | 9 | 52 | vascular smooth muscle cell proliferation |
| GO:0003208 | 0.00002 | 5.53196 | 2 | 11 | 79 | cardiac ventricle morphogenesis |
| GO:1903530 | 0.00002 | 2.08656 | 23 | 45 | 799 | regulation of secretion by cell |
| GO:0010817 | 0.00002 | 2.35858 | 15 | 34 | 535 | regulation of hormone levels |
| GO:0030279 | 0.00002 | 5.00902 | 3 | 12 | 94 | negative regulation of ossification |
| GO:0033674 | 0.00002 | 2.46669 | 13 | 31 | 467 | positive regulation of kinase activity |
| GO:0051253 | 0.00002 | 1.85651 | 36 | 62 | 1239 | negative regulation of RNA metabolic process |
| GO:0051051 | 0.00002 | 2.38280 | 15 | 33 | 514 | negative regulation of transport |
| GO:0003012 | 0.00002 | 2.64691 | 11 | 27 | 380 | muscle system process |
| GO:0090596 | 0.00002 | 2.90790 | 9 | 23 | 296 | sensory organ morphogenesis |
| GO:0044062 | 0.00002 | 10.36576 | 1 | 7 | 30 | regulation of excretion |
| GO:0061383 | 0.00002 | 6.98120 | 2 | 9 | 53 | trabecula morphogenesis |
| GO:0090101 | 0.00002 | 4.54418 | 3 | 13 | 111 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0048660 | 0.00002 | 3.76328 | 5 | 16 | 162 | regulation of smooth muscle cell proliferation |
| GO:0042391 | 0.00002 | 2.52429 | 12 | 29 | 427 | regulation of membrane potential |
| GO:0010631 | 0.00002 | 2.96385 | 8 | 22 | 278 | epithelial cell migration |
| GO:0007610 | 0.00002 | 2.14058 | 20 | 41 | 709 | behavior |
| GO:0003433 | 0.00002 | 13.60784 | 1 | 6 | 21 | chondrocyte development involved in endochondral bone morphogenesis |
| GO:0009725 | 0.00002 | 2.15822 | 20 | 40 | 686 | response to hormone |
| GO:0051252 | 0.00002 | 1.55126 | 86 | 123 | 2985 | regulation of RNA metabolic process |
| GO:0030509 | 0.00002 | 3.71210 | 5 | 16 | 164 | BMP signaling pathway |
| GO:0008154 | 0.00002 | 3.38249 | 6 | 18 | 201 | actin polymerization or depolymerization |
| GO:0031345 | 0.00002 | 3.38249 | 6 | 18 | 201 | negative regulation of cell projection organization |
| GO:0050770 | 0.00002 | 3.38249 | 6 | 18 | 201 | regulation of axonogenesis |
| GO:0060627 | 0.00002 | 2.31601 | 16 | 34 | 544 | regulation of vesicle-mediated transport |
| GO:0090132 | 0.00002 | 2.94061 | 8 | 22 | 280 | epithelium migration |
| GO:1902903 | 0.00002 | 2.71641 | 10 | 25 | 343 | regulation of supramolecular fiber organization |
| GO:0043549 | 0.00002 | 2.12745 | 21 | 41 | 713 | regulation of kinase activity |
| GO:0044092 | 0.00002 | 1.94362 | 28 | 52 | 990 | negative regulation of molecular function |
| GO:0010632 | 0.00002 | 3.23680 | 6 | 19 | 221 | regulation of epithelial cell migration |
| GO:0001837 | 0.00002 | 4.13735 | 4 | 14 | 130 | epithelial to mesenchymal transition |
| GO:0002064 | 0.00002 | 3.11639 | 7 | 20 | 241 | epithelial cell development |
| GO:0001558 | 0.00002 | 2.49241 | 12 | 29 | 432 | regulation of cell growth |
| GO:0010629 | 0.00003 | 1.70203 | 50 | 80 | 1748 | negative regulation of gene expression |
| GO:0001654 | 0.00003 | 2.58732 | 11 | 27 | 388 | eye development |
| GO:0150063 | 0.00003 | 2.58732 | 11 | 27 | 388 | visual system development |
| GO:0003206 | 0.00003 | 3.86925 | 4 | 15 | 148 | cardiac chamber morphogenesis |
| GO:0003231 | 0.00003 | 3.86925 | 4 | 15 | 148 | cardiac ventricle development |
| GO:0090130 | 0.00003 | 2.91773 | 8 | 22 | 282 | tissue migration |
| GO:0042060 | 0.00003 | 2.69919 | 10 | 25 | 345 | wound healing |
| GO:0000187 | 0.00003 | 4.36520 | 3 | 13 | 115 | activation of MAPK activity |
| GO:0003418 | 0.00003 | 12.75679 | 1 | 6 | 22 | growth plate cartilage chondrocyte differentiation |
| GO:0014015 | 0.00003 | 5.15191 | 2 | 11 | 84 | positive regulation of gliogenesis |
| GO:0048880 | 0.00003 | 2.56565 | 11 | 27 | 391 | sensory system development |
| GO:0070371 | 0.00003 | 2.67376 | 10 | 25 | 348 | ERK1 and ERK2 cascade |
| GO:0051338 | 0.00003 | 2.02807 | 24 | 45 | 820 | regulation of transferase activity |
| GO:0032787 | 0.00003 | 2.27942 | 16 | 34 | 552 | monocarboxylic acid metabolic process |
| GO:0008104 | 0.00003 | 1.58379 | 72 | 106 | 2504 | protein localization |
| GO:0048675 | 0.00003 | 4.03251 | 4 | 14 | 133 | axon extension |
| GO:0048771 | 0.00003 | 3.43558 | 5 | 17 | 187 | tissue remodeling |
| GO:0002521 | 0.00003 | 2.27044 | 16 | 34 | 554 | leukocyte differentiation |
| GO:0036294 | 0.00003 | 4.28087 | 3 | 13 | 117 | cellular response to decreased oxygen levels |
| GO:0003170 | 0.00003 | 6.39830 | 2 | 9 | 57 | heart valve development |
| GO:0031098 | 0.00003 | 2.85115 | 8 | 22 | 288 | stress-activated protein kinase signaling cascade |
| GO:0048841 | 0.00004 | 9.16849 | 1 | 7 | 33 | regulation of axon extension involved in axon guidance |
| GO:0003281 | 0.00004 | 5.01408 | 2 | 11 | 86 | ventricular septum development |
| GO:2000113 | 0.00004 | 1.77963 | 39 | 65 | 1352 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0010977 | 0.00004 | 3.54335 | 5 | 16 | 171 | negative regulation of neuron projection development |
| GO:0043269 | 0.00004 | 2.10125 | 20 | 40 | 703 | regulation of ion transport |
| GO:0048639 | 0.00004 | 3.23966 | 6 | 18 | 209 | positive regulation of developmental growth |
| GO:0010464 | 0.00004 | 7.37065 | 1 | 8 | 45 | regulation of mesenchymal cell proliferation |
| GO:1902667 | 0.00004 | 7.37065 | 1 | 8 | 45 | regulation of axon guidance |
| GO:0032870 | 0.00004 | 2.31188 | 15 | 32 | 512 | cellular response to hormone stimulus |
| GO:0008015 | 0.00004 | 2.38338 | 13 | 30 | 466 | blood circulation |
| GO:0031327 | 0.00004 | 1.75085 | 41 | 68 | 1438 | negative regulation of cellular biosynthetic process |
| GO:0010558 | 0.00004 | 1.76486 | 40 | 66 | 1384 | negative regulation of macromolecule biosynthetic process |
| GO:0014897 | 0.00004 | 4.51182 | 3 | 12 | 103 | striated muscle hypertrophy |
| GO:1901576 | 0.00004 | 1.43243 | 141 | 184 | 4910 | organic substance biosynthetic process |
| GO:0030308 | 0.00004 | 3.33668 | 6 | 17 | 192 | negative regulation of cell growth |
| GO:0071447 | 0.00004 | 33.93383 | 0 | 4 | 8 | cellular response to hydroperoxide |
| GO:0009798 | 0.00004 | 4.88341 | 3 | 11 | 88 | axis specification |
| GO:0001755 | 0.00004 | 6.14182 | 2 | 9 | 59 | neural crest cell migration |
| GO:0010812 | 0.00004 | 6.14182 | 2 | 9 | 59 | negative regulation of cell-substrate adhesion |
| GO:0010934 | 0.00005 | 16.98795 | 0 | 5 | 15 | macrophage cytokine production |
| GO:0032880 | 0.00005 | 1.89894 | 29 | 51 | 991 | regulation of protein localization |
| GO:0003181 | 0.00005 | 11.33836 | 1 | 6 | 24 | atrioventricular valve morphogenesis |
| GO:0033688 | 0.00005 | 11.33836 | 1 | 6 | 24 | regulation of osteoblast proliferation |
| GO:0034654 | 0.00005 | 1.50356 | 94 | 130 | 3250 | nucleobase-containing compound biosynthetic process |
| GO:0003205 | 0.00005 | 3.29868 | 6 | 17 | 194 | cardiac chamber development |
| GO:0060395 | 0.00005 | 4.82059 | 3 | 11 | 89 | SMAD protein signal transduction |
| GO:0003007 | 0.00005 | 2.85864 | 8 | 21 | 274 | heart morphogenesis |
| GO:0014896 | 0.00005 | 4.41440 | 3 | 12 | 105 | muscle hypertrophy |
| GO:0043010 | 0.00005 | 2.63736 | 10 | 24 | 338 | camera-type eye development |
| GO:0110053 | 0.00005 | 2.94154 | 7 | 20 | 254 | regulation of actin filament organization |
| GO:0008064 | 0.00005 | 3.43185 | 5 | 16 | 176 | regulation of actin polymerization or depolymerization |
| GO:0003179 | 0.00005 | 6.99205 | 1 | 8 | 47 | heart valve morphogenesis |
| GO:0003197 | 0.00005 | 6.99205 | 1 | 8 | 47 | endocardial cushion development |
| GO:0014888 | 0.00005 | 6.99205 | 1 | 8 | 47 | striated muscle adaptation |
| GO:0003013 | 0.00006 | 2.33423 | 14 | 30 | 475 | circulatory system process |
| GO:0045860 | 0.00006 | 2.40880 | 12 | 28 | 430 | positive regulation of protein kinase activity |
| GO:0010171 | 0.00006 | 5.90507 | 2 | 9 | 61 | body morphogenesis |
| GO:0010830 | 0.00006 | 5.90507 | 2 | 9 | 61 | regulation of myotube differentiation |
| GO:0045600 | 0.00006 | 5.90507 | 2 | 9 | 61 | positive regulation of fat cell differentiation |
| GO:0001935 | 0.00006 | 3.77715 | 4 | 14 | 141 | endothelial cell proliferation |
| GO:0014909 | 0.00006 | 4.69966 | 3 | 11 | 91 | smooth muscle cell migration |
| GO:0050873 | 0.00006 | 6.81694 | 1 | 8 | 48 | brown fat cell differentiation |
| GO:0060043 | 0.00006 | 6.81694 | 1 | 8 | 48 | regulation of cardiac muscle cell proliferation |
| GO:2000050 | 0.00006 | 10.74113 | 1 | 6 | 25 | regulation of non-canonical Wnt signaling pathway |
| GO:0030031 | 0.00006 | 2.27978 | 14 | 31 | 502 | cell projection assembly |
| GO:0061384 | 0.00006 | 8.21893 | 1 | 7 | 36 | heart trabecula morphogenesis |
| GO:0045765 | 0.00006 | 2.72661 | 9 | 22 | 300 | regulation of angiogenesis |
| GO:0007219 | 0.00006 | 3.36824 | 5 | 16 | 179 | Notch signaling pathway |
| GO:0030832 | 0.00006 | 3.36824 | 5 | 16 | 179 | regulation of actin filament length |
| GO:0003414 | 0.00007 | 15.44291 | 0 | 5 | 16 | chondrocyte morphogenesis involved in endochondral bone morphogenesis |
| GO:0003429 | 0.00007 | 15.44291 | 0 | 5 | 16 | growth plate cartilage chondrocyte morphogenesis |
| GO:0090171 | 0.00007 | 15.44291 | 0 | 5 | 16 | chondrocyte morphogenesis |
| GO:0030516 | 0.00007 | 4.27588 | 3 | 12 | 108 | regulation of axon extension |
| GO:0060393 | 0.00007 | 5.79340 | 2 | 9 | 62 | regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0007179 | 0.00007 | 3.52268 | 5 | 15 | 161 | transforming growth factor beta receptor signaling pathway |
| GO:0098742 | 0.00007 | 3.20734 | 6 | 17 | 199 | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:0030326 | 0.00007 | 3.71826 | 4 | 14 | 143 | embryonic limb morphogenesis |
| GO:0035113 | 0.00007 | 3.71826 | 4 | 14 | 143 | embryonic appendage morphogenesis |
| GO:0043406 | 0.00007 | 3.07710 | 6 | 18 | 219 | positive regulation of MAP kinase activity |
| GO:0045944 | 0.00007 | 1.79273 | 34 | 58 | 1193 | positive regulation of transcription by RNA polymerase II |
| GO:0071560 | 0.00007 | 3.18967 | 6 | 17 | 200 | cellular response to transforming growth factor beta stimulus |
| GO:0003002 | 0.00007 | 2.51560 | 11 | 25 | 368 | regionalization |
| GO:0071702 | 0.00008 | 1.55376 | 70 | 102 | 2444 | organic substance transport |
| GO:0002053 | 0.00008 | 7.94461 | 1 | 7 | 37 | positive regulation of mesenchymal cell proliferation |
| GO:0030501 | 0.00008 | 7.94461 | 1 | 7 | 37 | positive regulation of bone mineralization |
| GO:0018130 | 0.00008 | 1.48362 | 95 | 131 | 3313 | heterocycle biosynthetic process |
| GO:0051129 | 0.00008 | 2.02563 | 21 | 40 | 727 | negative regulation of cellular component organization |
| GO:0030099 | 0.00008 | 2.45308 | 11 | 26 | 392 | myeloid cell differentiation |
| GO:0060045 | 0.00008 | 10.20362 | 1 | 6 | 26 | positive regulation of cardiac muscle cell proliferation |
| GO:0042552 | 0.00008 | 3.66116 | 4 | 14 | 145 | myelination |
| GO:0030510 | 0.00008 | 4.52919 | 3 | 11 | 94 | regulation of BMP signaling pathway |
| GO:0040014 | 0.00008 | 4.52919 | 3 | 11 | 94 | regulation of multicellular organism growth |
| GO:0060021 | 0.00008 | 4.52919 | 3 | 11 | 94 | roof of mouth development |
| GO:0045934 | 0.00008 | 1.73222 | 39 | 64 | 1363 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0009948 | 0.00008 | 6.49175 | 1 | 8 | 50 | anterior/posterior axis specification |
| GO:0042551 | 0.00008 | 6.49175 | 1 | 8 | 50 | neuron maturation |
| GO:0060428 | 0.00008 | 6.49175 | 1 | 8 | 50 | lung epithelium development |
| GO:0009890 | 0.00008 | 1.70313 | 42 | 68 | 1474 | negative regulation of biosynthetic process |
| GO:1901362 | 0.00009 | 1.47155 | 99 | 135 | 3444 | organic cyclic compound biosynthetic process |
| GO:0043271 | 0.00009 | 3.42813 | 5 | 15 | 165 | negative regulation of ion transport |
| GO:0099173 | 0.00009 | 3.26726 | 5 | 16 | 184 | postsynapse organization |
| GO:0042493 | 0.00009 | 1.91244 | 25 | 46 | 885 | response to drug |
| GO:0019438 | 0.00009 | 1.47767 | 96 | 131 | 3324 | aromatic compound biosynthetic process |
| GO:0120162 | 0.00009 | 4.47507 | 3 | 11 | 95 | positive regulation of cold-induced thermogenesis |
| GO:0034220 | 0.00009 | 1.92499 | 25 | 45 | 860 | ion transmembrane transport |
| GO:0014734 | 0.00009 | 101.66216 | 0 | 3 | 4 | skeletal muscle hypertrophy |
| GO:0120031 | 0.00009 | 2.26160 | 14 | 30 | 489 | plasma membrane bounded cell projection assembly |
| GO:0001942 | 0.00009 | 4.10411 | 3 | 12 | 112 | hair follicle development |
| GO:0070372 | 0.00010 | 2.58191 | 9 | 23 | 330 | regulation of ERK1 and ERK2 cascade |
| GO:0001974 | 0.00010 | 6.34050 | 1 | 8 | 51 | blood vessel remodeling |
| GO:0060389 | 0.00010 | 5.48231 | 2 | 9 | 65 | pathway-restricted SMAD protein phosphorylation |
| GO:0071559 | 0.00010 | 3.10415 | 6 | 17 | 205 | response to transforming growth factor beta |
| GO:0003171 | 0.00010 | 9.71730 | 1 | 6 | 27 | atrioventricular valve development |
| GO:0033687 | 0.00010 | 9.71730 | 1 | 6 | 27 | osteoblast proliferation |
| GO:0048843 | 0.00010 | 9.71730 | 1 | 6 | 27 | negative regulation of axon extension involved in axon guidance |
| GO:0061041 | 0.00010 | 3.80301 | 4 | 13 | 130 | regulation of wound healing |
| GO:0071453 | 0.00010 | 3.80301 | 4 | 13 | 130 | cellular response to oxygen levels |
| GO:0007272 | 0.00010 | 3.57872 | 4 | 14 | 148 | ensheathment of neurons |
| GO:0008366 | 0.00010 | 3.57872 | 4 | 14 | 148 | axon ensheathment |
| GO:0043170 | 0.00010 | 1.34994 | 241 | 287 | 8357 | macromolecule metabolic process |
| GO:0008361 | 0.00010 | 3.08759 | 6 | 17 | 206 | regulation of cell size |
| GO:0048839 | 0.00010 | 3.08759 | 6 | 17 | 206 | inner ear development |
| GO:0060047 | 0.00010 | 3.08759 | 6 | 17 | 206 | heart contraction |
| GO:1901342 | 0.00010 | 2.56497 | 10 | 23 | 332 | regulation of vasculature development |
| GO:0010468 | 0.00011 | 1.44713 | 108 | 145 | 3768 | regulation of gene expression |
| GO:0010092 | 0.00011 | 7.44741 | 1 | 7 | 39 | specification of animal organ identity |
| GO:0098801 | 0.00011 | 7.44741 | 1 | 7 | 39 | regulation of renal system process |
| GO:0061035 | 0.00011 | 5.38589 | 2 | 9 | 66 | regulation of cartilage development |
| GO:0002040 | 0.00011 | 4.02328 | 3 | 12 | 114 | sprouting angiogenesis |
| GO:0098773 | 0.00011 | 4.02328 | 3 | 12 | 114 | skin epidermis development |
| GO:0021782 | 0.00012 | 4.32018 | 3 | 11 | 98 | glial cell development |
| GO:0055024 | 0.00012 | 4.32018 | 3 | 11 | 98 | regulation of cardiac muscle tissue development |
| GO:0022404 | 0.00012 | 3.98404 | 3 | 12 | 115 | molting cycle process |
| GO:0022405 | 0.00012 | 3.98404 | 3 | 12 | 115 | hair cycle process |
| GO:1902668 | 0.00012 | 9.27520 | 1 | 6 | 28 | negative regulation of axon guidance |
| GO:0060572 | 0.00012 | 13.06592 | 1 | 5 | 18 | morphogenesis of an epithelial bud |
| GO:0060688 | 0.00012 | 5.29279 | 2 | 9 | 67 | regulation of morphogenesis of a branching structure |
| GO:0045165 | 0.00013 | 2.74023 | 8 | 20 | 271 | cell fate commitment |
| GO:0048546 | 0.00013 | 6.05816 | 2 | 8 | 53 | digestive tract morphogenesis |
| GO:0048662 | 0.00013 | 6.05816 | 2 | 8 | 53 | negative regulation of smooth muscle cell proliferation |
| GO:0055010 | 0.00013 | 6.05816 | 2 | 8 | 53 | ventricular cardiac muscle tissue morphogenesis |
| GO:0099172 | 0.00013 | 6.05816 | 2 | 8 | 53 | presynapse organization |
| GO:0042692 | 0.00013 | 2.41542 | 11 | 25 | 382 | muscle cell differentiation |
| GO:0050920 | 0.00013 | 3.02305 | 6 | 17 | 210 | regulation of chemotaxis |
| GO:0003151 | 0.00013 | 4.67645 | 2 | 10 | 83 | outflow tract morphogenesis |
| GO:0048469 | 0.00014 | 3.13559 | 5 | 16 | 191 | cell maturation |
| GO:0046942 | 0.00014 | 2.63706 | 8 | 21 | 295 | carboxylic acid transport |
| GO:0015672 | 0.00015 | 2.27063 | 13 | 28 | 454 | monovalent inorganic cation transport |
| GO:0014910 | 0.00015 | 4.61305 | 2 | 10 | 84 | regulation of smooth muscle cell migration |
| GO:0015849 | 0.00015 | 2.62736 | 9 | 21 | 296 | organic acid transport |
| GO:0070306 | 0.00015 | 8.87153 | 1 | 6 | 29 | lens fiber cell differentiation |
| GO:0035107 | 0.00015 | 3.25340 | 5 | 15 | 173 | appendage morphogenesis |
| GO:0035108 | 0.00015 | 3.25340 | 5 | 15 | 173 | limb morphogenesis |
| GO:0009792 | 0.00015 | 1.92231 | 23 | 42 | 802 | embryo development ending in birth or egg hatching |
| GO:0060840 | 0.00016 | 4.17562 | 3 | 11 | 101 | artery development |
| GO:0051403 | 0.00016 | 2.76627 | 7 | 19 | 255 | stress-activated MAPK cascade |
| GO:0003214 | 0.00016 | 12.13210 | 1 | 5 | 19 | cardiac left ventricle morphogenesis |
| GO:0014032 | 0.00016 | 4.55134 | 2 | 10 | 85 | neural crest cell development |
| GO:0003015 | 0.00016 | 2.96114 | 6 | 17 | 214 | heart process |
| GO:0035270 | 0.00017 | 3.58721 | 4 | 13 | 137 | endocrine system development |
| GO:1901861 | 0.00017 | 3.21244 | 5 | 15 | 175 | regulation of muscle tissue development |
| GO:0060411 | 0.00018 | 4.49125 | 2 | 10 | 86 | cardiac septum morphogenesis |
| GO:0097581 | 0.00018 | 4.49125 | 2 | 10 | 86 | lamellipodium organization |
| GO:0022011 | 0.00018 | 8.50151 | 1 | 6 | 30 | myelination in peripheral nervous system |
| GO:0032292 | 0.00018 | 8.50151 | 1 | 6 | 30 | peripheral nervous system axon ensheathment |
| GO:0010770 | 0.00018 | 3.19235 | 5 | 15 | 176 | positive regulation of cell morphogenesis involved in differentiation |
| GO:0051146 | 0.00019 | 2.57986 | 9 | 21 | 301 | striated muscle cell differentiation |
| GO:0043009 | 0.00019 | 1.91792 | 23 | 41 | 784 | chordate embryonic development |
| GO:0007588 | 0.00019 | 5.67877 | 2 | 8 | 56 | excretion |
| GO:0043568 | 0.00019 | 19.38818 | 0 | 4 | 11 | positive regulation of insulin-like growth factor receptor signaling pathway |
| GO:0071864 | 0.00019 | 19.38818 | 0 | 4 | 11 | positive regulation of cell proliferation in bone marrow |
| GO:0055114 | 0.00019 | 1.82997 | 27 | 47 | 942 | oxidation-reduction process |
| GO:0001656 | 0.00020 | 4.43273 | 3 | 10 | 87 | metanephros development |
| GO:0008610 | 0.00020 | 2.12733 | 15 | 31 | 535 | lipid biosynthetic process |
| GO:0070482 | 0.00020 | 2.63406 | 8 | 20 | 281 | response to oxygen levels |
| GO:0051346 | 0.00020 | 2.34206 | 11 | 25 | 393 | negative regulation of hydrolase activity |
| GO:0043066 | 0.00021 | 1.82360 | 27 | 47 | 945 | negative regulation of apoptotic process |
| GO:0006631 | 0.00021 | 2.38300 | 11 | 24 | 371 | fatty acid metabolic process |
| GO:0022607 | 0.00022 | 1.48596 | 78 | 109 | 2723 | cellular component assembly |
| GO:0010922 | 0.00022 | 8.16109 | 1 | 6 | 31 | positive regulation of phosphatase activity |
| GO:0048736 | 0.00022 | 2.99745 | 6 | 16 | 199 | appendage development |
| GO:0060173 | 0.00022 | 2.99745 | 6 | 16 | 199 | limb development |
| GO:0014812 | 0.00022 | 3.99722 | 3 | 11 | 105 | muscle cell migration |
| GO:0045927 | 0.00022 | 2.54307 | 9 | 21 | 305 | positive regulation of growth |
| GO:0019233 | 0.00022 | 3.47449 | 4 | 13 | 141 | sensory perception of pain |
| GO:0032571 | 0.00023 | 50.82883 | 0 | 3 | 5 | response to vitamin K |
| GO:0045636 | 0.00023 | 50.82883 | 0 | 3 | 5 | positive regulation of melanocyte differentiation |
| GO:0070777 | 0.00023 | 50.82883 | 0 | 3 | 5 | D-aspartate transport |
| GO:0070779 | 0.00023 | 50.82883 | 0 | 3 | 5 | D-aspartate import across plasma membrane |
| GO:0044283 | 0.00023 | 2.03363 | 18 | 34 | 613 | small molecule biosynthetic process |
| GO:0061387 | 0.00023 | 3.69559 | 4 | 12 | 123 | regulation of extent of cell growth |
| GO:0016358 | 0.00023 | 2.60377 | 8 | 20 | 284 | dendrite development |
| GO:0003156 | 0.00024 | 6.43958 | 1 | 7 | 44 | regulation of animal organ formation |
| GO:1902904 | 0.00024 | 3.44740 | 4 | 13 | 142 | negative regulation of supramolecular fiber organization |
| GO:0007422 | 0.00024 | 4.79531 | 2 | 9 | 73 | peripheral nervous system development |
| GO:0030902 | 0.00024 | 3.26034 | 5 | 14 | 161 | hindbrain development |
| GO:0050803 | 0.00025 | 2.66358 | 8 | 19 | 264 | regulation of synapse structure or activity |
| GO:0007548 | 0.00026 | 2.58396 | 8 | 20 | 286 | sex differentiation |
| GO:0001701 | 0.00026 | 2.15405 | 14 | 29 | 494 | in utero embryonic development |
| GO:0030001 | 0.00026 | 1.87130 | 24 | 42 | 822 | metal ion transport |
| GO:0009059 | 0.00026 | 1.40550 | 116 | 151 | 4028 | macromolecule biosynthetic process |
| GO:0060977 | 0.00027 | 7.84685 | 1 | 6 | 32 | coronary vasculature morphogenesis |
| GO:0048286 | 0.00027 | 5.34401 | 2 | 8 | 59 | lung alveolus development |
| GO:0060324 | 0.00027 | 5.34401 | 2 | 8 | 59 | face development |
| GO:0048015 | 0.00028 | 3.39447 | 4 | 13 | 144 | phosphatidylinositol-mediated signaling |
| GO:0060323 | 0.00028 | 6.26984 | 1 | 7 | 45 | head morphogenesis |
| GO:0070169 | 0.00028 | 6.26984 | 1 | 7 | 45 | positive regulation of biomineral tissue development |
| GO:0050801 | 0.00028 | 1.87867 | 23 | 41 | 799 | ion homeostasis |
| GO:0048570 | 0.00028 | 16.96391 | 0 | 4 | 12 | notochord morphogenesis |
| GO:0071838 | 0.00028 | 16.96391 | 0 | 4 | 12 | cell proliferation in bone marrow |
| GO:0071863 | 0.00028 | 16.96391 | 0 | 4 | 12 | regulation of cell proliferation in bone marrow |
| GO:0050773 | 0.00028 | 3.05838 | 5 | 15 | 183 | regulation of dendrite development |
| GO:0120032 | 0.00028 | 3.05838 | 5 | 15 | 183 | regulation of plasma membrane bounded cell projection assembly |
| GO:0006954 | 0.00029 | 1.98404 | 19 | 35 | 646 | inflammatory response |
| GO:0048864 | 0.00029 | 4.21308 | 3 | 10 | 91 | stem cell development |
| GO:0060548 | 0.00029 | 1.75072 | 31 | 51 | 1067 | negative regulation of cell death |
| GO:0098655 | 0.00029 | 1.96137 | 19 | 36 | 672 | cation transmembrane transport |
| GO:0042445 | 0.00029 | 2.91708 | 6 | 16 | 204 | hormone metabolic process |
| GO:0097190 | 0.00030 | 2.02450 | 17 | 33 | 597 | apoptotic signaling pathway |
| GO:0043069 | 0.00030 | 1.79036 | 28 | 47 | 961 | negative regulation of programmed cell death |
| GO:0001936 | 0.00031 | 3.56641 | 4 | 12 | 127 | regulation of endothelial cell proliferation |
| GO:0045859 | 0.00031 | 1.97407 | 19 | 35 | 649 | regulation of protein kinase activity |
| GO:0060491 | 0.00032 | 3.02213 | 5 | 15 | 185 | regulation of cell projection assembly |
| GO:0001570 | 0.00032 | 4.16152 | 3 | 10 | 92 | vasculogenesis |
| GO:0014044 | 0.00032 | 7.55589 | 1 | 6 | 33 | Schwann cell development |
| GO:0045686 | 0.00032 | 7.55589 | 1 | 6 | 33 | negative regulation of glial cell differentiation |
| GO:0048009 | 0.00032 | 7.55589 | 1 | 6 | 33 | insulin-like growth factor receptor signaling pathway |
| GO:0003382 | 0.00032 | 6.10880 | 1 | 7 | 46 | epithelial cell morphogenesis |
| GO:0007157 | 0.00032 | 6.10880 | 1 | 7 | 46 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0030517 | 0.00032 | 6.10880 | 1 | 7 | 46 | negative regulation of axon extension |
| GO:0030900 | 0.00032 | 2.30864 | 11 | 24 | 382 | forebrain development |
| GO:0005975 | 0.00033 | 2.08939 | 15 | 30 | 526 | carbohydrate metabolic process |
| GO:0016525 | 0.00033 | 3.79450 | 3 | 11 | 110 | negative regulation of angiogenesis |
| GO:0048017 | 0.00034 | 3.31803 | 4 | 13 | 147 | inositol lipid-mediated signaling |
| GO:0009404 | 0.00034 | 9.98981 | 1 | 5 | 22 | toxin metabolic process |
| GO:0043567 | 0.00034 | 9.98981 | 1 | 5 | 22 | regulation of insulin-like growth factor receptor signaling pathway |
| GO:0044267 | 0.00034 | 1.37948 | 129 | 165 | 4494 | cellular protein metabolic process |
| GO:0072676 | 0.00034 | 4.11119 | 3 | 10 | 93 | lymphocyte migration |
| GO:0007163 | 0.00035 | 2.87087 | 6 | 16 | 207 | establishment or maintenance of cell polarity |
| GO:0033627 | 0.00035 | 5.14189 | 2 | 8 | 61 | cell adhesion mediated by integrin |
| GO:0009952 | 0.00035 | 2.76294 | 7 | 17 | 228 | anterior/posterior pattern specification |
| GO:0043405 | 0.00035 | 2.51692 | 8 | 20 | 293 | regulation of MAP kinase activity |
| GO:0007369 | 0.00035 | 3.13165 | 5 | 14 | 167 | gastrulation |
| GO:0099054 | 0.00037 | 5.95582 | 1 | 7 | 47 | presynapse assembly |
| GO:0120163 | 0.00037 | 5.95582 | 1 | 7 | 47 | negative regulation of cold-induced thermogenesis |
| GO:0034645 | 0.00037 | 1.39719 | 113 | 147 | 3933 | cellular macromolecule biosynthetic process |
| GO:0001890 | 0.00037 | 3.11117 | 5 | 14 | 168 | placenta development |
| GO:0045445 | 0.00038 | 4.06207 | 3 | 10 | 94 | myoblast differentiation |
| GO:0031069 | 0.00038 | 7.28571 | 1 | 6 | 34 | hair follicle morphogenesis |
| GO:0060326 | 0.00038 | 2.49839 | 8 | 20 | 295 | cell chemotaxis |
| GO:0032872 | 0.00039 | 2.73675 | 7 | 17 | 230 | regulation of stress-activated MAPK cascade |
| GO:0030178 | 0.00039 | 3.26894 | 4 | 13 | 149 | negative regulation of Wnt signaling pathway |
| GO:0046324 | 0.00039 | 5.04645 | 2 | 8 | 62 | regulation of glucose import |
| GO:0001892 | 0.00039 | 3.71903 | 3 | 11 | 112 | embryonic placenta development |
| GO:1903827 | 0.00039 | 2.09423 | 15 | 29 | 507 | regulation of cellular protein localization |
| GO:0007351 | 0.00040 | 15.07836 | 0 | 4 | 13 | tripartite regional subdivision |
| GO:0008595 | 0.00040 | 15.07836 | 0 | 4 | 13 | anterior/posterior axis specification, embryo |
| GO:0010935 | 0.00040 | 15.07836 | 0 | 4 | 13 | regulation of macrophage cytokine production |
| GO:0060601 | 0.00040 | 15.07836 | 0 | 4 | 13 | lateral sprouting from an epithelium |
| GO:0090331 | 0.00040 | 15.07836 | 0 | 4 | 13 | negative regulation of platelet aggregation |
| GO:0071902 | 0.00040 | 2.55798 | 8 | 19 | 274 | positive regulation of protein serine/threonine kinase activity |
| GO:0051047 | 0.00041 | 2.08977 | 15 | 29 | 508 | positive regulation of secretion |
| GO:0051494 | 0.00041 | 3.24494 | 4 | 13 | 150 | negative regulation of cytoskeleton organization |
| GO:0010862 | 0.00042 | 5.81029 | 1 | 7 | 48 | positive regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0022037 | 0.00042 | 3.68240 | 3 | 11 | 113 | metencephalon development |
| GO:2000181 | 0.00042 | 3.68240 | 3 | 11 | 113 | negative regulation of blood vessel morphogenesis |
| GO:0070302 | 0.00043 | 2.71105 | 7 | 17 | 232 | regulation of stress-activated protein kinase signaling cascade |
| GO:0045661 | 0.00043 | 4.95448 | 2 | 8 | 63 | regulation of myoblast differentiation |
| GO:0042303 | 0.00044 | 3.41705 | 4 | 12 | 132 | molting cycle |
| GO:0042633 | 0.00044 | 3.41705 | 4 | 12 | 132 | hair cycle |
| GO:0035909 | 0.00044 | 7.03417 | 1 | 6 | 35 | aorta morphogenesis |
| GO:0038031 | 0.00045 | 33.88438 | 0 | 3 | 6 | non-canonical Wnt signaling pathway via JNK cascade |
| GO:0060842 | 0.00045 | 33.88438 | 0 | 3 | 6 | arterial endothelial cell differentiation |
| GO:0061304 | 0.00045 | 33.88438 | 0 | 3 | 6 | retinal blood vessel morphogenesis |
| GO:0072602 | 0.00045 | 33.88438 | 0 | 3 | 6 | interleukin-4 secretion |
| GO:1905563 | 0.00045 | 33.88438 | 0 | 3 | 6 | negative regulation of vascular endothelial cell proliferation |
| GO:0046394 | 0.00045 | 2.34938 | 10 | 22 | 344 | carboxylic acid biosynthetic process |
| GO:0008406 | 0.00045 | 2.79701 | 6 | 16 | 212 | gonad development |
| GO:0032409 | 0.00046 | 2.60549 | 7 | 18 | 255 | regulation of transporter activity |
| GO:1902532 | 0.00046 | 2.07209 | 15 | 29 | 512 | negative regulation of intracellular signal transduction |
| GO:0002790 | 0.00046 | 1.97071 | 18 | 33 | 612 | peptide secretion |
| GO:0016053 | 0.00046 | 2.34200 | 10 | 22 | 345 | organic acid biosynthetic process |
| GO:0048593 | 0.00047 | 3.38866 | 4 | 12 | 133 | camera-type eye morphogenesis |
| GO:0006898 | 0.00047 | 2.78269 | 6 | 16 | 213 | receptor-mediated endocytosis |
| GO:0008016 | 0.00048 | 3.03187 | 5 | 14 | 172 | regulation of heart contraction |
| GO:0016202 | 0.00048 | 3.03187 | 5 | 14 | 172 | regulation of striated muscle tissue development |
| GO:0010563 | 0.00048 | 2.03893 | 15 | 30 | 538 | negative regulation of phosphorus metabolic process |
| GO:0045936 | 0.00048 | 2.03893 | 15 | 30 | 538 | negative regulation of phosphate metabolic process |
| GO:0050807 | 0.00050 | 2.58346 | 7 | 18 | 257 | regulation of synapse organization |
| GO:0050919 | 0.00052 | 6.79940 | 1 | 6 | 36 | negative chemotaxis |
| GO:0035813 | 0.00053 | 8.93746 | 1 | 5 | 24 | regulation of renal sodium excretion |
| GO:0060420 | 0.00053 | 4.26098 | 2 | 9 | 81 | regulation of heart growth |
| GO:0046677 | 0.00054 | 2.42689 | 9 | 20 | 303 | response to antibiotic |
| GO:0017145 | 0.00054 | 5.53956 | 1 | 7 | 50 | stem cell division |
| GO:0060736 | 0.00054 | 13.56992 | 0 | 4 | 14 | prostate gland growth |
| GO:0070307 | 0.00054 | 13.56992 | 0 | 4 | 14 | lens fiber cell development |
| GO:0050900 | 0.00054 | 2.36574 | 9 | 21 | 326 | leukocyte migration |
| GO:0045137 | 0.00055 | 2.74058 | 6 | 16 | 216 | development of primary sexual characteristics |
| GO:1990778 | 0.00056 | 2.35790 | 9 | 21 | 327 | protein localization to cell periphery |
| GO:0099175 | 0.00057 | 3.54281 | 3 | 11 | 117 | regulation of postsynapse organization |
| GO:0043086 | 0.00057 | 1.90388 | 19 | 35 | 671 | negative regulation of catalytic activity |
| GO:0048634 | 0.00060 | 2.95648 | 5 | 14 | 176 | regulation of muscle organ development |
| GO:0010831 | 0.00060 | 6.57977 | 1 | 6 | 37 | positive regulation of myotube differentiation |
| GO:0019934 | 0.00060 | 6.57977 | 1 | 6 | 37 | cGMP-mediated signaling |
| GO:0071320 | 0.00060 | 6.57977 | 1 | 6 | 37 | cellular response to cAMP |
| GO:0090090 | 0.00061 | 3.50954 | 3 | 11 | 118 | negative regulation of canonical Wnt signaling pathway |
| GO:0030901 | 0.00061 | 5.41342 | 1 | 7 | 51 | midbrain development |
| GO:0098657 | 0.00061 | 1.79993 | 24 | 41 | 831 | import into cell |
| GO:0009628 | 0.00063 | 1.71566 | 29 | 48 | 1021 | response to abiotic stimulus |
| GO:1901652 | 0.00063 | 2.28458 | 10 | 22 | 353 | response to peptide |
| GO:0010827 | 0.00063 | 4.14545 | 2 | 9 | 83 | regulation of glucose transmembrane transport |
| GO:0030903 | 0.00064 | 8.49021 | 1 | 5 | 25 | notochord development |
| GO:0035812 | 0.00064 | 8.49021 | 1 | 5 | 25 | renal sodium excretion |
| GO:0021549 | 0.00067 | 3.74844 | 3 | 10 | 101 | cerebellum development |
| GO:0061351 | 0.00067 | 2.92016 | 5 | 14 | 178 | neural precursor cell proliferation |
| GO:0030514 | 0.00069 | 5.29288 | 1 | 7 | 52 | negative regulation of BMP signaling pathway |
| GO:0000578 | 0.00070 | 6.37387 | 1 | 6 | 38 | embryonic axis specification |
| GO:0010878 | 0.00072 | 12.33575 | 0 | 4 | 15 | cholesterol storage |
| GO:0048715 | 0.00072 | 12.33575 | 0 | 4 | 15 | negative regulation of oligodendrocyte differentiation |
| GO:0050872 | 0.00072 | 12.33575 | 0 | 4 | 15 | white fat cell differentiation |
| GO:0071404 | 0.00072 | 12.33575 | 0 | 4 | 15 | cellular response to low-density lipoprotein particle stimulus |
| GO:1901213 | 0.00072 | 12.33575 | 0 | 4 | 15 | regulation of transcription from RNA polymerase II promoter involved in heart development |
| GO:0043473 | 0.00072 | 3.70753 | 3 | 10 | 102 | pigmentation |
| GO:0061053 | 0.00072 | 3.70753 | 3 | 10 | 102 | somite development |
| GO:0010633 | 0.00073 | 4.54060 | 2 | 8 | 68 | negative regulation of epithelial cell migration |
| GO:1903532 | 0.00073 | 2.09687 | 13 | 26 | 453 | positive regulation of secretion by cell |
| GO:0009636 | 0.00074 | 2.30445 | 10 | 21 | 334 | response to toxic substance |
| GO:0003160 | 0.00076 | 25.41216 | 0 | 3 | 7 | endocardium morphogenesis |
| GO:0038030 | 0.00076 | 25.41216 | 0 | 3 | 7 | non-canonical Wnt signaling pathway via MAPK cascade |
| GO:0042940 | 0.00076 | 25.41216 | 0 | 3 | 7 | D-amino acid transport |
| GO:0045634 | 0.00076 | 25.41216 | 0 | 3 | 7 | regulation of melanocyte differentiation |
| GO:0050942 | 0.00076 | 25.41216 | 0 | 3 | 7 | positive regulation of pigment cell differentiation |
| GO:0060385 | 0.00076 | 25.41216 | 0 | 3 | 7 | axonogenesis involved in innervation |
| GO:0060501 | 0.00076 | 25.41216 | 0 | 3 | 7 | positive regulation of epithelial cell proliferation involved in lung morphogenesis |
| GO:0061343 | 0.00076 | 25.41216 | 0 | 3 | 7 | cell adhesion involved in heart morphogenesis |
| GO:0022407 | 0.00077 | 2.20277 | 11 | 23 | 382 | regulation of cell-cell adhesion |
| GO:0003085 | 0.00078 | 8.08556 | 1 | 5 | 26 | negative regulation of systemic arterial blood pressure |
| GO:0030318 | 0.00078 | 8.08556 | 1 | 5 | 26 | melanocyte differentiation |
| GO:0060065 | 0.00078 | 8.08556 | 1 | 5 | 26 | uterus development |
| GO:0089718 | 0.00078 | 8.08556 | 1 | 5 | 26 | amino acid import across plasma membrane |
| GO:1903825 | 0.00078 | 3.66750 | 3 | 10 | 103 | organic acid transmembrane transport |
| GO:1905039 | 0.00078 | 3.66750 | 3 | 10 | 103 | carboxylic acid transmembrane transport |
| GO:1901701 | 0.00078 | 1.65246 | 34 | 53 | 1170 | cellular response to oxygen-containing compound |
| GO:0022408 | 0.00079 | 2.86732 | 5 | 14 | 181 | negative regulation of cell-cell adhesion |
| GO:0022898 | 0.00079 | 2.55499 | 7 | 17 | 245 | regulation of transmembrane transporter activity |
| GO:0051223 | 0.00080 | 1.86464 | 20 | 35 | 684 | regulation of protein transport |
| GO:0045669 | 0.00081 | 4.46596 | 2 | 8 | 69 | positive regulation of osteoblast differentiation |
| GO:0048730 | 0.00081 | 6.18045 | 1 | 6 | 39 | epidermis morphogenesis |
| GO:0051154 | 0.00081 | 6.18045 | 1 | 6 | 39 | negative regulation of striated muscle cell differentiation |
| GO:0060325 | 0.00081 | 6.18045 | 1 | 6 | 39 | face morphogenesis |
| GO:0010921 | 0.00081 | 3.38247 | 4 | 11 | 122 | regulation of phosphatase activity |
| GO:0007229 | 0.00082 | 3.98341 | 2 | 9 | 86 | integrin-mediated signaling pathway |
| GO:0042986 | 0.00083 | Inf | 0 | 2 | 2 | positive regulation of amyloid precursor protein biosynthetic process |
| GO:0060599 | 0.00083 | Inf | 0 | 2 | 2 | lateral sprouting involved in mammary gland duct morphogenesis |
| GO:0061344 | 0.00083 | Inf | 0 | 2 | 2 | regulation of cell adhesion involved in heart morphogenesis |
| GO:0062044 | 0.00083 | Inf | 0 | 2 | 2 | negative regulation of cardiac epithelial to mesenchymal transition |
| GO:0070778 | 0.00083 | Inf | 0 | 2 | 2 | L-aspartate transmembrane transport |
| GO:0140009 | 0.00083 | Inf | 0 | 2 | 2 | L-aspartate import across plasma membrane |
| GO:1901189 | 0.00083 | Inf | 0 | 2 | 2 | positive regulation of ephrin receptor signaling pathway |
| GO:1904397 | 0.00083 | Inf | 0 | 2 | 2 | negative regulation of neuromuscular junction development |
| GO:1904933 | 0.00083 | Inf | 0 | 2 | 2 | regulation of cell proliferation in midbrain |
| GO:1905006 | 0.00083 | Inf | 0 | 2 | 2 | negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:2000575 | 0.00083 | Inf | 0 | 2 | 2 | negative regulation of microtubule motor activity |
| GO:0008643 | 0.00085 | 3.15279 | 4 | 12 | 142 | carbohydrate transport |
| GO:0046890 | 0.00085 | 2.98200 | 5 | 13 | 162 | regulation of lipid biosynthetic process |
| GO:0035306 | 0.00087 | 5.06720 | 2 | 7 | 54 | positive regulation of dephosphorylation |
| GO:0048562 | 0.00087 | 2.32692 | 9 | 20 | 315 | embryonic organ morphogenesis |
| GO:0044271 | 0.00088 | 1.36605 | 113 | 144 | 3918 | cellular nitrogen compound biosynthetic process |
| GO:0001816 | 0.00088 | 1.83635 | 21 | 36 | 714 | cytokine production |
| GO:0033554 | 0.00089 | 1.53440 | 49 | 71 | 1692 | cellular response to stress |
| GO:1903034 | 0.00090 | 2.96199 | 5 | 13 | 163 | regulation of response to wounding |
| GO:0050708 | 0.00092 | 2.06239 | 13 | 26 | 460 | regulation of protein secretion |
| GO:0014037 | 0.00093 | 5.99840 | 1 | 6 | 40 | Schwann cell differentiation |
| GO:0048103 | 0.00093 | 7.71769 | 1 | 5 | 27 | somatic stem cell division |
| GO:0003222 | 0.00094 | 11.30727 | 0 | 4 | 16 | ventricular trabecula myocardium morphogenesis |
| GO:0048070 | 0.00094 | 11.30727 | 0 | 4 | 16 | regulation of developmental pigmentation |
| GO:0051127 | 0.00094 | 11.30727 | 0 | 4 | 16 | positive regulation of actin nucleation |
| GO:0060979 | 0.00094 | 11.30727 | 0 | 4 | 16 | vasculogenesis involved in coronary vascular morphogenesis |
| GO:0140058 | 0.00094 | 11.30727 | 0 | 4 | 16 | neuron projection arborization |
| GO:0016311 | 0.00094 | 2.21000 | 10 | 22 | 364 | dephosphorylation |
| GO:0005996 | 0.00094 | 2.51048 | 7 | 17 | 249 | monosaccharide metabolic process |
| GO:0010243 | 0.00095 | 1.75612 | 24 | 41 | 850 | response to organonitrogen compound |
| GO:2000401 | 0.00097 | 4.96142 | 2 | 7 | 55 | regulation of lymphocyte migration |
| GO:0008088 | 0.00097 | 4.32380 | 2 | 8 | 71 | axo-dendritic transport |
| GO:0046323 | 0.00097 | 4.32380 | 2 | 8 | 71 | glucose import |
| GO:0007626 | 0.00099 | 2.49960 | 7 | 17 | 250 | locomotory behavior |
| GO:1901343 | 0.00099 | 3.29302 | 4 | 11 | 125 | negative regulation of vasculature development |
| GO:0046328 | 0.00103 | 2.78335 | 5 | 14 | 186 | regulation of JNK cascade |
| GO:0001938 | 0.00105 | 3.83352 | 3 | 9 | 89 | positive regulation of endothelial cell proliferation |
| GO:0034446 | 0.00105 | 3.83352 | 3 | 9 | 89 | substrate adhesion-dependent cell spreading |
| GO:0055023 | 0.00106 | 5.82676 | 1 | 6 | 41 | positive regulation of cardiac muscle tissue growth |
| GO:0016051 | 0.00108 | 2.76714 | 5 | 14 | 187 | carbohydrate biosynthetic process |
| GO:0051098 | 0.00109 | 2.14211 | 11 | 23 | 392 | regulation of binding |
| GO:0001759 | 0.00110 | 7.38181 | 1 | 5 | 28 | organ induction |
| GO:0008045 | 0.00110 | 7.38181 | 1 | 5 | 28 | motor neuron axon guidance |
| GO:0030224 | 0.00110 | 7.38181 | 1 | 5 | 28 | monocyte differentiation |
| GO:0061082 | 0.00110 | 7.38181 | 1 | 5 | 28 | myeloid leukocyte cytokine production |
| GO:0098698 | 0.00110 | 7.38181 | 1 | 5 | 28 | postsynaptic specialization assembly |
| GO:1903131 | 0.00110 | 7.38181 | 1 | 5 | 28 | mononuclear cell differentiation |
| GO:0032271 | 0.00112 | 2.64542 | 6 | 15 | 209 | regulation of protein polymerization |
| GO:0090087 | 0.00113 | 1.80883 | 21 | 36 | 724 | regulation of peptide transport |
| GO:0090257 | 0.00113 | 2.54767 | 7 | 16 | 231 | regulation of muscle system process |
| GO:0002685 | 0.00114 | 2.75111 | 5 | 14 | 188 | regulation of leukocyte migration |
| GO:0071900 | 0.00115 | 2.09430 | 12 | 24 | 418 | regulation of protein serine/threonine kinase activity |
| GO:0046660 | 0.00115 | 3.03535 | 4 | 12 | 147 | female sex differentiation |
| GO:0001505 | 0.00116 | 2.17131 | 11 | 22 | 370 | regulation of neurotransmitter levels |
| GO:0072657 | 0.00117 | 1.96835 | 15 | 28 | 518 | protein localization to membrane |
| GO:0009306 | 0.00117 | 1.91896 | 16 | 30 | 569 | protein secretion |
| GO:0051155 | 0.00117 | 4.19039 | 2 | 8 | 73 | positive regulation of striated muscle cell differentiation |
| GO:0006813 | 0.00119 | 2.53576 | 7 | 16 | 232 | potassium ion transport |
| GO:0030100 | 0.00119 | 2.38183 | 8 | 18 | 277 | regulation of endocytosis |
| GO:0003190 | 0.00119 | 20.32883 | 0 | 3 | 8 | atrioventricular valve formation |
| GO:0048087 | 0.00119 | 20.32883 | 0 | 3 | 8 | positive regulation of developmental pigmentation |
| GO:1900454 | 0.00119 | 20.32883 | 0 | 3 | 8 | positive regulation of long-term synaptic depression |
| GO:1903236 | 0.00119 | 20.32883 | 0 | 3 | 8 | regulation of leukocyte tethering or rolling |
| GO:0007350 | 0.00120 | 10.43702 | 0 | 4 | 17 | blastoderm segmentation |
| GO:0016486 | 0.00120 | 10.43702 | 0 | 4 | 17 | peptide hormone processing |
| GO:0035988 | 0.00120 | 10.43702 | 0 | 4 | 17 | chondrocyte proliferation |
| GO:0040015 | 0.00120 | 10.43702 | 0 | 4 | 17 | negative regulation of multicellular organism growth |
| GO:0003279 | 0.00120 | 3.20815 | 4 | 11 | 128 | cardiac septum development |
| GO:0031128 | 0.00121 | 5.66466 | 1 | 6 | 42 | developmental induction |
| GO:1901617 | 0.00123 | 2.61819 | 6 | 15 | 211 | organic hydroxy compound biosynthetic process |
| GO:0032386 | 0.00124 | 2.04729 | 13 | 25 | 445 | regulation of intracellular transport |
| GO:0042326 | 0.00124 | 2.04729 | 13 | 25 | 445 | negative regulation of phosphorylation |
| GO:0032874 | 0.00126 | 2.84731 | 5 | 13 | 169 | positive regulation of stress-activated MAPK cascade |
| GO:0051641 | 0.00128 | 1.42576 | 73 | 98 | 2523 | cellular localization |
| GO:0002088 | 0.00128 | 4.12671 | 2 | 8 | 74 | lens development in camera-type eye |
| GO:0055021 | 0.00128 | 4.12671 | 2 | 8 | 74 | regulation of cardiac muscle tissue growth |
| GO:0035282 | 0.00129 | 3.40971 | 3 | 10 | 110 | segmentation |
| GO:0060571 | 0.00130 | 7.07392 | 1 | 5 | 29 | morphogenesis of an epithelial fold |
| GO:0061037 | 0.00130 | 7.07392 | 1 | 5 | 29 | negative regulation of cartilage development |
| GO:1905314 | 0.00130 | 7.07392 | 1 | 5 | 29 | semi-lunar valve development |
| GO:0071804 | 0.00133 | 2.70412 | 5 | 14 | 191 | cellular potassium ion transport |
| GO:0071805 | 0.00133 | 2.70412 | 5 | 14 | 191 | potassium ion transmembrane transport |
| GO:0070304 | 0.00133 | 2.82904 | 5 | 13 | 170 | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0002791 | 0.00136 | 1.97324 | 14 | 27 | 498 | regulation of peptide secretion |
| GO:0050906 | 0.00136 | 3.15396 | 4 | 11 | 130 | detection of stimulus involved in sensory perception |
| GO:0015711 | 0.00137 | 2.10157 | 11 | 23 | 399 | organic anion transport |
| GO:0001569 | 0.00137 | 5.51131 | 1 | 6 | 43 | branching involved in blood vessel morphogenesis |
| GO:0050974 | 0.00137 | 5.51131 | 1 | 6 | 43 | detection of mechanical stimulus involved in sensory perception |
| GO:0098739 | 0.00139 | 3.37580 | 3 | 10 | 111 | import across plasma membrane |
| GO:1905330 | 0.00139 | 3.37580 | 3 | 10 | 111 | regulation of morphogenesis of an epithelium |
| GO:1900076 | 0.00140 | 4.06494 | 2 | 8 | 75 | regulation of cellular response to insulin stimulus |
| GO:0030041 | 0.00140 | 2.81101 | 5 | 13 | 171 | actin filament polymerization |
| GO:0009100 | 0.00145 | 2.27755 | 9 | 19 | 305 | glycoprotein metabolic process |
| GO:0006109 | 0.00148 | 2.79321 | 5 | 13 | 172 | regulation of carbohydrate metabolic process |
| GO:0048592 | 0.00148 | 2.79321 | 5 | 13 | 172 | eye morphogenesis |
| GO:0060711 | 0.00148 | 4.57896 | 2 | 7 | 59 | labyrinthine layer development |
| GO:0032412 | 0.00148 | 2.47784 | 7 | 16 | 237 | regulation of ion transmembrane transporter activity |
| GO:0010638 | 0.00149 | 1.88667 | 17 | 30 | 578 | positive regulation of organelle organization |
| GO:0010544 | 0.00151 | 9.69108 | 1 | 4 | 18 | negative regulation of platelet activation |
| GO:0022010 | 0.00151 | 9.69108 | 1 | 4 | 18 | central nervous system myelination |
| GO:0032291 | 0.00151 | 9.69108 | 1 | 4 | 18 | axon ensheathment in central nervous system |
| GO:0034111 | 0.00151 | 9.69108 | 1 | 4 | 18 | negative regulation of homotypic cell-cell adhesion |
| GO:1904706 | 0.00151 | 9.69108 | 1 | 4 | 18 | negative regulation of vascular smooth muscle cell proliferation |
| GO:0030193 | 0.00152 | 4.00498 | 2 | 8 | 76 | regulation of blood coagulation |
| GO:0033273 | 0.00153 | 6.79066 | 1 | 5 | 30 | response to vitamin |
| GO:0043090 | 0.00153 | 6.79066 | 1 | 5 | 30 | amino acid import |
| GO:0099560 | 0.00153 | 6.79066 | 1 | 5 | 30 | synaptic membrane adhesion |
| GO:0043542 | 0.00154 | 2.65869 | 6 | 14 | 194 | endothelial cell migration |
| GO:0002063 | 0.00155 | 5.36604 | 1 | 6 | 44 | chondrocyte development |
| GO:0035088 | 0.00155 | 5.36604 | 1 | 6 | 44 | establishment or maintenance of apical/basal cell polarity |
| GO:0060421 | 0.00155 | 5.36604 | 1 | 6 | 44 | positive regulation of heart growth |
| GO:0061245 | 0.00155 | 5.36604 | 1 | 6 | 44 | establishment or maintenance of bipolar cell polarity |
| GO:0043270 | 0.00156 | 2.26153 | 9 | 19 | 307 | positive regulation of ion transport |
| GO:0034765 | 0.00158 | 2.00829 | 13 | 25 | 453 | regulation of ion transmembrane transport |
| GO:0044085 | 0.00158 | 1.38811 | 85 | 111 | 2940 | cellular component biogenesis |
| GO:0008585 | 0.00159 | 3.30996 | 3 | 10 | 113 | female gonad development |
| GO:0043500 | 0.00159 | 3.30996 | 3 | 10 | 113 | muscle adaptation |
| GO:0015850 | 0.00161 | 2.45539 | 7 | 16 | 239 | organic hydroxy compound transport |
| GO:0003008 | 0.00162 | 1.39074 | 83 | 109 | 2880 | system process |
| GO:0010594 | 0.00162 | 2.90540 | 4 | 12 | 153 | regulation of endothelial cell migration |
| GO:0034764 | 0.00163 | 2.53974 | 6 | 15 | 217 | positive regulation of transmembrane transport |
| GO:0051926 | 0.00163 | 4.49236 | 2 | 7 | 60 | negative regulation of calcium ion transport |
| GO:0055123 | 0.00164 | 3.07599 | 4 | 11 | 133 | digestive system development |
| GO:0051781 | 0.00166 | 3.94676 | 2 | 8 | 77 | positive regulation of cell division |
| GO:1900046 | 0.00166 | 3.94676 | 2 | 8 | 77 | regulation of hemostasis |
| GO:0070201 | 0.00167 | 1.77981 | 21 | 35 | 714 | regulation of establishment of protein localization |
| GO:0002274 | 0.00169 | 2.62924 | 6 | 14 | 196 | myeloid leukocyte activation |
| GO:0008217 | 0.00169 | 2.62924 | 6 | 14 | 196 | regulation of blood pressure |
| GO:0062012 | 0.00170 | 2.19133 | 10 | 20 | 333 | regulation of small molecule metabolic process |
| GO:1902743 | 0.00174 | 5.22822 | 1 | 6 | 45 | regulation of lamellipodium organization |
| GO:0003139 | 0.00175 | 16.93994 | 0 | 3 | 9 | secondary heart field specification |
| GO:0010692 | 0.00175 | 16.93994 | 0 | 3 | 9 | regulation of alkaline phosphatase activity |
| GO:0050932 | 0.00175 | 16.93994 | 0 | 3 | 9 | regulation of pigment cell differentiation |
| GO:0060837 | 0.00175 | 16.93994 | 0 | 3 | 9 | blood vessel endothelial cell differentiation |
| GO:0062042 | 0.00175 | 16.93994 | 0 | 3 | 9 | regulation of cardiac epithelial to mesenchymal transition |
| GO:2000794 | 0.00175 | 16.93994 | 0 | 3 | 9 | regulation of epithelial cell proliferation involved in lung morphogenesis |
| GO:0090162 | 0.00178 | 6.52919 | 1 | 5 | 31 | establishment of epithelial cell polarity |
| GO:0019748 | 0.00180 | 4.40897 | 2 | 7 | 61 | secondary metabolic process |
| GO:0045668 | 0.00180 | 4.40897 | 2 | 7 | 61 | negative regulation of osteoblast differentiation |
| GO:0048708 | 0.00180 | 3.89021 | 2 | 8 | 78 | astrocyte differentiation |
| GO:0060976 | 0.00180 | 3.89021 | 2 | 8 | 78 | coronary vasculature development |
| GO:0072089 | 0.00185 | 3.02611 | 4 | 11 | 135 | stem cell proliferation |
| GO:0010766 | 0.00187 | 9.04461 | 1 | 4 | 19 | negative regulation of sodium ion transport |
| GO:0032823 | 0.00187 | 9.04461 | 1 | 4 | 19 | regulation of natural killer cell differentiation |
| GO:0033194 | 0.00187 | 9.04461 | 1 | 4 | 19 | response to hydroperoxide |
| GO:0035690 | 0.00188 | 2.12522 | 10 | 21 | 360 | cellular response to drug |
| GO:0030833 | 0.00191 | 2.84450 | 4 | 12 | 156 | regulation of actin filament polymerization |
| GO:0097237 | 0.00191 | 2.84450 | 4 | 12 | 156 | cellular response to toxic substance |
| GO:1901653 | 0.00192 | 2.33731 | 8 | 17 | 266 | cellular response to peptide |
| GO:0046545 | 0.00193 | 3.21585 | 3 | 10 | 116 | development of primary female sexual characteristics |
| GO:0001817 | 0.00195 | 1.81153 | 18 | 32 | 641 | regulation of cytokine production |
| GO:0035904 | 0.00198 | 4.32862 | 2 | 7 | 62 | aorta development |
| GO:0007254 | 0.00204 | 2.57224 | 6 | 14 | 200 | JNK cascade |
| GO:0060669 | 0.00206 | 6.28709 | 1 | 5 | 32 | embryonic placenta morphogenesis |
| GO:0003073 | 0.00206 | 3.18565 | 3 | 10 | 117 | regulation of systemic arterial blood pressure |
| GO:0023061 | 0.00207 | 1.91104 | 15 | 27 | 513 | signal release |
| GO:0050772 | 0.00208 | 3.44448 | 3 | 9 | 98 | positive regulation of axonogenesis |
| GO:0035050 | 0.00212 | 3.78181 | 2 | 8 | 80 | embryonic heart tube development |
| GO:0050818 | 0.00212 | 3.78181 | 2 | 8 | 80 | regulation of coagulation |
| GO:0003407 | 0.00217 | 4.25113 | 2 | 7 | 63 | neural retina development |
| GO:0001889 | 0.00219 | 3.15602 | 3 | 10 | 118 | liver development |
| GO:0048706 | 0.00220 | 2.95423 | 4 | 11 | 138 | embryonic skeletal system development |
| GO:0035051 | 0.00221 | 2.65845 | 5 | 13 | 180 | cardiocyte differentiation |
| GO:0030705 | 0.00224 | 2.78607 | 5 | 12 | 159 | cytoskeleton-dependent intracellular transport |
| GO:0048511 | 0.00225 | 2.29994 | 8 | 17 | 270 | rhythmic process |
| GO:0051258 | 0.00225 | 2.29994 | 8 | 17 | 270 | protein polymerization |
| GO:0043254 | 0.00226 | 1.98157 | 13 | 24 | 440 | regulation of protein complex assembly |
| GO:0003177 | 0.00228 | 8.47895 | 1 | 4 | 20 | pulmonary valve development |
| GO:0033605 | 0.00228 | 8.47895 | 1 | 4 | 20 | positive regulation of catecholamine secretion |
| GO:0070977 | 0.00228 | 8.47895 | 1 | 4 | 20 | bone maturation |
| GO:0090330 | 0.00228 | 8.47895 | 1 | 4 | 20 | regulation of platelet aggregation |
| GO:0008593 | 0.00229 | 3.72984 | 2 | 8 | 81 | regulation of Notch signaling pathway |
| GO:0016331 | 0.00232 | 2.64251 | 5 | 13 | 181 | morphogenesis of embryonic epithelium |
| GO:0032869 | 0.00232 | 2.64251 | 5 | 13 | 181 | cellular response to insulin stimulus |
| GO:0043491 | 0.00232 | 2.64251 | 5 | 13 | 181 | protein kinase B signaling |
| GO:0051048 | 0.00234 | 2.35919 | 7 | 16 | 248 | negative regulation of secretion |
| GO:0072330 | 0.00234 | 2.35919 | 7 | 16 | 248 | monocarboxylic acid biosynthetic process |
| GO:0034641 | 0.00236 | 1.29040 | 156 | 188 | 5435 | cellular nitrogen compound metabolic process |
| GO:0010737 | 0.00237 | 6.06228 | 1 | 5 | 33 | protein kinase A signaling |
| GO:0050766 | 0.00238 | 4.17637 | 2 | 7 | 64 | positive regulation of phagocytosis |
| GO:0003300 | 0.00239 | 3.36848 | 3 | 9 | 100 | cardiac muscle hypertrophy |
| GO:0002930 | 0.00244 | 67.67316 | 0 | 2 | 3 | trabecular meshwork development |
| GO:0003213 | 0.00244 | 67.67316 | 0 | 2 | 3 | cardiac right atrium morphogenesis |
| GO:0045726 | 0.00244 | 67.67316 | 0 | 2 | 3 | positive regulation of integrin biosynthetic process |
| GO:0055095 | 0.00244 | 67.67316 | 0 | 2 | 3 | lipoprotein particle mediated signaling |
| GO:0055096 | 0.00244 | 67.67316 | 0 | 2 | 3 | low-density lipoprotein particle mediated signaling |
| GO:0061144 | 0.00244 | 67.67316 | 0 | 2 | 3 | alveolar secondary septum development |
| GO:0071603 | 0.00244 | 67.67316 | 0 | 2 | 3 | endothelial cell-cell adhesion |
| GO:0072138 | 0.00244 | 67.67316 | 0 | 2 | 3 | mesenchymal cell proliferation involved in ureteric bud development |
| GO:1900275 | 0.00244 | 67.67316 | 0 | 2 | 3 | negative regulation of phospholipase C activity |
| GO:1901187 | 0.00244 | 67.67316 | 0 | 2 | 3 | regulation of ephrin receptor signaling pathway |
| GO:1904457 | 0.00244 | 67.67316 | 0 | 2 | 3 | positive regulation of neuronal action potential |
| GO:1990523 | 0.00244 | 67.67316 | 0 | 2 | 3 | bone regeneration |
| GO:0055082 | 0.00244 | 1.70796 | 23 | 37 | 785 | cellular chemical homeostasis |
| GO:0003149 | 0.00245 | 14.51931 | 0 | 3 | 10 | membranous septum morphogenesis |
| GO:0051639 | 0.00245 | 14.51931 | 0 | 3 | 10 | actin filament network formation |
| GO:0060513 | 0.00245 | 14.51931 | 0 | 3 | 10 | prostatic bud formation |
| GO:0061626 | 0.00245 | 14.51931 | 0 | 3 | 10 | pharyngeal arch artery morphogenesis |
| GO:0072017 | 0.00245 | 14.51931 | 0 | 3 | 10 | distal tubule development |
| GO:0072070 | 0.00245 | 14.51931 | 0 | 3 | 10 | loop of Henle development |
| GO:0090009 | 0.00245 | 14.51931 | 0 | 3 | 10 | primitive streak formation |
| GO:0014065 | 0.00248 | 3.09836 | 3 | 10 | 120 | phosphatidylinositol 3-kinase signaling |
| GO:0046717 | 0.00248 | 3.09836 | 3 | 10 | 120 | acid secretion |
| GO:0048565 | 0.00248 | 3.09836 | 3 | 10 | 120 | digestive tract development |
| GO:0017015 | 0.00256 | 3.33172 | 3 | 9 | 101 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0006855 | 0.00260 | 4.10418 | 2 | 7 | 65 | drug transmembrane transport |
| GO:0051591 | 0.00260 | 4.10418 | 2 | 7 | 65 | response to cAMP |
| GO:0048545 | 0.00263 | 2.40740 | 7 | 15 | 228 | response to steroid hormone |
| GO:0061008 | 0.00264 | 3.07031 | 3 | 10 | 121 | hepaticobiliary system development |
| GO:0008544 | 0.00267 | 2.14812 | 9 | 19 | 322 | epidermis development |
| GO:0098662 | 0.00267 | 1.80879 | 17 | 30 | 601 | inorganic cation transmembrane transport |
| GO:1901379 | 0.00268 | 3.63006 | 2 | 8 | 83 | regulation of potassium ion transmembrane transport |
| GO:0070727 | 0.00270 | 1.47754 | 47 | 67 | 1648 | cellular macromolecule localization |
| GO:0099068 | 0.00271 | 5.85298 | 1 | 5 | 34 | postsynapse assembly |
| GO:1904707 | 0.00271 | 5.85298 | 1 | 5 | 34 | positive regulation of vascular smooth muscle cell proliferation |
| GO:0010596 | 0.00272 | 4.74103 | 1 | 6 | 49 | negative regulation of endothelial cell migration |
| GO:0042136 | 0.00273 | 3.29575 | 3 | 9 | 102 | neurotransmitter biosynthetic process |
| GO:0098771 | 0.00274 | 1.72222 | 21 | 35 | 736 | inorganic ion homeostasis |
| GO:0046330 | 0.00275 | 2.86351 | 4 | 11 | 142 | positive regulation of JNK cascade |
| GO:0035303 | 0.00275 | 2.71178 | 5 | 12 | 163 | regulation of dephosphorylation |
| GO:0043501 | 0.00276 | 7.97983 | 1 | 4 | 21 | skeletal muscle adaptation |
| GO:0097107 | 0.00276 | 7.97983 | 1 | 4 | 21 | postsynaptic density assembly |
| GO:0101023 | 0.00276 | 7.97983 | 1 | 4 | 21 | vascular endothelial cell proliferation |
| GO:1901522 | 0.00276 | 7.97983 | 1 | 4 | 21 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus |
| GO:1905562 | 0.00276 | 7.97983 | 1 | 4 | 21 | regulation of vascular endothelial cell proliferation |
| GO:0007492 | 0.00284 | 4.03444 | 2 | 7 | 66 | endoderm development |
| GO:1904062 | 0.00285 | 2.13385 | 9 | 19 | 324 | regulation of cation transmembrane transport |
| GO:0051222 | 0.00287 | 1.97334 | 12 | 23 | 423 | positive regulation of protein transport |
| GO:0045844 | 0.00289 | 3.58213 | 2 | 8 | 84 | positive regulation of striated muscle tissue development |
| GO:0048636 | 0.00289 | 3.58213 | 2 | 8 | 84 | positive regulation of muscle organ development |
| GO:0030879 | 0.00289 | 2.69382 | 5 | 12 | 164 | mammary gland development |
| GO:1900006 | 0.00292 | 3.26054 | 3 | 9 | 103 | positive regulation of dendrite development |
| GO:1903844 | 0.00292 | 3.26054 | 3 | 9 | 103 | regulation of cellular response to transforming growth factor beta stimulus |
| GO:0043268 | 0.00301 | 4.63307 | 1 | 6 | 50 | positive regulation of potassium ion transport |
| GO:0030183 | 0.00306 | 2.82020 | 4 | 11 | 144 | B cell differentiation |
| GO:0042311 | 0.00309 | 5.65763 | 1 | 5 | 35 | vasodilation |
| GO:0048147 | 0.00309 | 5.65763 | 1 | 5 | 35 | negative regulation of fibroblast proliferation |
| GO:0034109 | 0.00309 | 3.96702 | 2 | 7 | 67 | homotypic cell-cell adhesion |
| GO:0050771 | 0.00309 | 3.96702 | 2 | 7 | 67 | negative regulation of axonogenesis |
| GO:0061045 | 0.00309 | 3.96702 | 2 | 7 | 67 | negative regulation of wound healing |
| GO:1903522 | 0.00310 | 2.36260 | 7 | 15 | 232 | regulation of blood circulation |
| GO:0015908 | 0.00311 | 3.53545 | 2 | 8 | 85 | fatty acid transport |
| GO:1901863 | 0.00311 | 3.53545 | 2 | 8 | 85 | positive regulation of muscle tissue development |
| GO:0043266 | 0.00312 | 3.22608 | 3 | 9 | 104 | regulation of potassium ion transport |
| GO:0045446 | 0.00312 | 3.22608 | 3 | 9 | 104 | endothelial cell differentiation |
| GO:0030595 | 0.00319 | 2.43991 | 6 | 14 | 210 | leukocyte chemotaxis |
| GO:0042593 | 0.00321 | 2.27973 | 7 | 16 | 256 | glucose homeostasis |
| GO:0043434 | 0.00328 | 2.15436 | 9 | 18 | 304 | response to peptide hormone |
| GO:0014912 | 0.00329 | 7.53617 | 1 | 4 | 22 | negative regulation of smooth muscle cell migration |
| GO:0060390 | 0.00329 | 7.53617 | 1 | 4 | 22 | regulation of SMAD protein signal transduction |
| GO:0060749 | 0.00329 | 7.53617 | 1 | 4 | 22 | mammary gland alveolus development |
| GO:0061377 | 0.00329 | 7.53617 | 1 | 4 | 22 | mammary gland lobule development |
| GO:0085029 | 0.00329 | 7.53617 | 1 | 4 | 22 | extracellular matrix assembly |
| GO:0002921 | 0.00330 | 12.70383 | 0 | 3 | 11 | negative regulation of humoral immune response |
| GO:0003306 | 0.00330 | 12.70383 | 0 | 3 | 11 | Wnt signaling pathway involved in heart development |
| GO:0038063 | 0.00330 | 12.70383 | 0 | 3 | 11 | collagen-activated tyrosine kinase receptor signaling pathway |
| GO:0097264 | 0.00330 | 12.70383 | 0 | 3 | 11 | self proteolysis |
| GO:0098935 | 0.00330 | 12.70383 | 0 | 3 | 11 | dendritic transport |
| GO:0038127 | 0.00332 | 3.19233 | 3 | 9 | 105 | ERBB signaling pathway |
| GO:0048661 | 0.00332 | 3.19233 | 3 | 9 | 105 | positive regulation of smooth muscle cell proliferation |
| GO:1904659 | 0.00332 | 3.19233 | 3 | 9 | 105 | glucose transmembrane transport |
| GO:0033500 | 0.00333 | 2.27017 | 7 | 16 | 257 | carbohydrate homeostasis |
| GO:0030834 | 0.00333 | 4.52991 | 1 | 6 | 51 | regulation of actin filament depolymerization |
| GO:0045687 | 0.00333 | 4.52991 | 1 | 6 | 51 | positive regulation of glial cell differentiation |
| GO:0048806 | 0.00333 | 4.52991 | 1 | 6 | 51 | genitalia development |
| GO:2000649 | 0.00333 | 4.52991 | 1 | 6 | 51 | regulation of sodium ion transmembrane transporter activity |
| GO:0010717 | 0.00334 | 3.48997 | 2 | 8 | 86 | regulation of epithelial to mesenchymal transition |
| GO:0044344 | 0.00334 | 3.48997 | 2 | 8 | 86 | cellular response to fibroblast growth factor stimulus |
| GO:1901879 | 0.00334 | 3.48997 | 2 | 8 | 86 | regulation of protein depolymerization |
| GO:0051248 | 0.00335 | 1.58271 | 30 | 46 | 1052 | negative regulation of protein metabolic process |
| GO:0030032 | 0.00337 | 3.90181 | 2 | 7 | 68 | lamellipodium assembly |
| GO:1903670 | 0.00337 | 3.90181 | 2 | 7 | 68 | regulation of sprouting angiogenesis |
| GO:0006820 | 0.00340 | 1.83756 | 15 | 27 | 532 | anion transport |
| GO:1901698 | 0.00341 | 1.61661 | 27 | 42 | 940 | response to nitrogen compound |
| GO:0080135 | 0.00341 | 1.75810 | 18 | 31 | 638 | regulation of cellular response to stress |
| GO:0032868 | 0.00347 | 2.41505 | 6 | 14 | 212 | response to insulin |
| GO:0045197 | 0.00351 | 5.47488 | 1 | 5 | 36 | establishment or maintenance of epithelial cell apical/basal polarity |
| GO:0046326 | 0.00351 | 5.47488 | 1 | 5 | 36 | positive regulation of glucose import |
| GO:0048710 | 0.00351 | 5.47488 | 1 | 5 | 36 | regulation of astrocyte differentiation |
| GO:0050931 | 0.00351 | 5.47488 | 1 | 5 | 36 | pigment cell differentiation |
| GO:0099174 | 0.00351 | 5.47488 | 1 | 5 | 36 | regulation of presynapse organization |
| GO:0006006 | 0.00353 | 2.50714 | 5 | 13 | 190 | glucose metabolic process |
| GO:0034613 | 0.00362 | 1.46102 | 47 | 66 | 1639 | cellular protein localization |
| GO:1903725 | 0.00365 | 3.83871 | 2 | 7 | 69 | regulation of phospholipid metabolic process |
| GO:0007528 | 0.00368 | 4.43124 | 1 | 6 | 52 | neuromuscular junction development |
| GO:0021587 | 0.00368 | 4.43124 | 1 | 6 | 52 | cerebellum morphogenesis |
| GO:0045599 | 0.00368 | 4.43124 | 1 | 6 | 52 | negative regulation of fat cell differentiation |
| GO:0045773 | 0.00368 | 4.43124 | 1 | 6 | 52 | positive regulation of axon extension |
| GO:0048066 | 0.00368 | 4.43124 | 1 | 6 | 52 | developmental pigmentation |
| GO:2000351 | 0.00368 | 4.43124 | 1 | 6 | 52 | regulation of endothelial cell apoptotic process |
| GO:0007416 | 0.00369 | 2.60745 | 5 | 12 | 169 | synapse assembly |
| GO:0010959 | 0.00376 | 1.95937 | 12 | 22 | 407 | regulation of metal ion transport |
| GO:0008645 | 0.00377 | 3.12690 | 3 | 9 | 107 | hexose transmembrane transport |
| GO:0048145 | 0.00377 | 3.12690 | 3 | 9 | 107 | regulation of fibroblast proliferation |
| GO:0030258 | 0.00377 | 2.39069 | 6 | 14 | 214 | lipid modification |
| GO:0043393 | 0.00378 | 2.30887 | 7 | 15 | 237 | regulation of protein binding |
| GO:0051149 | 0.00385 | 3.40242 | 3 | 8 | 88 | positive regulation of muscle cell differentiation |
| GO:0071774 | 0.00385 | 3.40242 | 3 | 8 | 88 | response to fibroblast growth factor |
| GO:0071236 | 0.00386 | 2.47891 | 6 | 13 | 192 | cellular response to antibiotic |
| GO:0055094 | 0.00390 | 7.13922 | 1 | 4 | 23 | response to lipoprotein particle |
| GO:0030513 | 0.00396 | 5.30356 | 1 | 5 | 37 | positive regulation of BMP signaling pathway |
| GO:0071514 | 0.00396 | 5.30356 | 1 | 5 | 37 | genetic imprinting |
| GO:0021536 | 0.00396 | 3.77761 | 2 | 7 | 70 | diencephalon development |
| GO:0015718 | 0.00397 | 2.71741 | 4 | 11 | 149 | monocarboxylic acid transport |
| GO:0051260 | 0.00401 | 2.02090 | 10 | 20 | 359 | protein homooligomerization |
| GO:0015844 | 0.00401 | 3.09518 | 3 | 9 | 108 | monoamine transport |
| GO:0043588 | 0.00405 | 2.16159 | 8 | 17 | 286 | skin development |
| GO:0045824 | 0.00405 | 4.33677 | 2 | 6 | 53 | negative regulation of innate immune response |
| GO:0048247 | 0.00405 | 4.33677 | 2 | 6 | 53 | lymphocyte chemotaxis |
| GO:0098930 | 0.00405 | 4.33677 | 2 | 6 | 53 | axonal transport |
| GO:0051937 | 0.00413 | 3.36027 | 3 | 8 | 89 | catecholamine transport |
| GO:0098660 | 0.00418 | 1.73171 | 19 | 31 | 647 | inorganic ion transmembrane transport |
| GO:0046661 | 0.00418 | 2.69774 | 4 | 11 | 150 | male sex differentiation |
| GO:0010876 | 0.00426 | 2.00887 | 10 | 20 | 361 | lipid localization |
| GO:0014074 | 0.00426 | 3.06409 | 3 | 9 | 109 | response to purine-containing compound |
| GO:0015749 | 0.00426 | 3.06409 | 3 | 9 | 109 | monosaccharide transmembrane transport |
| GO:0048144 | 0.00426 | 3.06409 | 3 | 9 | 109 | fibroblast proliferation |
| GO:0032825 | 0.00430 | 11.29179 | 0 | 3 | 12 | positive regulation of natural killer cell differentiation |
| GO:0051798 | 0.00430 | 11.29179 | 0 | 3 | 12 | positive regulation of hair follicle development |
| GO:0060502 | 0.00430 | 11.29179 | 0 | 3 | 12 | epithelial cell proliferation involved in lung morphogenesis |
| GO:0060525 | 0.00430 | 11.29179 | 0 | 3 | 12 | prostate glandular acinus development |
| GO:0061299 | 0.00430 | 11.29179 | 0 | 3 | 12 | retina vasculature morphogenesis in camera-type eye |
| GO:0070444 | 0.00430 | 11.29179 | 0 | 3 | 12 | oligodendrocyte progenitor proliferation |
| GO:0070445 | 0.00430 | 11.29179 | 0 | 3 | 12 | regulation of oligodendrocyte progenitor proliferation |
| GO:1903729 | 0.00430 | 11.29179 | 0 | 3 | 12 | regulation of plasma membrane organization |
| GO:1904994 | 0.00430 | 11.29179 | 0 | 3 | 12 | regulation of leukocyte adhesion to vascular endothelial cell |
| GO:0001775 | 0.00435 | 1.55837 | 31 | 46 | 1067 | cell activation |
| GO:0014066 | 0.00442 | 3.31914 | 3 | 8 | 90 | regulation of phosphatidylinositol 3-kinase signaling |
| GO:0035272 | 0.00445 | 4.24623 | 2 | 6 | 54 | exocrine system development |
| GO:0055025 | 0.00445 | 4.24623 | 2 | 6 | 54 | positive regulation of cardiac muscle tissue development |
| GO:0002686 | 0.00445 | 5.14262 | 1 | 5 | 38 | negative regulation of leukocyte migration |
| GO:0045880 | 0.00445 | 5.14262 | 1 | 5 | 38 | positive regulation of smoothened signaling pathway |
| GO:0071542 | 0.00445 | 5.14262 | 1 | 5 | 38 | dopaminergic neuron differentiation |
| GO:2000403 | 0.00445 | 5.14262 | 1 | 5 | 38 | positive regulation of lymphocyte migration |
| GO:0002688 | 0.00453 | 3.03362 | 3 | 9 | 110 | regulation of leukocyte chemotaxis |
| GO:0034219 | 0.00453 | 3.03362 | 3 | 9 | 110 | carbohydrate transmembrane transport |
| GO:0060078 | 0.00453 | 3.03362 | 3 | 9 | 110 | regulation of postsynaptic membrane potential |
| GO:0042474 | 0.00457 | 6.78195 | 1 | 4 | 24 | middle ear morphogenesis |
| GO:0044342 | 0.00457 | 6.78195 | 1 | 4 | 24 | type B pancreatic cell proliferation |
| GO:0048799 | 0.00457 | 6.78195 | 1 | 4 | 24 | animal organ maturation |
| GO:1904738 | 0.00457 | 6.78195 | 1 | 4 | 24 | vascular associated smooth muscle cell migration |
| GO:1904752 | 0.00457 | 6.78195 | 1 | 4 | 24 | regulation of vascular associated smooth muscle cell migration |
| GO:0051896 | 0.00462 | 2.65924 | 4 | 11 | 152 | regulation of protein kinase B signaling |
| GO:0019318 | 0.00463 | 2.33186 | 6 | 14 | 219 | hexose metabolic process |
| GO:0008543 | 0.00464 | 3.66105 | 2 | 7 | 72 | fibroblast growth factor receptor signaling pathway |
| GO:0051384 | 0.00473 | 3.27900 | 3 | 8 | 91 | response to glucocorticoid |
| GO:0050890 | 0.00475 | 2.07355 | 9 | 18 | 315 | cognition |
| GO:1904951 | 0.00476 | 1.88683 | 13 | 23 | 441 | positive regulation of establishment of protein localization |
| GO:0001757 | 0.00478 | 33.83508 | 0 | 2 | 4 | somite specification |
| GO:0003273 | 0.00478 | 33.83508 | 0 | 2 | 4 | cell migration involved in endocardial cushion formation |
| GO:0006682 | 0.00478 | 33.83508 | 0 | 2 | 4 | galactosylceramide biosynthetic process |
| GO:0007223 | 0.00478 | 33.83508 | 0 | 2 | 4 | Wnt signaling pathway, calcium modulating pathway |
| GO:0009092 | 0.00478 | 33.83508 | 0 | 2 | 4 | homoserine metabolic process |
| GO:0019346 | 0.00478 | 33.83508 | 0 | 2 | 4 | transsulfuration |
| GO:0019375 | 0.00478 | 33.83508 | 0 | 2 | 4 | galactolipid biosynthetic process |
| GO:0019482 | 0.00478 | 33.83508 | 0 | 2 | 4 | beta-alanine metabolic process |
| GO:0060221 | 0.00478 | 33.83508 | 0 | 2 | 4 | retinal rod cell differentiation |
| GO:0061209 | 0.00478 | 33.83508 | 0 | 2 | 4 | cell proliferation involved in mesonephros development |
| GO:0070814 | 0.00478 | 33.83508 | 0 | 2 | 4 | hydrogen sulfide biosynthetic process |
| GO:0072236 | 0.00478 | 33.83508 | 0 | 2 | 4 | metanephric loop of Henle development |
| GO:0090154 | 0.00478 | 33.83508 | 0 | 2 | 4 | positive regulation of sphingolipid biosynthetic process |
| GO:1903964 | 0.00478 | 33.83508 | 0 | 2 | 4 | monounsaturated fatty acid metabolic process |
| GO:1903966 | 0.00478 | 33.83508 | 0 | 2 | 4 | monounsaturated fatty acid biosynthetic process |
| GO:2000304 | 0.00478 | 33.83508 | 0 | 2 | 4 | positive regulation of ceramide biosynthetic process |
| GO:2000669 | 0.00478 | 33.83508 | 0 | 2 | 4 | negative regulation of dendritic cell apoptotic process |
| GO:1902115 | 0.00479 | 2.41101 | 6 | 13 | 197 | regulation of organelle assembly |
| GO:0097193 | 0.00481 | 2.12167 | 8 | 17 | 291 | intrinsic apoptotic signaling pathway |
| GO:0043244 | 0.00481 | 3.00374 | 3 | 9 | 111 | regulation of protein complex disassembly |
| GO:1901360 | 0.00483 | 1.27018 | 147 | 175 | 5097 | organic cyclic compound metabolic process |
| GO:0030042 | 0.00487 | 4.15939 | 2 | 6 | 55 | actin filament depolymerization |
| GO:0072577 | 0.00487 | 4.15939 | 2 | 6 | 55 | endothelial cell apoptotic process |
| GO:0001508 | 0.00492 | 2.79211 | 4 | 10 | 132 | action potential |
| GO:0071417 | 0.00492 | 1.78334 | 16 | 27 | 547 | cellular response to organonitrogen compound |
| GO:0006687 | 0.00499 | 4.99114 | 1 | 5 | 39 | glycosphingolipid metabolic process |
| GO:0043551 | 0.00499 | 4.99114 | 1 | 5 | 39 | regulation of phosphatidylinositol 3-kinase activity |
| GO:0055026 | 0.00499 | 4.99114 | 1 | 5 | 39 | negative regulation of cardiac muscle tissue development |
| GO:0003333 | 0.00500 | 3.60542 | 2 | 7 | 73 | amino acid transmembrane transport |
| GO:0032272 | 0.00500 | 3.60542 | 2 | 7 | 73 | negative regulation of protein polymerization |
| GO:0070997 | 0.00506 | 1.93912 | 11 | 21 | 392 | neuron death |
| GO:0045321 | 0.00508 | 1.57635 | 28 | 42 | 962 | leukocyte activation |
| GO:0055065 | 0.00509 | 1.70607 | 19 | 31 | 656 | metal ion homeostasis |
| GO:0051302 | 0.00509 | 2.62181 | 4 | 11 | 154 | regulation of cell division |
| GO:0050663 | 0.00521 | 2.29792 | 6 | 14 | 222 | cytokine secretion |
| GO:0044089 | 0.00523 | 1.79584 | 15 | 26 | 523 | positive regulation of cellular component biogenesis |
| GO:0007413 | 0.00532 | 6.45872 | 1 | 4 | 25 | axonal fasciculation |
| GO:0010742 | 0.00532 | 6.45872 | 1 | 4 | 25 | macrophage derived foam cell differentiation |
| GO:0010829 | 0.00532 | 6.45872 | 1 | 4 | 25 | negative regulation of glucose transmembrane transport |
| GO:0043171 | 0.00532 | 6.45872 | 1 | 4 | 25 | peptide catabolic process |
| GO:0048714 | 0.00532 | 6.45872 | 1 | 4 | 25 | positive regulation of oligodendrocyte differentiation |
| GO:0071402 | 0.00532 | 6.45872 | 1 | 4 | 25 | cellular response to lipoprotein particle stimulus |
| GO:0106030 | 0.00532 | 6.45872 | 1 | 4 | 25 | neuron projection fasciculation |
| GO:1903671 | 0.00532 | 6.45872 | 1 | 4 | 25 | negative regulation of sprouting angiogenesis |
| GO:1904861 | 0.00532 | 6.45872 | 1 | 4 | 25 | excitatory synapse assembly |
| GO:0019725 | 0.00532 | 1.58997 | 26 | 40 | 908 | cellular homeostasis |
| GO:0002067 | 0.00533 | 4.07602 | 2 | 6 | 56 | glandular epithelial cell differentiation |
| GO:0021575 | 0.00533 | 4.07602 | 2 | 6 | 56 | hindbrain morphogenesis |
| GO:0046622 | 0.00533 | 4.07602 | 2 | 6 | 56 | positive regulation of organ growth |
| GO:1901654 | 0.00533 | 2.48014 | 5 | 12 | 177 | response to ketone |
| GO:0043506 | 0.00539 | 3.20157 | 3 | 8 | 93 | regulation of JUN kinase activity |
| GO:1901880 | 0.00539 | 3.55145 | 2 | 7 | 74 | negative regulation of protein depolymerization |
| GO:1901216 | 0.00540 | 2.94572 | 3 | 9 | 113 | positive regulation of neuron death |
| GO:0042471 | 0.00547 | 2.74683 | 4 | 10 | 134 | ear morphogenesis |
| GO:0003157 | 0.00547 | 10.16216 | 0 | 3 | 13 | endocardium development |
| GO:0010885 | 0.00547 | 10.16216 | 0 | 3 | 13 | regulation of cholesterol storage |
| GO:0033690 | 0.00547 | 10.16216 | 0 | 3 | 13 | positive regulation of osteoblast proliferation |
| GO:0038065 | 0.00547 | 10.16216 | 0 | 3 | 13 | collagen-activated signaling pathway |
| GO:0042635 | 0.00547 | 10.16216 | 0 | 3 | 13 | positive regulation of hair cycle |
| GO:2000052 | 0.00547 | 10.16216 | 0 | 3 | 13 | positive regulation of non-canonical Wnt signaling pathway |
| GO:0021983 | 0.00557 | 4.84832 | 1 | 5 | 40 | pituitary gland development |
| GO:0045747 | 0.00557 | 4.84832 | 1 | 5 | 40 | positive regulation of Notch signaling pathway |
| GO:1900077 | 0.00557 | 4.84832 | 1 | 5 | 40 | negative regulation of cellular response to insulin stimulus |
| GO:0031347 | 0.00557 | 1.74561 | 17 | 28 | 579 | regulation of defense response |
| GO:2001235 | 0.00558 | 2.46509 | 5 | 12 | 178 | positive regulation of apoptotic signaling pathway |
| GO:0031348 | 0.00566 | 2.35929 | 6 | 13 | 201 | negative regulation of defense response |
| GO:1903706 | 0.00566 | 1.91809 | 11 | 21 | 396 | regulation of hemopoiesis |
| GO:0001676 | 0.00574 | 3.16420 | 3 | 8 | 94 | long-chain fatty acid metabolic process |
| GO:0070373 | 0.00580 | 3.49907 | 2 | 7 | 75 | negative regulation of ERK1 and ERK2 cascade |
| GO:0051148 | 0.00581 | 3.99592 | 2 | 6 | 57 | negative regulation of muscle cell differentiation |
| GO:0099601 | 0.00581 | 3.99592 | 2 | 6 | 57 | regulation of neurotransmitter receptor activity |
| GO:0014070 | 0.00584 | 1.64614 | 21 | 34 | 745 | response to organic cyclic compound |
| GO:0051345 | 0.00597 | 1.79800 | 14 | 25 | 502 | positive regulation of hydrolase activity |
| GO:0046620 | 0.00605 | 2.88988 | 3 | 9 | 115 | regulation of organ growth |
| GO:0006869 | 0.00612 | 2.01843 | 9 | 18 | 323 | lipid transport |
| GO:0031960 | 0.00612 | 3.12769 | 3 | 8 | 95 | response to corticosteroid |
| GO:0046683 | 0.00612 | 3.12769 | 3 | 8 | 95 | response to organophosphorus |
| GO:0002089 | 0.00615 | 6.16487 | 1 | 4 | 26 | lens morphogenesis in camera-type eye |
| GO:0003299 | 0.00615 | 6.16487 | 1 | 4 | 26 | muscle hypertrophy in response to stress |
| GO:0014898 | 0.00615 | 6.16487 | 1 | 4 | 26 | cardiac muscle hypertrophy in response to stress |
| GO:0050901 | 0.00615 | 6.16487 | 1 | 4 | 26 | leukocyte tethering or rolling |
| GO:0051125 | 0.00615 | 6.16487 | 1 | 4 | 26 | regulation of actin nucleation |
| GO:0090077 | 0.00615 | 6.16487 | 1 | 4 | 26 | foam cell differentiation |
| GO:0006979 | 0.00616 | 1.90261 | 11 | 21 | 399 | response to oxidative stress |
| GO:0019932 | 0.00620 | 1.87034 | 12 | 22 | 425 | second-messenger-mediated signaling |
| GO:0007431 | 0.00620 | 4.71344 | 1 | 5 | 41 | salivary gland development |
| GO:0099084 | 0.00620 | 4.71344 | 1 | 5 | 41 | postsynaptic specialization organization |
| GO:0110111 | 0.00620 | 4.71344 | 1 | 5 | 41 | negative regulation of animal organ morphogenesis |
| GO:2000404 | 0.00620 | 4.71344 | 1 | 5 | 41 | regulation of T cell migration |
| GO:1901862 | 0.00624 | 3.44820 | 2 | 7 | 76 | negative regulation of muscle tissue development |
| GO:0050982 | 0.00633 | 3.91890 | 2 | 6 | 58 | detection of mechanical stimulus |
| GO:2000134 | 0.00633 | 3.91890 | 2 | 6 | 58 | negative regulation of G1/S transition of mitotic cell cycle |
| GO:0044262 | 0.00635 | 2.11070 | 8 | 16 | 275 | cellular carbohydrate metabolic process |
| GO:1901615 | 0.00636 | 1.83753 | 13 | 23 | 452 | organic hydroxy compound metabolic process |
| GO:0003158 | 0.00640 | 2.86274 | 3 | 9 | 116 | endothelium development |
| GO:0009896 | 0.00650 | 1.89242 | 12 | 21 | 401 | positive regulation of catabolic process |
| GO:0016485 | 0.00655 | 2.23289 | 7 | 14 | 228 | protein processing |
| GO:0097191 | 0.00655 | 2.23289 | 7 | 14 | 228 | extrinsic apoptotic signaling pathway |
| GO:0043525 | 0.00669 | 3.39879 | 2 | 7 | 77 | positive regulation of neuron apoptotic process |
| GO:0002687 | 0.00670 | 2.66052 | 4 | 10 | 138 | positive regulation of leukocyte migration |
| GO:0051640 | 0.00682 | 1.71685 | 17 | 28 | 588 | organelle localization |
| GO:0010715 | 0.00682 | 9.23792 | 0 | 3 | 14 | regulation of extracellular matrix disassembly |
| GO:0060396 | 0.00682 | 9.23792 | 0 | 3 | 14 | growth hormone receptor signaling pathway |
| GO:0070293 | 0.00682 | 9.23792 | 0 | 3 | 14 | renal absorption |
| GO:0071378 | 0.00682 | 9.23792 | 0 | 3 | 14 | cellular response to growth hormone stimulus |
| GO:0090136 | 0.00682 | 9.23792 | 0 | 3 | 14 | epithelial cell-cell adhesion |
| GO:0099151 | 0.00682 | 9.23792 | 0 | 3 | 14 | regulation of postsynaptic density assembly |
| GO:0052547 | 0.00687 | 1.88234 | 12 | 21 | 403 | regulation of peptidase activity |
| GO:0005978 | 0.00687 | 4.58584 | 1 | 5 | 42 | glycogen biosynthetic process |
| GO:0009250 | 0.00687 | 4.58584 | 1 | 5 | 42 | glucan biosynthetic process |
| GO:0010765 | 0.00687 | 4.58584 | 1 | 5 | 42 | positive regulation of sodium ion transport |
| GO:0030835 | 0.00687 | 4.58584 | 1 | 5 | 42 | negative regulation of actin filament depolymerization |
| GO:0042181 | 0.00687 | 4.58584 | 1 | 5 | 42 | ketone biosynthetic process |
| GO:0050918 | 0.00687 | 4.58584 | 1 | 5 | 42 | positive chemotaxis |
| GO:2000826 | 0.00687 | 4.58584 | 1 | 5 | 42 | regulation of heart morphogenesis |
| GO:0045776 | 0.00688 | 3.84479 | 2 | 6 | 59 | negative regulation of blood pressure |
| GO:0007584 | 0.00692 | 3.05713 | 3 | 8 | 97 | response to nutrient |
| GO:2001233 | 0.00705 | 1.87735 | 12 | 21 | 404 | regulation of apoptotic signaling pathway |
| GO:0014887 | 0.00705 | 5.89657 | 1 | 4 | 27 | cardiac muscle adaptation |
| GO:0048745 | 0.00705 | 5.89657 | 1 | 4 | 27 | smooth muscle tissue development |
| GO:0060713 | 0.00705 | 5.89657 | 1 | 4 | 27 | labyrinthine layer morphogenesis |
| GO:0071375 | 0.00706 | 2.21202 | 7 | 14 | 230 | cellular response to peptide hormone stimulus |
| GO:0046879 | 0.00709 | 1.94603 | 10 | 19 | 353 | hormone secretion |
| GO:0043507 | 0.00718 | 3.35077 | 2 | 7 | 78 | positive regulation of JUN kinase activity |
| GO:0045682 | 0.00718 | 3.35077 | 2 | 7 | 78 | regulation of epidermis development |
| GO:2001236 | 0.00738 | 2.48202 | 5 | 11 | 162 | regulation of extrinsic apoptotic signaling pathway |
| GO:0014911 | 0.00746 | 3.77342 | 2 | 6 | 60 | positive regulation of smooth muscle cell migration |
| GO:1905207 | 0.00746 | 3.77342 | 2 | 6 | 60 | regulation of cardiocyte differentiation |
| GO:0019935 | 0.00747 | 2.27388 | 6 | 13 | 208 | cyclic-nucleotide-mediated signaling |
| GO:0071407 | 0.00751 | 1.78451 | 14 | 24 | 485 | cellular response to organic cyclic compound |
| GO:0050865 | 0.00757 | 1.65430 | 19 | 31 | 675 | regulation of cell activation |
| GO:0070527 | 0.00760 | 4.46497 | 1 | 5 | 43 | platelet aggregation |
| GO:0045913 | 0.00768 | 3.30409 | 2 | 7 | 79 | positive regulation of carbohydrate metabolic process |
| GO:0060113 | 0.00768 | 3.30409 | 2 | 7 | 79 | inner ear receptor cell differentiation |
| GO:0010634 | 0.00775 | 2.59924 | 4 | 10 | 141 | positive regulation of epithelial cell migration |
| GO:0055007 | 0.00775 | 2.59924 | 4 | 10 | 141 | cardiac muscle cell differentiation |
| GO:0015893 | 0.00777 | 2.26218 | 6 | 13 | 209 | drug transport |
| GO:0010771 | 0.00780 | 2.98968 | 3 | 8 | 99 | negative regulation of cell morphogenesis involved in differentiation |
| GO:0003096 | 0.00781 | 22.55572 | 0 | 2 | 5 | renal sodium ion transport |
| GO:0003192 | 0.00781 | 22.55572 | 0 | 2 | 5 | mitral valve formation |
| GO:0003241 | 0.00781 | 22.55572 | 0 | 2 | 5 | growth involved in heart morphogenesis |
| GO:0007171 | 0.00781 | 22.55572 | 0 | 2 | 5 | activation of transmembrane receptor protein tyrosine kinase activity |
| GO:0007354 | 0.00781 | 22.55572 | 0 | 2 | 5 | zygotic determination of anterior/posterior axis, embryo |
| GO:0007494 | 0.00781 | 22.55572 | 0 | 2 | 5 | midgut development |
| GO:0009403 | 0.00781 | 22.55572 | 0 | 2 | 5 | toxin biosynthetic process |
| GO:0010694 | 0.00781 | 22.55572 | 0 | 2 | 5 | positive regulation of alkaline phosphatase activity |
| GO:0010936 | 0.00781 | 22.55572 | 0 | 2 | 5 | negative regulation of macrophage cytokine production |
| GO:0032898 | 0.00781 | 22.55572 | 0 | 2 | 5 | neurotrophin production |
| GO:0042078 | 0.00781 | 22.55572 | 0 | 2 | 5 | germ-line stem cell division |
| GO:0045113 | 0.00781 | 22.55572 | 0 | 2 | 5 | regulation of integrin biosynthetic process |
| GO:0046476 | 0.00781 | 22.55572 | 0 | 2 | 5 | glycosylceramide biosynthetic process |
| GO:0048133 | 0.00781 | 22.55572 | 0 | 2 | 5 | male germ-line stem cell asymmetric division |
| GO:0048818 | 0.00781 | 22.55572 | 0 | 2 | 5 | positive regulation of hair follicle maturation |
| GO:0070100 | 0.00781 | 22.55572 | 0 | 2 | 5 | negative regulation of chemokine-mediated signaling pathway |
| GO:0098728 | 0.00781 | 22.55572 | 0 | 2 | 5 | germline stem cell asymmetric division |
| GO:1900736 | 0.00781 | 22.55572 | 0 | 2 | 5 | regulation of phospholipase C-activating G protein-coupled receptor signaling pathway |
| GO:1903238 | 0.00781 | 22.55572 | 0 | 2 | 5 | positive regulation of leukocyte tethering or rolling |
| GO:1904393 | 0.00781 | 22.55572 | 0 | 2 | 5 | regulation of skeletal muscle acetylcholine-gated channel clustering |
| GO:0043933 | 0.00785 | 1.38239 | 55 | 73 | 1910 | protein-containing complex subunit organization |
| GO:0014902 | 0.00794 | 2.75909 | 3 | 9 | 120 | myotube differentiation |
| GO:1902806 | 0.00794 | 2.75909 | 3 | 9 | 120 | regulation of cell cycle G1/S phase transition |
| GO:0007611 | 0.00800 | 2.05451 | 8 | 16 | 282 | learning or memory |
| GO:0032269 | 0.00804 | 1.52949 | 28 | 42 | 989 | negative regulation of cellular protein metabolic process |
| GO:0010719 | 0.00805 | 5.65063 | 1 | 4 | 28 | negative regulation of epithelial to mesenchymal transition |
| GO:0035162 | 0.00805 | 5.65063 | 1 | 4 | 28 | embryonic hemopoiesis |
| GO:0060039 | 0.00805 | 5.65063 | 1 | 4 | 28 | pericardium development |
| GO:0060445 | 0.00805 | 5.65063 | 1 | 4 | 28 | branching involved in salivary gland morphogenesis |
| GO:1901186 | 0.00805 | 5.65063 | 1 | 4 | 28 | positive regulation of ERBB signaling pathway |
| GO:0051100 | 0.00807 | 2.44936 | 5 | 11 | 164 | negative regulation of binding |
| GO:0070059 | 0.00808 | 3.70465 | 2 | 6 | 61 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
| GO:1902305 | 0.00808 | 3.70465 | 2 | 6 | 61 | regulation of sodium ion transmembrane transport |
| GO:0034599 | 0.00812 | 2.10735 | 7 | 15 | 258 | cellular response to oxidative stress |
| GO:0002065 | 0.00813 | 2.57944 | 4 | 10 | 142 | columnar/cuboidal epithelial cell differentiation |
| GO:1905952 | 0.00813 | 2.57944 | 4 | 10 | 142 | regulation of lipid localization |
| GO:0070663 | 0.00816 | 2.17141 | 7 | 14 | 234 | regulation of leukocyte proliferation |
| GO:0051402 | 0.00826 | 2.04672 | 8 | 16 | 283 | neuron apoptotic process |
| GO:0019218 | 0.00828 | 2.95705 | 3 | 8 | 100 | regulation of steroid metabolic process |
| GO:0003128 | 0.00834 | 8.46772 | 0 | 3 | 15 | heart field specification |
| GO:0003188 | 0.00834 | 8.46772 | 0 | 3 | 15 | heart valve formation |
| GO:0006677 | 0.00834 | 8.46772 | 0 | 3 | 15 | glycosylceramide metabolic process |
| GO:0007379 | 0.00834 | 8.46772 | 0 | 3 | 15 | segment specification |
| GO:0009083 | 0.00834 | 8.46772 | 0 | 3 | 15 | branched-chain amino acid catabolic process |
| GO:0010523 | 0.00834 | 8.46772 | 0 | 3 | 15 | negative regulation of calcium ion transport into cytosol |
| GO:0042416 | 0.00834 | 8.46772 | 0 | 3 | 15 | dopamine biosynthetic process |
| GO:0042953 | 0.00834 | 8.46772 | 0 | 3 | 15 | lipoprotein transport |
| GO:0043129 | 0.00834 | 8.46772 | 0 | 3 | 15 | surfactant homeostasis |
| GO:0044872 | 0.00834 | 8.46772 | 0 | 3 | 15 | lipoprotein localization |
| GO:0060192 | 0.00834 | 8.46772 | 0 | 3 | 15 | negative regulation of lipase activity |
| GO:0060742 | 0.00834 | 8.46772 | 0 | 3 | 15 | epithelial cell differentiation involved in prostate gland development |
| GO:0098703 | 0.00834 | 8.46772 | 0 | 3 | 15 | calcium ion import across plasma membrane |
| GO:1902656 | 0.00834 | 8.46772 | 0 | 3 | 15 | calcium ion import into cytosol |
| GO:2000811 | 0.00834 | 8.46772 | 0 | 3 | 15 | negative regulation of anoikis |
| GO:0090279 | 0.00837 | 4.35029 | 1 | 5 | 44 | regulation of calcium ion import |
| GO:1903727 | 0.00837 | 4.35029 | 1 | 5 | 44 | positive regulation of phospholipid metabolic process |
| GO:0006814 | 0.00838 | 2.23913 | 6 | 13 | 211 | sodium ion transport |
| GO:0017157 | 0.00845 | 2.16149 | 7 | 14 | 235 | regulation of exocytosis |
| GO:0051726 | 0.00852 | 1.54009 | 27 | 40 | 935 | regulation of cell cycle |
| GO:0033993 | 0.00867 | 1.57621 | 24 | 36 | 822 | response to lipid |
| GO:1902807 | 0.00873 | 3.63833 | 2 | 6 | 62 | negative regulation of cell cycle G1/S phase transition |
| GO:0006952 | 0.00874 | 1.41932 | 44 | 60 | 1525 | defense response |
| GO:0051897 | 0.00877 | 2.92512 | 3 | 8 | 101 | positive regulation of protein kinase B signaling |
| GO:0043242 | 0.00878 | 3.21450 | 2 | 7 | 81 | negative regulation of protein complex disassembly |
| GO:0061572 | 0.00880 | 2.41754 | 5 | 11 | 166 | actin filament bundle organization |
| GO:0050714 | 0.00880 | 2.03132 | 8 | 16 | 285 | positive regulation of protein secretion |
| GO:0002761 | 0.00880 | 2.71002 | 4 | 9 | 122 | regulation of myeloid leukocyte differentiation |
| GO:0098693 | 0.00893 | 2.54071 | 4 | 10 | 144 | regulation of synaptic vesicle cycle |
| GO:1901699 | 0.00902 | 1.67691 | 17 | 28 | 601 | cellular response to nitrogen compound |
| GO:0008202 | 0.00909 | 2.02371 | 8 | 16 | 286 | steroid metabolic process |
| GO:0006139 | 0.00910 | 1.25208 | 136 | 161 | 4720 | nucleobase-containing compound metabolic process |
| GO:0003148 | 0.00912 | 5.42436 | 1 | 4 | 29 | outflow tract septum morphogenesis |
| GO:0007097 | 0.00912 | 5.42436 | 1 | 4 | 29 | nuclear migration |
| GO:0022617 | 0.00912 | 5.42436 | 1 | 4 | 29 | extracellular matrix disassembly |
| GO:0034110 | 0.00912 | 5.42436 | 1 | 4 | 29 | regulation of homotypic cell-cell adhesion |
| GO:0048820 | 0.00912 | 5.42436 | 1 | 4 | 29 | hair follicle maturation |
| GO:0051642 | 0.00912 | 5.42436 | 1 | 4 | 29 | centrosome localization |
| GO:0060914 | 0.00912 | 5.42436 | 1 | 4 | 29 | heart formation |
| GO:0061756 | 0.00912 | 5.42436 | 1 | 4 | 29 | leukocyte adhesion to vascular endothelial cell |
| GO:0009914 | 0.00914 | 1.89420 | 10 | 19 | 362 | hormone transport |
| GO:0097479 | 0.00919 | 2.29768 | 5 | 12 | 190 | synaptic vesicle localization |
| GO:0008089 | 0.00920 | 4.24134 | 1 | 5 | 45 | anterograde axonal transport |
| GO:0071526 | 0.00920 | 4.24134 | 1 | 5 | 45 | semaphorin-plexin signaling pathway |
| GO:0007368 | 0.00926 | 2.68612 | 4 | 9 | 123 | determination of left/right symmetry |
| GO:0050886 | 0.00928 | 2.89387 | 3 | 8 | 102 | endocrine process |
| GO:0050878 | 0.00928 | 1.92864 | 10 | 18 | 337 | regulation of body fluid levels |
| GO:0010675 | 0.00936 | 2.52178 | 4 | 10 | 145 | regulation of cellular carbohydrate metabolic process |
| GO:0030856 | 0.00936 | 2.52178 | 4 | 10 | 145 | regulation of epithelial cell differentiation |
| GO:0042133 | 0.00936 | 2.52178 | 4 | 10 | 145 | neurotransmitter metabolic process |
| GO:0071322 | 0.00936 | 2.52178 | 4 | 10 | 145 | cellular response to carbohydrate stimulus |
| GO:0045471 | 0.00937 | 3.17150 | 2 | 7 | 82 | response to ethanol |
| GO:1903035 | 0.00937 | 3.17150 | 2 | 7 | 82 | negative regulation of response to wounding |
| GO:0006066 | 0.00938 | 2.01615 | 8 | 16 | 287 | alcohol metabolic process |
| GO:1902105 | 0.00938 | 2.01615 | 8 | 16 | 287 | regulation of leukocyte differentiation |
| GO:0033692 | 0.00942 | 3.57434 | 2 | 6 | 63 | cellular polysaccharide biosynthetic process |
| GO:0016070 | 0.00944 | 1.27607 | 106 | 129 | 3688 | RNA metabolic process |
| GO:0051656 | 0.00945 | 1.77018 | 13 | 23 | 468 | establishment of organelle localization |
| GO:0072659 | 0.00959 | 2.06441 | 8 | 15 | 263 | protein localization to plasma membrane |
| GO:0071705 | 0.00960 | 1.35518 | 60 | 78 | 2081 | nitrogen compound transport |
| GO:0034763 | 0.00974 | 2.66265 | 4 | 9 | 124 | negative regulation of transmembrane transport |
| GO:0050777 | 0.00980 | 2.50312 | 4 | 10 | 146 | negative regulation of immune response |
| GO:0050866 | 0.00994 | 2.27194 | 6 | 12 | 192 | negative regulation of cell activation |
| GO:0001756 | 0.00998 | 3.12963 | 2 | 7 | 83 | somitogenesis |
| GO:0060079 | 0.00998 | 3.12963 | 2 | 7 | 83 | excitatory postsynaptic potential |
| GO:0070301 | 0.00998 | 3.12963 | 2 | 7 | 83 | cellular response to hydrogen peroxide |
| GO:0001886 | 0.01005 | 7.81601 | 0 | 3 | 16 | endothelial cell morphogenesis |
| GO:0010566 | 0.01005 | 7.81601 | 0 | 3 | 16 | regulation of ketone biosynthetic process |
| GO:0032570 | 0.01005 | 7.81601 | 0 | 3 | 16 | response to progesterone |
| GO:0045821 | 0.01005 | 7.81601 | 0 | 3 | 16 | positive regulation of glycolytic process |
| GO:0051386 | 0.01005 | 7.81601 | 0 | 3 | 16 | regulation of neurotrophin TRK receptor signaling pathway |
| GO:0060253 | 0.01005 | 7.81601 | 0 | 3 | 16 | negative regulation of glial cell proliferation |
| GO:0072673 | 0.01005 | 7.81601 | 0 | 3 | 16 | lamellipodium morphogenesis |
| GO:0099640 | 0.01005 | 7.81601 | 0 | 3 | 16 | axo-dendritic protein transport |
| GO:1900452 | 0.01005 | 7.81601 | 0 | 3 | 16 | regulation of long-term synaptic depression |
| GO:1904889 | 0.01005 | 7.81601 | 0 | 3 | 16 | regulation of excitatory synapse assembly |
| GO:2000651 | 0.01005 | 7.81601 | 0 | 3 | 16 | positive regulation of sodium ion transmembrane transporter activity |
| GO:0010718 | 0.01008 | 4.13771 | 1 | 5 | 46 | positive regulation of epithelial to mesenchymal transition |
| GO:0010828 | 0.01008 | 4.13771 | 1 | 5 | 46 | positive regulation of glucose transmembrane transport |
| GO:0032309 | 0.01008 | 4.13771 | 1 | 5 | 46 | icosanoid secretion |
| GO:0071385 | 0.01008 | 4.13771 | 1 | 5 | 46 | cellular response to glucocorticoid stimulus |
| GO:0010970 | 0.01025 | 2.48474 | 4 | 10 | 147 | transport along microtubule |
| GO:0099111 | 0.01025 | 2.48474 | 4 | 10 | 147 | microtubule-based transport |
| GO:0002021 | 0.01029 | 5.21550 | 1 | 4 | 30 | response to dietary excess |
| GO:0030947 | 0.01029 | 5.21550 | 1 | 4 | 30 | regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:0035640 | 0.01029 | 5.21550 | 1 | 4 | 30 | exploration behavior |
| GO:0035767 | 0.01029 | 5.21550 | 1 | 4 | 30 | endothelial cell chemotaxis |
| GO:0061036 | 0.01029 | 5.21550 | 1 | 4 | 30 | positive regulation of cartilage development |
| GO:0061842 | 0.01029 | 5.21550 | 1 | 4 | 30 | microtubule organizing center localization |
| GO:0099633 | 0.01029 | 5.21550 | 1 | 4 | 30 | protein localization to postsynaptic specialization membrane |
| GO:0099645 | 0.01029 | 5.21550 | 1 | 4 | 30 | neurotransmitter receptor localization to postsynaptic specialization membrane |
| GO:1902745 | 0.01029 | 5.21550 | 1 | 4 | 30 | positive regulation of lamellipodium organization |
| GO:1901135 | 0.01073 | 1.51539 | 27 | 40 | 949 | carbohydrate derivative metabolic process |
| GO:0055080 | 0.01077 | 1.59536 | 21 | 32 | 721 | cation homeostasis |
| GO:0060425 | 0.01092 | 3.45287 | 2 | 6 | 65 | lung morphogenesis |
| GO:0022411 | 0.01099 | 1.89252 | 10 | 18 | 343 | cellular component disassembly |
| GO:2000725 | 0.01102 | 4.03901 | 1 | 5 | 47 | regulation of cardiac muscle cell differentiation |
| GO:0050707 | 0.01115 | 2.23440 | 6 | 12 | 195 | regulation of cytokine secretion |
| GO:0071248 | 0.01120 | 2.44877 | 4 | 10 | 149 | cellular response to metal ion |
| GO:0010469 | 0.01129 | 2.59461 | 4 | 9 | 127 | regulation of signaling receptor activity |
| GO:0048813 | 0.01130 | 2.32682 | 5 | 11 | 172 | dendrite morphogenesis |
| GO:0008589 | 0.01130 | 3.04911 | 2 | 7 | 85 | regulation of smoothened signaling pathway |
| GO:0035418 | 0.01130 | 3.04911 | 2 | 7 | 85 | protein localization to synapse |
| GO:0042490 | 0.01130 | 3.04911 | 2 | 7 | 85 | mechanoreceptor differentiation |
| GO:1904035 | 0.01130 | 3.04911 | 2 | 7 | 85 | regulation of epithelial cell apoptotic process |
| GO:0006725 | 0.01138 | 1.23909 | 141 | 166 | 4913 | cellular aromatic compound metabolic process |
| GO:0046483 | 0.01142 | 1.24008 | 140 | 164 | 4848 | heterocycle metabolic process |
| GO:0001705 | 0.01149 | 16.91604 | 0 | 2 | 6 | ectoderm formation |
| GO:0007221 | 0.01149 | 16.91604 | 0 | 2 | 6 | positive regulation of transcription of Notch receptor target |
| GO:0007619 | 0.01149 | 16.91604 | 0 | 2 | 6 | courtship behavior |
| GO:0010701 | 0.01149 | 16.91604 | 0 | 2 | 6 | positive regulation of norepinephrine secretion |
| GO:0014043 | 0.01149 | 16.91604 | 0 | 2 | 6 | negative regulation of neuron maturation |
| GO:0021869 | 0.01149 | 16.91604 | 0 | 2 | 6 | forebrain ventricular zone progenitor cell division |
| GO:0038007 | 0.01149 | 16.91604 | 0 | 2 | 6 | netrin-activated signaling pathway |
| GO:0045112 | 0.01149 | 16.91604 | 0 | 2 | 6 | integrin biosynthetic process |
| GO:0045925 | 0.01149 | 16.91604 | 0 | 2 | 6 | positive regulation of female receptivity |
| GO:0060685 | 0.01149 | 16.91604 | 0 | 2 | 6 | regulation of prostatic bud formation |
| GO:0061312 | 0.01149 | 16.91604 | 0 | 2 | 6 | BMP signaling pathway involved in heart development |
| GO:0061419 | 0.01149 | 16.91604 | 0 | 2 | 6 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia |
| GO:0070099 | 0.01149 | 16.91604 | 0 | 2 | 6 | regulation of chemokine-mediated signaling pathway |
| GO:0070447 | 0.01149 | 16.91604 | 0 | 2 | 6 | positive regulation of oligodendrocyte progenitor proliferation |
| GO:0070813 | 0.01149 | 16.91604 | 0 | 2 | 6 | hydrogen sulfide metabolic process |
| GO:0071865 | 0.01149 | 16.91604 | 0 | 2 | 6 | regulation of apoptotic process in bone marrow |
| GO:0071866 | 0.01149 | 16.91604 | 0 | 2 | 6 | negative regulation of apoptotic process in bone marrow |
| GO:0072177 | 0.01149 | 16.91604 | 0 | 2 | 6 | mesonephric duct development |
| GO:0098961 | 0.01149 | 16.91604 | 0 | 2 | 6 | dendritic transport of ribonucleoprotein complex |
| GO:0098963 | 0.01149 | 16.91604 | 0 | 2 | 6 | dendritic transport of messenger ribonucleoprotein complex |
| GO:0099566 | 0.01149 | 16.91604 | 0 | 2 | 6 | regulation of postsynaptic cytosolic calcium ion concentration |
| GO:1904753 | 0.01149 | 16.91604 | 0 | 2 | 6 | negative regulation of vascular associated smooth muscle cell migration |
| GO:1905005 | 0.01149 | 16.91604 | 0 | 2 | 6 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:0070661 | 0.01149 | 1.92254 | 9 | 17 | 319 | leukocyte proliferation |
| GO:0010837 | 0.01156 | 5.02211 | 1 | 4 | 31 | regulation of keratinocyte proliferation |
| GO:0043537 | 0.01156 | 5.02211 | 1 | 4 | 31 | negative regulation of blood vessel endothelial cell migration |
| GO:0044030 | 0.01156 | 5.02211 | 1 | 4 | 31 | regulation of DNA methylation |
| GO:0045616 | 0.01156 | 5.02211 | 1 | 4 | 31 | regulation of keratinocyte differentiation |
| GO:0045662 | 0.01156 | 5.02211 | 1 | 4 | 31 | negative regulation of myoblast differentiation |
| GO:0048011 | 0.01156 | 5.02211 | 1 | 4 | 31 | neurotrophin TRK receptor signaling pathway |
| GO:2000352 | 0.01156 | 5.02211 | 1 | 4 | 31 | negative regulation of endothelial cell apoptotic process |
| GO:0120034 | 0.01156 | 2.77526 | 3 | 8 | 106 | positive regulation of plasma membrane bounded cell projection assembly |
| GO:2000045 | 0.01156 | 2.77526 | 3 | 8 | 106 | regulation of G1/S transition of mitotic cell cycle |
| GO:1903531 | 0.01163 | 2.14091 | 6 | 13 | 220 | negative regulation of secretion by cell |
| GO:0007405 | 0.01173 | 3.39517 | 2 | 6 | 66 | neuroblast proliferation |
| GO:0014068 | 0.01173 | 3.39517 | 2 | 6 | 66 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0055081 | 0.01173 | 3.39517 | 2 | 6 | 66 | anion homeostasis |
| GO:1901184 | 0.01173 | 3.39517 | 2 | 6 | 66 | regulation of ERBB signaling pathway |
| GO:2000179 | 0.01173 | 3.39517 | 2 | 6 | 66 | positive regulation of neural precursor cell proliferation |
| GO:0009612 | 0.01176 | 2.31236 | 5 | 11 | 173 | response to mechanical stimulus |
| GO:0010035 | 0.01193 | 1.73050 | 14 | 23 | 478 | response to inorganic substance |
| GO:0002689 | 0.01195 | 7.25740 | 0 | 3 | 17 | negative regulation of leukocyte chemotaxis |
| GO:0003184 | 0.01195 | 7.25740 | 0 | 3 | 17 | pulmonary valve morphogenesis |
| GO:0014041 | 0.01195 | 7.25740 | 0 | 3 | 17 | regulation of neuron maturation |
| GO:0030813 | 0.01195 | 7.25740 | 0 | 3 | 17 | positive regulation of nucleotide catabolic process |
| GO:0042308 | 0.01195 | 7.25740 | 0 | 3 | 17 | negative regulation of protein import into nucleus |
| GO:0048875 | 0.01195 | 7.25740 | 0 | 3 | 17 | chemical homeostasis within a tissue |
| GO:0051197 | 0.01195 | 7.25740 | 0 | 3 | 17 | positive regulation of coenzyme metabolic process |
| GO:0060416 | 0.01195 | 7.25740 | 0 | 3 | 17 | response to growth hormone |
| GO:0072234 | 0.01195 | 7.25740 | 0 | 3 | 17 | metanephric nephron tubule development |
| GO:1904590 | 0.01195 | 7.25740 | 0 | 3 | 17 | negative regulation of protein import |
| GO:0002762 | 0.01202 | 3.94491 | 1 | 5 | 48 | negative regulation of myeloid leukocyte differentiation |
| GO:0030195 | 0.01202 | 3.94491 | 1 | 5 | 48 | negative regulation of blood coagulation |
| GO:0043030 | 0.01202 | 3.94491 | 1 | 5 | 48 | regulation of macrophage activation |
| GO:0043550 | 0.01202 | 3.94491 | 1 | 5 | 48 | regulation of lipid kinase activity |
| GO:0046513 | 0.01202 | 3.94491 | 1 | 5 | 48 | ceramide biosynthetic process |
| GO:0071384 | 0.01202 | 3.94491 | 1 | 5 | 48 | cellular response to corticosteroid stimulus |
| GO:1902930 | 0.01202 | 3.94491 | 1 | 5 | 48 | regulation of alcohol biosynthetic process |
| GO:0035725 | 0.01219 | 2.74711 | 3 | 8 | 107 | sodium ion transmembrane transport |
| GO:0043467 | 0.01219 | 2.74711 | 3 | 8 | 107 | regulation of generation of precursor metabolites and energy |
| GO:0001678 | 0.01222 | 2.41382 | 4 | 10 | 151 | cellular glucose homeostasis |
| GO:0045995 | 0.01242 | 2.55114 | 4 | 9 | 129 | regulation of embryonic development |
| GO:1904375 | 0.01242 | 2.55114 | 4 | 9 | 129 | regulation of protein localization to cell periphery |
| GO:0006029 | 0.01258 | 3.33937 | 2 | 6 | 67 | proteoglycan metabolic process |
| GO:1905475 | 0.01274 | 2.28395 | 5 | 11 | 175 | regulation of protein localization to membrane |
| GO:0007215 | 0.01274 | 2.97262 | 3 | 7 | 87 | glutamate receptor signaling pathway |
| GO:1905954 | 0.01274 | 2.97262 | 3 | 7 | 87 | positive regulation of lipid localization |
| GO:0006694 | 0.01276 | 2.39672 | 4 | 10 | 152 | steroid biosynthetic process |
| GO:0006939 | 0.01285 | 2.71952 | 3 | 8 | 108 | smooth muscle contraction |
| GO:1904019 | 0.01285 | 2.71952 | 3 | 8 | 108 | epithelial cell apoptotic process |
| GO:0001779 | 0.01291 | 4.84253 | 1 | 4 | 32 | natural killer cell differentiation |
| GO:0010453 | 0.01291 | 4.84253 | 1 | 4 | 32 | regulation of cell fate commitment |
| GO:0010543 | 0.01291 | 4.84253 | 1 | 4 | 32 | regulation of platelet activation |
| GO:0014741 | 0.01291 | 4.84253 | 1 | 4 | 32 | negative regulation of muscle hypertrophy |
| GO:1905606 | 0.01291 | 4.84253 | 1 | 4 | 32 | regulation of presynapse assembly |
| GO:0010761 | 0.01308 | 3.85508 | 1 | 5 | 49 | fibroblast migration |
| GO:0042491 | 0.01308 | 3.85508 | 1 | 5 | 49 | inner ear auditory receptor cell differentiation |
| GO:0050701 | 0.01308 | 3.85508 | 1 | 5 | 49 | interleukin-1 secretion |
| GO:0055078 | 0.01308 | 3.85508 | 1 | 5 | 49 | sodium ion homeostasis |
| GO:1900047 | 0.01308 | 3.85508 | 1 | 5 | 49 | negative regulation of hemostasis |
| GO:0034330 | 0.01311 | 2.04022 | 7 | 14 | 248 | cell junction organization |
| GO:0001933 | 0.01314 | 1.78995 | 12 | 20 | 402 | negative regulation of protein phosphorylation |
| GO:0051606 | 0.01335 | 2.09995 | 6 | 13 | 224 | detection of stimulus |
| GO:0030888 | 0.01347 | 3.28536 | 2 | 6 | 68 | regulation of B cell proliferation |
| GO:0001708 | 0.01351 | 2.93579 | 3 | 7 | 88 | cell fate specification |
| GO:0031016 | 0.01351 | 2.93579 | 3 | 7 | 88 | pancreas development |
| GO:0010467 | 0.01352 | 1.23541 | 136 | 159 | 4707 | gene expression |
| GO:2000106 | 0.01353 | 2.69247 | 3 | 8 | 109 | regulation of leukocyte apoptotic process |
| GO:2000177 | 0.01353 | 2.69247 | 3 | 8 | 109 | regulation of neural precursor cell proliferation |
| GO:0070374 | 0.01354 | 2.03144 | 7 | 14 | 249 | positive regulation of ERK1 and ERK2 cascade |
| GO:0071887 | 0.01363 | 2.50909 | 4 | 9 | 131 | leukocyte apoptotic process |
| GO:0006897 | 0.01372 | 1.57609 | 20 | 31 | 706 | endocytosis |
| GO:1903707 | 0.01388 | 2.36322 | 4 | 10 | 154 | negative regulation of hemopoiesis |
| GO:0031667 | 0.01401 | 1.84078 | 10 | 18 | 352 | response to nutrient levels |
| GO:0006688 | 0.01404 | 6.77327 | 1 | 3 | 18 | glycosphingolipid biosynthetic process |
| GO:0008090 | 0.01404 | 6.77327 | 1 | 3 | 18 | retrograde axonal transport |
| GO:0010002 | 0.01404 | 6.77327 | 1 | 3 | 18 | cardioblast differentiation |
| GO:0010996 | 0.01404 | 6.77327 | 1 | 3 | 18 | response to auditory stimulus |
| GO:0014061 | 0.01404 | 6.77327 | 1 | 3 | 18 | regulation of norepinephrine secretion |
| GO:0030002 | 0.01404 | 6.77327 | 1 | 3 | 18 | cellular anion homeostasis |
| GO:0030320 | 0.01404 | 6.77327 | 1 | 3 | 18 | cellular monovalent inorganic anion homeostasis |
| GO:0030540 | 0.01404 | 6.77327 | 1 | 3 | 18 | female genitalia development |
| GO:0032516 | 0.01404 | 6.77327 | 1 | 3 | 18 | positive regulation of phosphoprotein phosphatase activity |
| GO:0042447 | 0.01404 | 6.77327 | 1 | 3 | 18 | hormone catabolic process |
| GO:0042572 | 0.01404 | 6.77327 | 1 | 3 | 18 | retinol metabolic process |
| GO:0048243 | 0.01404 | 6.77327 | 1 | 3 | 18 | norepinephrine secretion |
| GO:0048268 | 0.01404 | 6.77327 | 1 | 3 | 18 | clathrin coat assembly |
| GO:0048712 | 0.01404 | 6.77327 | 1 | 3 | 18 | negative regulation of astrocyte differentiation |
| GO:0050910 | 0.01404 | 6.77327 | 1 | 3 | 18 | detection of mechanical stimulus involved in sensory perception of sound |
| GO:0060712 | 0.01404 | 6.77327 | 1 | 3 | 18 | spongiotrophoblast layer development |
| GO:0099150 | 0.01404 | 6.77327 | 1 | 3 | 18 | regulation of postsynaptic specialization assembly |
| GO:0150052 | 0.01404 | 6.77327 | 1 | 3 | 18 | regulation of postsynapse assembly |
| GO:0048701 | 0.01420 | 3.76924 | 1 | 5 | 50 | embryonic cranial skeleton morphogenesis |
| GO:0050819 | 0.01420 | 3.76924 | 1 | 5 | 50 | negative regulation of coagulation |
| GO:0070542 | 0.01420 | 3.76924 | 1 | 5 | 50 | response to fatty acid |
| GO:1900024 | 0.01420 | 3.76924 | 1 | 5 | 50 | regulation of substrate adhesion-dependent cell spreading |
| GO:1900449 | 0.01420 | 3.76924 | 1 | 5 | 50 | regulation of glutamate receptor signaling pathway |
| GO:0048814 | 0.01423 | 2.66595 | 3 | 8 | 110 | regulation of dendrite morphogenesis |
| GO:0009855 | 0.01427 | 2.48858 | 4 | 9 | 132 | determination of bilateral symmetry |
| GO:2001056 | 0.01427 | 2.48858 | 4 | 9 | 132 | positive regulation of cysteine-type endopeptidase activity |
| GO:0050764 | 0.01431 | 2.89986 | 3 | 7 | 89 | regulation of phagocytosis |
| GO:0048013 | 0.01437 | 4.67534 | 1 | 4 | 33 | ephrin receptor signaling pathway |
| GO:0001541 | 0.01440 | 3.23307 | 2 | 6 | 69 | ovarian follicle development |
| GO:0051649 | 0.01454 | 1.34682 | 54 | 70 | 1872 | establishment of localization in cell |
| GO:0009991 | 0.01466 | 1.79830 | 11 | 19 | 380 | response to extracellular stimulus |
| GO:0001764 | 0.01486 | 2.22918 | 5 | 11 | 179 | neuron migration |
| GO:0048489 | 0.01486 | 2.22918 | 5 | 11 | 179 | synaptic vesicle transport |
| GO:0097480 | 0.01486 | 2.22918 | 5 | 11 | 179 | establishment of synaptic vesicle localization |
| GO:0009799 | 0.01493 | 2.46840 | 4 | 9 | 133 | specification of symmetry |
| GO:0031099 | 0.01493 | 2.46840 | 4 | 9 | 133 | regeneration |
| GO:1901655 | 0.01493 | 2.46840 | 4 | 9 | 133 | cellular response to ketone |
| GO:0090304 | 0.01495 | 1.24132 | 121 | 143 | 4198 | nucleic acid metabolic process |
| GO:0032411 | 0.01496 | 2.63995 | 3 | 8 | 111 | positive regulation of transporter activity |
| GO:0046889 | 0.01515 | 2.86479 | 3 | 7 | 90 | positive regulation of lipid biosynthetic process |
| GO:0001894 | 0.01526 | 2.06051 | 7 | 13 | 228 | tissue homeostasis |
| GO:0051648 | 0.01528 | 1.94536 | 8 | 15 | 278 | vesicle localization |
| GO:0043618 | 0.01538 | 3.68714 | 1 | 5 | 51 | regulation of transcription from RNA polymerase II promoter in response to stress |
| GO:0051954 | 0.01538 | 3.68714 | 1 | 5 | 51 | positive regulation of amine transport |
| GO:0071715 | 0.01538 | 3.68714 | 1 | 5 | 51 | icosanoid transport |
| GO:1901571 | 0.01538 | 3.68714 | 1 | 5 | 51 | fatty acid derivative transport |
| GO:0000271 | 0.01538 | 3.18241 | 2 | 6 | 70 | polysaccharide biosynthetic process |
| GO:0051668 | 0.01544 | 2.21589 | 5 | 11 | 180 | localization within membrane |
| GO:0030010 | 0.01561 | 2.44855 | 4 | 9 | 134 | establishment of cell polarity |
| GO:0007565 | 0.01570 | 2.31468 | 5 | 10 | 157 | female pregnancy |
| GO:0007596 | 0.01570 | 2.31468 | 5 | 10 | 157 | blood coagulation |
| GO:0002158 | 0.01579 | 13.53223 | 0 | 2 | 7 | osteoclast proliferation |
| GO:0003256 | 0.01579 | 13.53223 | 0 | 2 | 7 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation |
| GO:0003307 | 0.01579 | 13.53223 | 0 | 2 | 7 | regulation of Wnt signaling pathway involved in heart development |
| GO:0006551 | 0.01579 | 13.53223 | 0 | 2 | 7 | leucine metabolic process |
| GO:0006573 | 0.01579 | 13.53223 | 0 | 2 | 7 | valine metabolic process |
| GO:0006681 | 0.01579 | 13.53223 | 0 | 2 | 7 | galactosylceramide metabolic process |
| GO:0010519 | 0.01579 | 13.53223 | 0 | 2 | 7 | negative regulation of phospholipase activity |
| GO:0010886 | 0.01579 | 13.53223 | 0 | 2 | 7 | positive regulation of cholesterol storage |
| GO:0030885 | 0.01579 | 13.53223 | 0 | 2 | 7 | regulation of myeloid dendritic cell activation |
| GO:0032347 | 0.01579 | 13.53223 | 0 | 2 | 7 | regulation of aldosterone biosynthetic process |
| GO:0032808 | 0.01579 | 13.53223 | 0 | 2 | 7 | lacrimal gland development |
| GO:0033278 | 0.01579 | 13.53223 | 0 | 2 | 7 | cell proliferation in midbrain |
| GO:0033629 | 0.01579 | 13.53223 | 0 | 2 | 7 | negative regulation of cell adhesion mediated by integrin |
| GO:0035754 | 0.01579 | 13.53223 | 0 | 2 | 7 | B cell chemotaxis |
| GO:0035864 | 0.01579 | 13.53223 | 0 | 2 | 7 | response to potassium ion |
| GO:0035865 | 0.01579 | 13.53223 | 0 | 2 | 7 | cellular response to potassium ion |
| GO:0035931 | 0.01579 | 13.53223 | 0 | 2 | 7 | mineralocorticoid secretion |
| GO:0035932 | 0.01579 | 13.53223 | 0 | 2 | 7 | aldosterone secretion |
| GO:0042904 | 0.01579 | 13.53223 | 0 | 2 | 7 | 9-cis-retinoic acid biosynthetic process |
| GO:0042905 | 0.01579 | 13.53223 | 0 | 2 | 7 | 9-cis-retinoic acid metabolic process |
| GO:0045916 | 0.01579 | 13.53223 | 0 | 2 | 7 | negative regulation of complement activation |
| GO:0048702 | 0.01579 | 13.53223 | 0 | 2 | 7 | embryonic neurocranium morphogenesis |
| GO:0048842 | 0.01579 | 13.53223 | 0 | 2 | 7 | positive regulation of axon extension involved in axon guidance |
| GO:0060029 | 0.01579 | 13.53223 | 0 | 2 | 7 | convergent extension involved in organogenesis |
| GO:0060526 | 0.01579 | 13.53223 | 0 | 2 | 7 | prostate glandular acinus morphogenesis |
| GO:0060527 | 0.01579 | 13.53223 | 0 | 2 | 7 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis |
| GO:0061314 | 0.01579 | 13.53223 | 0 | 2 | 7 | Notch signaling involved in heart development |
| GO:0097048 | 0.01579 | 13.53223 | 0 | 2 | 7 | dendritic cell apoptotic process |
| GO:0150011 | 0.01579 | 13.53223 | 0 | 2 | 7 | regulation of neuron projection arborization |
| GO:0150012 | 0.01579 | 13.53223 | 0 | 2 | 7 | positive regulation of neuron projection arborization |
| GO:1903288 | 0.01579 | 13.53223 | 0 | 2 | 7 | positive regulation of potassium ion import |
| GO:1903367 | 0.01579 | 13.53223 | 0 | 2 | 7 | positive regulation of fear response |
| GO:2000258 | 0.01579 | 13.53223 | 0 | 2 | 7 | negative regulation of protein activation cascade |
| GO:2000601 | 0.01579 | 13.53223 | 0 | 2 | 7 | positive regulation of Arp2/3 complex-mediated actin nucleation |
| GO:2000653 | 0.01579 | 13.53223 | 0 | 2 | 7 | regulation of genetic imprinting |
| GO:2000668 | 0.01579 | 13.53223 | 0 | 2 | 7 | regulation of dendritic cell apoptotic process |
| GO:2000855 | 0.01579 | 13.53223 | 0 | 2 | 7 | regulation of mineralocorticoid secretion |
| GO:2000858 | 0.01579 | 13.53223 | 0 | 2 | 7 | regulation of aldosterone secretion |
| GO:2000987 | 0.01579 | 13.53223 | 0 | 2 | 7 | positive regulation of behavioral fear response |
| GO:0001773 | 0.01592 | 4.51930 | 1 | 4 | 34 | myeloid dendritic cell activation |
| GO:0002701 | 0.01592 | 4.51930 | 1 | 4 | 34 | negative regulation of production of molecular mediator of immune response |
| GO:0003209 | 0.01592 | 4.51930 | 1 | 4 | 34 | cardiac atrium morphogenesis |
| GO:0014003 | 0.01592 | 4.51930 | 1 | 4 | 34 | oligodendrocyte development |
| GO:0033032 | 0.01592 | 4.51930 | 1 | 4 | 34 | regulation of myeloid cell apoptotic process |
| GO:0035116 | 0.01592 | 4.51930 | 1 | 4 | 34 | embryonic hindlimb morphogenesis |
| GO:0051647 | 0.01592 | 4.51930 | 1 | 4 | 34 | nucleus localization |
| GO:2000108 | 0.01592 | 4.51930 | 1 | 4 | 34 | positive regulation of leukocyte apoptotic process |
| GO:2000406 | 0.01592 | 4.51930 | 1 | 4 | 34 | positive regulation of T cell migration |
| GO:0002027 | 0.01602 | 2.83056 | 3 | 7 | 91 | regulation of heart rate |
| GO:0002028 | 0.01602 | 2.83056 | 3 | 7 | 91 | regulation of sodium ion transport |
| GO:0030838 | 0.01602 | 2.83056 | 3 | 7 | 91 | positive regulation of actin filament polymerization |
| GO:0016192 | 0.01618 | 1.38457 | 42 | 56 | 1453 | vesicle-mediated transport |
| GO:0006936 | 0.01621 | 1.93050 | 8 | 15 | 280 | muscle contraction |
| GO:0002043 | 0.01632 | 6.34966 | 1 | 3 | 19 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:0003215 | 0.01632 | 6.34966 | 1 | 3 | 19 | cardiac right ventricle morphogenesis |
| GO:0007635 | 0.01632 | 6.34966 | 1 | 3 | 19 | chemosensory behavior |
| GO:0009081 | 0.01632 | 6.34966 | 1 | 3 | 19 | branched-chain amino acid metabolic process |
| GO:0010623 | 0.01632 | 6.34966 | 1 | 3 | 19 | programmed cell death involved in cell development |
| GO:0015740 | 0.01632 | 6.34966 | 1 | 3 | 19 | C4-dicarboxylate transport |
| GO:0043931 | 0.01632 | 6.34966 | 1 | 3 | 19 | ossification involved in bone maturation |
| GO:0098840 | 0.01632 | 6.34966 | 1 | 3 | 19 | protein transport along microtubule |
| GO:0099118 | 0.01632 | 6.34966 | 1 | 3 | 19 | microtubule-based protein transport |
| GO:1905874 | 0.01632 | 6.34966 | 1 | 3 | 19 | regulation of postsynaptic density organization |
| GO:2000726 | 0.01632 | 6.34966 | 1 | 3 | 19 | negative regulation of cardiac muscle cell differentiation |
| GO:2001257 | 0.01635 | 2.29894 | 5 | 10 | 158 | regulation of cation channel activity |
| GO:0042733 | 0.01640 | 3.13331 | 2 | 6 | 71 | embryonic digit morphogenesis |
| GO:0050433 | 0.01640 | 3.13331 | 2 | 6 | 71 | regulation of catecholamine secretion |
| GO:0050810 | 0.01640 | 3.13331 | 2 | 6 | 71 | regulation of steroid biosynthetic process |
| GO:0097755 | 0.01640 | 3.13331 | 2 | 6 | 71 | positive regulation of blood vessel diameter |
| GO:0034308 | 0.01662 | 3.60853 | 1 | 5 | 52 | primary alcohol metabolic process |
| GO:0045604 | 0.01662 | 3.60853 | 1 | 5 | 52 | regulation of epidermal cell differentiation |
| GO:0043523 | 0.01684 | 1.97206 | 7 | 14 | 256 | regulation of neuron apoptotic process |
| GO:0007599 | 0.01701 | 2.28341 | 5 | 10 | 159 | hemostasis |
| GO:0042180 | 0.01725 | 2.17695 | 5 | 11 | 183 | cellular ketone metabolic process |
| GO:0030098 | 0.01742 | 1.76354 | 11 | 19 | 387 | lymphocyte differentiation |
| GO:0014743 | 0.01747 | 3.08570 | 2 | 6 | 72 | regulation of muscle hypertrophy |
| GO:0060191 | 0.01747 | 3.08570 | 2 | 6 | 72 | regulation of lipase activity |
| GO:0019432 | 0.01757 | 4.37332 | 1 | 4 | 35 | triglyceride biosynthetic process |
| GO:0055083 | 0.01757 | 4.37332 | 1 | 4 | 35 | monovalent inorganic anion homeostasis |
| GO:0097106 | 0.01757 | 4.37332 | 1 | 4 | 35 | postsynaptic density organization |
| GO:1900026 | 0.01757 | 4.37332 | 1 | 4 | 35 | positive regulation of substrate adhesion-dependent cell spreading |
| GO:0010564 | 0.01767 | 1.60989 | 17 | 26 | 579 | regulation of cell cycle process |
| GO:0060041 | 0.01770 | 2.26808 | 5 | 10 | 160 | retina development in camera-type eye |
| GO:0007050 | 0.01779 | 2.39084 | 4 | 9 | 137 | cell cycle arrest |
| GO:0018108 | 0.01780 | 1.86293 | 9 | 16 | 309 | peptidyl-tyrosine phosphorylation |
| GO:0099565 | 0.01786 | 2.76449 | 3 | 7 | 93 | chemical synaptic transmission, postsynaptic |
| GO:0010517 | 0.01793 | 3.53320 | 2 | 5 | 53 | regulation of phospholipase activity |
| GO:0072678 | 0.01793 | 3.53320 | 2 | 5 | 53 | T cell migration |
| GO:0090303 | 0.01793 | 3.53320 | 2 | 5 | 53 | positive regulation of wound healing |
| GO:0042542 | 0.01817 | 2.54081 | 3 | 8 | 115 | response to hydrogen peroxide |
| GO:0051261 | 0.01817 | 2.54081 | 3 | 8 | 115 | protein depolymerization |
| GO:0031331 | 0.01825 | 1.81870 | 10 | 17 | 336 | positive regulation of cellular catabolic process |
| GO:0050817 | 0.01840 | 2.25296 | 5 | 10 | 161 | coagulation |
| GO:0045843 | 0.01859 | 3.03951 | 2 | 6 | 73 | negative regulation of striated muscle tissue development |
| GO:0051145 | 0.01859 | 3.03951 | 2 | 6 | 73 | smooth muscle cell differentiation |
| GO:0003094 | 0.01880 | 5.97589 | 1 | 3 | 20 | glomerular filtration |
| GO:0003176 | 0.01880 | 5.97589 | 1 | 3 | 20 | aortic valve development |
| GO:0032148 | 0.01880 | 5.97589 | 1 | 3 | 20 | activation of protein kinase B activity |
| GO:0042573 | 0.01880 | 5.97589 | 1 | 3 | 20 | retinoic acid metabolic process |
| GO:0046325 | 0.01880 | 5.97589 | 1 | 3 | 20 | negative regulation of glucose import |
| GO:0050966 | 0.01880 | 5.97589 | 1 | 3 | 20 | detection of mechanical stimulus involved in sensory perception of pain |
| GO:0072079 | 0.01880 | 5.97589 | 1 | 3 | 20 | nephron tubule formation |
| GO:0072148 | 0.01880 | 5.97589 | 1 | 3 | 20 | epithelial cell fate commitment |
| GO:0072170 | 0.01880 | 5.97589 | 1 | 3 | 20 | metanephric tubule development |
| GO:0072243 | 0.01880 | 5.97589 | 1 | 3 | 20 | metanephric nephron epithelium development |
| GO:2001224 | 0.01880 | 5.97589 | 1 | 3 | 20 | positive regulation of neuron migration |
| GO:0002367 | 0.01884 | 2.73259 | 3 | 7 | 94 | cytokine production involved in immune response |
| GO:0007200 | 0.01884 | 2.73259 | 3 | 7 | 94 | phospholipase C-activating G protein-coupled receptor signaling pathway |
| GO:0006873 | 0.01897 | 1.56990 | 18 | 28 | 639 | cellular ion homeostasis |
| GO:0051650 | 0.01899 | 1.93965 | 7 | 14 | 260 | establishment of vesicle localization |
| GO:0045786 | 0.01916 | 1.69268 | 13 | 21 | 445 | negative regulation of cell cycle |
| GO:0018212 | 0.01929 | 1.84380 | 9 | 16 | 312 | peptidyl-tyrosine modification |
| GO:0035019 | 0.01931 | 3.46094 | 2 | 5 | 54 | somatic stem cell population maintenance |
| GO:0035315 | 0.01931 | 3.46094 | 2 | 5 | 54 | hair cell differentiation |
| GO:0014823 | 0.01933 | 4.23647 | 1 | 4 | 36 | response to activity |
| GO:1902475 | 0.01933 | 4.23647 | 1 | 4 | 36 | L-alpha-amino acid transmembrane transport |
| GO:0032675 | 0.01936 | 2.35385 | 4 | 9 | 139 | regulation of interleukin-6 production |
| GO:0006790 | 0.01956 | 1.93171 | 8 | 14 | 261 | sulfur compound metabolic process |
| GO:0006809 | 0.01976 | 2.99468 | 2 | 6 | 74 | nitric oxide biosynthetic process |
| GO:0030148 | 0.01976 | 2.99468 | 2 | 6 | 74 | sphingolipid biosynthetic process |
| GO:0031646 | 0.01976 | 2.99468 | 2 | 6 | 74 | positive regulation of neurological system process |
| GO:0034637 | 0.01976 | 2.99468 | 2 | 6 | 74 | cellular carbohydrate biosynthetic process |
| GO:0050432 | 0.01976 | 2.99468 | 2 | 6 | 74 | catecholamine secretion |
| GO:0060563 | 0.01976 | 2.99468 | 2 | 6 | 74 | neuroepithelial cell differentiation |
| GO:0002793 | 0.01981 | 1.83751 | 9 | 16 | 313 | positive regulation of peptide secretion |
| GO:0034754 | 0.01985 | 2.70142 | 3 | 7 | 95 | cellular hormone metabolic process |
| GO:0043502 | 0.01985 | 2.70142 | 3 | 7 | 95 | regulation of muscle adaptation |
| GO:0051017 | 0.01987 | 2.22331 | 5 | 10 | 163 | actin filament bundle assembly |
| GO:0044706 | 0.01991 | 2.12709 | 5 | 11 | 187 | multi-multicellular organism process |
| GO:0051963 | 0.01994 | 2.49397 | 3 | 8 | 117 | regulation of synapse assembly |
| GO:0031333 | 0.02018 | 2.33577 | 4 | 9 | 140 | negative regulation of protein complex assembly |
| GO:0045637 | 0.02027 | 2.04292 | 6 | 12 | 212 | regulation of myeloid cell differentiation |
| GO:0050731 | 0.02062 | 2.11498 | 5 | 11 | 188 | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0007442 | 0.02065 | 11.27636 | 0 | 2 | 8 | hindgut morphogenesis |
| GO:0009912 | 0.02065 | 11.27636 | 0 | 2 | 8 | auditory receptor cell fate commitment |
| GO:0019374 | 0.02065 | 11.27636 | 0 | 2 | 8 | galactolipid metabolic process |
| GO:0032287 | 0.02065 | 11.27636 | 0 | 2 | 8 | peripheral nervous system myelin maintenance |
| GO:0032344 | 0.02065 | 11.27636 | 0 | 2 | 8 | regulation of aldosterone metabolic process |
| GO:0035814 | 0.02065 | 11.27636 | 0 | 2 | 8 | negative regulation of renal sodium excretion |
| GO:0035912 | 0.02065 | 11.27636 | 0 | 2 | 8 | dorsal aorta morphogenesis |
| GO:0042045 | 0.02065 | 11.27636 | 0 | 2 | 8 | epithelial fluid transport |
| GO:0043320 | 0.02065 | 11.27636 | 0 | 2 | 8 | natural killer cell degranulation |
| GO:0051388 | 0.02065 | 11.27636 | 0 | 2 | 8 | positive regulation of neurotrophin TRK receptor signaling pathway |
| GO:0060120 | 0.02065 | 11.27636 | 0 | 2 | 8 | inner ear receptor cell fate commitment |
| GO:0060907 | 0.02065 | 11.27636 | 0 | 2 | 8 | positive regulation of macrophage cytokine production |
| GO:0062043 | 0.02065 | 11.27636 | 0 | 2 | 8 | positive regulation of cardiac epithelial to mesenchymal transition |
| GO:0070235 | 0.02065 | 11.27636 | 0 | 2 | 8 | regulation of activation-induced cell death of T cells |
| GO:0072201 | 0.02065 | 11.27636 | 0 | 2 | 8 | negative regulation of mesenchymal cell proliferation |
| GO:1903286 | 0.02065 | 11.27636 | 0 | 2 | 8 | regulation of potassium ion import |
| GO:1904996 | 0.02065 | 11.27636 | 0 | 2 | 8 | positive regulation of leukocyte adhesion to vascular endothelial cell |
| GO:2000303 | 0.02065 | 11.27636 | 0 | 2 | 8 | regulation of ceramide biosynthetic process |
| GO:2000543 | 0.02065 | 11.27636 | 0 | 2 | 8 | positive regulation of gastrulation |
| GO:0045184 | 0.02070 | 1.32821 | 52 | 67 | 1812 | establishment of protein localization |
| GO:0003044 | 0.02075 | 3.39157 | 2 | 5 | 55 | regulation of systemic arterial blood pressure mediated by a chemical signal |
| GO:0008584 | 0.02087 | 2.47119 | 3 | 8 | 118 | male gonad development |
| GO:0051952 | 0.02087 | 2.47119 | 3 | 8 | 118 | regulation of amine transport |
| GO:0046849 | 0.02090 | 2.67095 | 3 | 7 | 96 | bone remodeling |
| GO:0006470 | 0.02095 | 1.96806 | 7 | 13 | 238 | protein dephosphorylation |
| GO:0002718 | 0.02097 | 2.95114 | 2 | 6 | 75 | regulation of cytokine production involved in immune response |
| GO:0048635 | 0.02097 | 2.95114 | 2 | 6 | 75 | negative regulation of muscle organ development |
| GO:0072384 | 0.02097 | 2.95114 | 2 | 6 | 75 | organelle transport along microtubule |
| GO:0002700 | 0.02103 | 2.31798 | 4 | 9 | 141 | regulation of production of molecular mediator of immune response |
| GO:0007601 | 0.02103 | 2.31798 | 4 | 9 | 141 | visual perception |
| GO:0055074 | 0.02116 | 1.65270 | 14 | 22 | 477 | calcium ion homeostasis |
| GO:0001953 | 0.02120 | 4.10791 | 1 | 4 | 37 | negative regulation of cell-matrix adhesion |
| GO:0007435 | 0.02120 | 4.10791 | 1 | 4 | 37 | salivary gland morphogenesis |
| GO:0008207 | 0.02120 | 4.10791 | 1 | 4 | 37 | C21-steroid hormone metabolic process |
| GO:0032633 | 0.02120 | 4.10791 | 1 | 4 | 37 | interleukin-4 production |
| GO:0033028 | 0.02120 | 4.10791 | 1 | 4 | 37 | myeloid cell apoptotic process |
| GO:0045684 | 0.02120 | 4.10791 | 1 | 4 | 37 | positive regulation of epidermis development |
| GO:0060674 | 0.02120 | 4.10791 | 1 | 4 | 37 | placenta blood vessel development |
| GO:0010038 | 0.02133 | 1.90827 | 8 | 14 | 264 | response to metal ion |
| GO:0010743 | 0.02147 | 5.64364 | 1 | 3 | 21 | regulation of macrophage derived foam cell differentiation |
| GO:0042094 | 0.02147 | 5.64364 | 1 | 3 | 21 | interleukin-2 biosynthetic process |
| GO:0072111 | 0.02147 | 5.64364 | 1 | 3 | 21 | cell proliferation involved in kidney development |
| GO:0097205 | 0.02147 | 5.64364 | 1 | 3 | 21 | renal filtration |
| GO:1901741 | 0.02147 | 5.64364 | 1 | 3 | 21 | positive regulation of myoblast fusion |
| GO:2000209 | 0.02147 | 5.64364 | 1 | 3 | 21 | regulation of anoikis |
| GO:0051604 | 0.02148 | 1.85947 | 8 | 15 | 290 | protein maturation |
| GO:0031334 | 0.02160 | 1.95926 | 7 | 13 | 239 | positive regulation of protein complex assembly |
| GO:0006644 | 0.02178 | 1.77908 | 10 | 17 | 343 | phospholipid metabolic process |
| GO:0046546 | 0.02183 | 2.44881 | 3 | 8 | 119 | development of primary male sexual characteristics |
| GO:0045216 | 0.02190 | 2.30044 | 4 | 9 | 142 | cell-cell junction organization |
| GO:0045638 | 0.02198 | 2.64115 | 3 | 7 | 97 | negative regulation of myeloid cell differentiation |
| GO:0050954 | 0.02207 | 1.85265 | 8 | 15 | 291 | sensory perception of mechanical stimulus |
| GO:0006672 | 0.02223 | 2.90886 | 2 | 6 | 76 | ceramide metabolic process |
| GO:0042116 | 0.02223 | 2.90886 | 2 | 6 | 76 | macrophage activation |
| GO:0044272 | 0.02223 | 2.90886 | 2 | 6 | 76 | sulfur compound biosynthetic process |
| GO:0034767 | 0.02224 | 2.18027 | 5 | 10 | 166 | positive regulation of ion transmembrane transport |
| GO:0071383 | 0.02224 | 2.18027 | 5 | 10 | 166 | cellular response to steroid hormone stimulus |
| GO:0043620 | 0.02226 | 3.32492 | 2 | 5 | 56 | regulation of DNA-templated transcription in response to stress |
| GO:0050727 | 0.02257 | 1.80668 | 9 | 16 | 318 | regulation of inflammatory response |
| GO:0007586 | 0.02283 | 2.42684 | 3 | 8 | 120 | digestion |
| GO:0007623 | 0.02286 | 2.07945 | 5 | 11 | 191 | circadian rhythm |
| GO:0003230 | 0.02317 | 3.98691 | 1 | 4 | 38 | cardiac atrium development |
| GO:0033628 | 0.02317 | 3.98691 | 1 | 4 | 38 | regulation of cell adhesion mediated by integrin |
| GO:0046460 | 0.02317 | 3.98691 | 1 | 4 | 38 | neutral lipid biosynthetic process |
| GO:0046463 | 0.02317 | 3.98691 | 1 | 4 | 38 | acylglycerol biosynthetic process |
| GO:0060251 | 0.02317 | 3.98691 | 1 | 4 | 38 | regulation of glial cell proliferation |
| GO:1905332 | 0.02317 | 3.98691 | 1 | 4 | 38 | positive regulation of morphogenesis of an epithelium |
| GO:0099537 | 0.02325 | 1.46800 | 25 | 35 | 853 | trans-synaptic signaling |
| GO:0016042 | 0.02329 | 1.83915 | 8 | 15 | 293 | lipid catabolic process |
| GO:0006835 | 0.02354 | 2.86776 | 2 | 6 | 77 | dicarboxylic acid transport |
| GO:0046209 | 0.02354 | 2.86776 | 2 | 6 | 77 | nitric oxide metabolic process |
| GO:0061180 | 0.02354 | 2.86776 | 2 | 6 | 77 | mammary gland epithelium development |
| GO:1902905 | 0.02365 | 2.06787 | 6 | 11 | 192 | positive regulation of supramolecular fiber organization |
| GO:0006865 | 0.02372 | 2.26616 | 4 | 9 | 144 | amino acid transport |
| GO:0062013 | 0.02372 | 2.26616 | 4 | 9 | 144 | positive regulation of small molecule metabolic process |
| GO:0070665 | 0.02372 | 2.26616 | 4 | 9 | 144 | positive regulation of leukocyte proliferation |
| GO:0015909 | 0.02385 | 3.26083 | 2 | 5 | 57 | long-chain fatty acid transport |
| GO:0045123 | 0.02385 | 3.26083 | 2 | 5 | 57 | cellular extravasation |
| GO:0098900 | 0.02385 | 3.26083 | 2 | 5 | 57 | regulation of action potential |
| GO:1901016 | 0.02385 | 3.26083 | 2 | 5 | 57 | regulation of potassium ion transmembrane transporter activity |
| GO:1903510 | 0.02385 | 3.26083 | 2 | 5 | 57 | mucopolysaccharide metabolic process |
| GO:0001959 | 0.02427 | 2.58351 | 3 | 7 | 99 | regulation of cytokine-mediated signaling pathway |
| GO:0034440 | 0.02427 | 2.58351 | 3 | 7 | 99 | lipid oxidation |
| GO:0003323 | 0.02434 | 5.34637 | 1 | 3 | 22 | type B pancreatic cell development |
| GO:0015874 | 0.02434 | 5.34637 | 1 | 3 | 22 | norepinephrine transport |
| GO:0042537 | 0.02434 | 5.34637 | 1 | 3 | 22 | benzene-containing compound metabolic process |
| GO:0044851 | 0.02434 | 5.34637 | 1 | 3 | 22 | hair cycle phase |
| GO:0051194 | 0.02434 | 5.34637 | 1 | 3 | 22 | positive regulation of cofactor metabolic process |
| GO:0051797 | 0.02434 | 5.34637 | 1 | 3 | 22 | regulation of hair follicle development |
| GO:0070230 | 0.02434 | 5.34637 | 1 | 3 | 22 | positive regulation of lymphocyte apoptotic process |
| GO:0072574 | 0.02434 | 5.34637 | 1 | 3 | 22 | hepatocyte proliferation |
| GO:0072575 | 0.02434 | 5.34637 | 1 | 3 | 22 | epithelial cell proliferation involved in liver morphogenesis |
| GO:1901623 | 0.02434 | 5.34637 | 1 | 3 | 22 | regulation of lymphocyte chemotaxis |
| GO:1902307 | 0.02434 | 5.34637 | 1 | 3 | 22 | positive regulation of sodium ion transmembrane transport |
| GO:2001026 | 0.02434 | 5.34637 | 1 | 3 | 22 | regulation of endothelial cell chemotaxis |
| GO:0006875 | 0.02443 | 1.57474 | 16 | 25 | 568 | cellular metal ion homeostasis |
| GO:0050953 | 0.02468 | 2.24940 | 4 | 9 | 145 | sensory perception of light stimulus |
| GO:0015837 | 0.02491 | 2.38405 | 4 | 8 | 122 | amine transport |
| GO:0050805 | 0.02491 | 2.82780 | 2 | 6 | 78 | negative regulation of synaptic transmission |
| GO:0018209 | 0.02498 | 1.78274 | 9 | 16 | 322 | peptidyl-serine modification |
| GO:0007257 | 0.02524 | 3.87282 | 1 | 4 | 39 | activation of JUN kinase activity |
| GO:0031670 | 0.02524 | 3.87282 | 1 | 4 | 39 | cellular response to nutrient |
| GO:0046627 | 0.02524 | 3.87282 | 1 | 4 | 39 | negative regulation of insulin receptor signaling pathway |
| GO:0097484 | 0.02524 | 3.87282 | 1 | 4 | 39 | dendrite extension |
| GO:1903053 | 0.02524 | 3.87282 | 1 | 4 | 39 | regulation of extracellular matrix organization |
| GO:2001025 | 0.02524 | 3.87282 | 1 | 4 | 39 | positive regulation of response to drug |
| GO:0009743 | 0.02528 | 2.04509 | 6 | 11 | 194 | response to carbohydrate |
| GO:0046907 | 0.02528 | 1.34548 | 43 | 56 | 1491 | intracellular transport |
| GO:0001947 | 0.02550 | 3.19916 | 2 | 5 | 58 | heart looping |
| GO:0015807 | 0.02550 | 3.19916 | 2 | 5 | 58 | L-amino acid transport |
| GO:1902017 | 0.02550 | 3.19916 | 2 | 5 | 58 | regulation of cilium assembly |
| GO:0032635 | 0.02565 | 2.23288 | 4 | 9 | 146 | interleukin-6 production |
| GO:0043409 | 0.02570 | 2.12538 | 5 | 10 | 170 | negative regulation of MAPK cascade |
| GO:0009582 | 0.02599 | 2.36322 | 4 | 8 | 123 | detection of abiotic stimulus |
| GO:0032273 | 0.02599 | 2.36322 | 4 | 8 | 123 | positive regulation of protein polymerization |
| GO:0003223 | 0.02605 | 9.66502 | 0 | 2 | 9 | ventricular compact myocardium morphogenesis |
| GO:0003344 | 0.02605 | 9.66502 | 0 | 2 | 9 | pericardium morphogenesis |
| GO:0007567 | 0.02605 | 9.66502 | 0 | 2 | 9 | parturition |
| GO:0015791 | 0.02605 | 9.66502 | 0 | 2 | 9 | polyol transport |
| GO:0015886 | 0.02605 | 9.66502 | 0 | 2 | 9 | heme transport |
| GO:0032836 | 0.02605 | 9.66502 | 0 | 2 | 9 | glomerular basement membrane development |
| GO:0033689 | 0.02605 | 9.66502 | 0 | 2 | 9 | negative regulation of osteoblast proliferation |
| GO:0034351 | 0.02605 | 9.66502 | 0 | 2 | 9 | negative regulation of glial cell apoptotic process |
| GO:0035234 | 0.02605 | 9.66502 | 0 | 2 | 9 | ectopic germ cell programmed cell death |
| GO:0043031 | 0.02605 | 9.66502 | 0 | 2 | 9 | negative regulation of macrophage activation |
| GO:0043569 | 0.02605 | 9.66502 | 0 | 2 | 9 | negative regulation of insulin-like growth factor receptor signaling pathway |
| GO:0046113 | 0.02605 | 9.66502 | 0 | 2 | 9 | nucleobase catabolic process |
| GO:0046533 | 0.02605 | 9.66502 | 0 | 2 | 9 | negative regulation of photoreceptor cell differentiation |
| GO:0048819 | 0.02605 | 9.66502 | 0 | 2 | 9 | regulation of hair follicle maturation |
| GO:0060406 | 0.02605 | 9.66502 | 0 | 2 | 9 | positive regulation of penile erection |
| GO:0060638 | 0.02605 | 9.66502 | 0 | 2 | 9 | mesenchymal-epithelial cell signaling |
| GO:0061009 | 0.02605 | 9.66502 | 0 | 2 | 9 | common bile duct development |
| GO:0061370 | 0.02605 | 9.66502 | 0 | 2 | 9 | testosterone biosynthetic process |
| GO:0061525 | 0.02605 | 9.66502 | 0 | 2 | 9 | hindgut development |
| GO:0071372 | 0.02605 | 9.66502 | 0 | 2 | 9 | cellular response to follicle-stimulating hormone stimulus |
| GO:0090091 | 0.02605 | 9.66502 | 0 | 2 | 9 | positive regulation of extracellular matrix disassembly |
| GO:0090153 | 0.02605 | 9.66502 | 0 | 2 | 9 | regulation of sphingolipid biosynthetic process |
| GO:0099545 | 0.02605 | 9.66502 | 0 | 2 | 9 | trans-synaptic signaling by trans-synaptic complex |
| GO:0099641 | 0.02605 | 9.66502 | 0 | 2 | 9 | anterograde axonal protein transport |
| GO:1902033 | 0.02605 | 9.66502 | 0 | 2 | 9 | regulation of hematopoietic stem cell proliferation |
| GO:1902669 | 0.02605 | 9.66502 | 0 | 2 | 9 | positive regulation of axon guidance |
| GO:1903242 | 0.02605 | 9.66502 | 0 | 2 | 9 | regulation of cardiac muscle hypertrophy in response to stress |
| GO:1905038 | 0.02605 | 9.66502 | 0 | 2 | 9 | regulation of membrane lipid metabolic process |
| GO:1905383 | 0.02605 | 9.66502 | 0 | 2 | 9 | protein localization to presynapse |
| GO:2000392 | 0.02605 | 9.66502 | 0 | 2 | 9 | regulation of lamellipodium morphogenesis |
| GO:0006996 | 0.02611 | 1.23141 | 101 | 119 | 3492 | organelle organization |
| GO:0099536 | 0.02620 | 1.45324 | 25 | 35 | 861 | synaptic signaling |
| GO:0006874 | 0.02634 | 1.63373 | 13 | 21 | 460 | cellular calcium ion homeostasis |
| GO:0061024 | 0.02661 | 1.48735 | 21 | 31 | 745 | membrane organization |
| GO:0032680 | 0.02666 | 2.21660 | 4 | 9 | 147 | regulation of tumor necrosis factor production |
| GO:0007519 | 0.02699 | 2.02280 | 6 | 11 | 196 | skeletal muscle tissue development |
| GO:0009581 | 0.02711 | 2.34274 | 4 | 8 | 124 | detection of external stimulus |
| GO:0015872 | 0.02722 | 3.13978 | 2 | 5 | 59 | dopamine transport |
| GO:0030837 | 0.02722 | 3.13978 | 2 | 5 | 59 | negative regulation of actin filament polymerization |
| GO:0034394 | 0.02722 | 3.13978 | 2 | 5 | 59 | protein localization to cell surface |
| GO:0060986 | 0.02722 | 3.13978 | 2 | 5 | 59 | endocrine hormone secretion |
| GO:1903829 | 0.02725 | 1.79981 | 9 | 15 | 299 | positive regulation of cellular protein localization |
| GO:0002719 | 0.02741 | 5.07883 | 1 | 3 | 23 | negative regulation of cytokine production involved in immune response |
| GO:0030539 | 0.02741 | 5.07883 | 1 | 3 | 23 | male genitalia development |
| GO:0031954 | 0.02741 | 5.07883 | 1 | 3 | 23 | positive regulation of protein autophosphorylation |
| GO:0043496 | 0.02741 | 5.07883 | 1 | 3 | 23 | regulation of protein homodimerization activity |
| GO:0072207 | 0.02741 | 5.07883 | 1 | 3 | 23 | metanephric epithelium development |
| GO:0090190 | 0.02741 | 5.07883 | 1 | 3 | 23 | positive regulation of branching involved in ureteric bud morphogenesis |
| GO:1905208 | 0.02741 | 5.07883 | 1 | 3 | 23 | negative regulation of cardiocyte differentiation |
| GO:0035307 | 0.02743 | 3.76508 | 1 | 4 | 40 | positive regulation of protein dephosphorylation |
| GO:0038179 | 0.02743 | 3.76508 | 1 | 4 | 40 | neurotrophin signaling pathway |
| GO:0050435 | 0.02743 | 3.76508 | 1 | 4 | 40 | amyloid-beta metabolic process |
| GO:0060122 | 0.02743 | 3.76508 | 1 | 4 | 40 | inner ear receptor cell stereocilium organization |
| GO:1903523 | 0.02743 | 3.76508 | 1 | 4 | 40 | negative regulation of blood circulation |
| GO:0002684 | 0.02763 | 1.40529 | 30 | 41 | 1043 | positive regulation of immune system process |
| GO:0006937 | 0.02769 | 2.20056 | 4 | 9 | 148 | regulation of muscle contraction |
| GO:0008360 | 0.02769 | 2.20056 | 4 | 9 | 148 | regulation of cell shape |
| GO:0010950 | 0.02769 | 2.20056 | 4 | 9 | 148 | positive regulation of endopeptidase activity |
| GO:1901214 | 0.02771 | 1.72536 | 10 | 17 | 353 | regulation of neuron death |
| GO:0099003 | 0.02810 | 1.88347 | 7 | 13 | 248 | vesicle-mediated transport in synapse |
| GO:0050670 | 0.02859 | 1.93547 | 6 | 12 | 223 | regulation of lymphocyte proliferation |
| GO:0018105 | 0.02867 | 1.78707 | 9 | 15 | 301 | peptidyl-serine phosphorylation |
| GO:0032640 | 0.02875 | 2.18474 | 4 | 9 | 149 | tumor necrosis factor production |
| GO:1903555 | 0.02875 | 2.18474 | 4 | 9 | 149 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0097529 | 0.02878 | 2.00098 | 6 | 11 | 198 | myeloid leukocyte migration |
| GO:1904018 | 0.02878 | 2.00098 | 6 | 11 | 198 | positive regulation of vasculature development |
| GO:0001207 | 0.02879 | Inf | 0 | 1 | 1 | histone displacement |
| GO:0001519 | 0.02879 | Inf | 0 | 1 | 1 | peptide amidation |
| GO:0001715 | 0.02879 | Inf | 0 | 1 | 1 | ectodermal cell fate specification |
| GO:0002174 | 0.02879 | Inf | 0 | 1 | 1 | mammary stem cell proliferation |
| GO:0002785 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of antimicrobial peptide production |
| GO:0002787 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of antibacterial peptide production |
| GO:0003059 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of the force of heart contraction by epinephrine |
| GO:0003138 | 0.02879 | Inf | 0 | 1 | 1 | primary heart field specification |
| GO:0003172 | 0.02879 | Inf | 0 | 1 | 1 | sinoatrial valve development |
| GO:0003178 | 0.02879 | Inf | 0 | 1 | 1 | coronary sinus valve development |
| GO:0003182 | 0.02879 | Inf | 0 | 1 | 1 | coronary sinus valve morphogenesis |
| GO:0003185 | 0.02879 | Inf | 0 | 1 | 1 | sinoatrial valve morphogenesis |
| GO:0003243 | 0.02879 | Inf | 0 | 1 | 1 | circumferential growth involved in left ventricle morphogenesis |
| GO:0003270 | 0.02879 | Inf | 0 | 1 | 1 | Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation |
| GO:0003421 | 0.02879 | Inf | 0 | 1 | 1 | growth plate cartilage axis specification |
| GO:0006147 | 0.02879 | Inf | 0 | 1 | 1 | guanine catabolic process |
| GO:0006535 | 0.02879 | Inf | 0 | 1 | 1 | cysteine biosynthetic process from serine |
| GO:0006539 | 0.02879 | Inf | 0 | 1 | 1 | glutamate catabolic process via 2-oxoglutarate |
| GO:0007497 | 0.02879 | Inf | 0 | 1 | 1 | posterior midgut development |
| GO:0008057 | 0.02879 | Inf | 0 | 1 | 1 | eye pigment granule organization |
| GO:0008348 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of antimicrobial humoral response |
| GO:0010585 | 0.02879 | Inf | 0 | 1 | 1 | glutamine secretion |
| GO:0010849 | 0.02879 | Inf | 0 | 1 | 1 | regulation of proton-transporting ATPase activity, rotational mechanism |
| GO:0014861 | 0.02879 | Inf | 0 | 1 | 1 | regulation of skeletal muscle contraction via regulation of action potential |
| GO:0016131 | 0.02879 | Inf | 0 | 1 | 1 | brassinosteroid metabolic process |
| GO:0016132 | 0.02879 | Inf | 0 | 1 | 1 | brassinosteroid biosynthetic process |
| GO:0017055 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly |
| GO:0018032 | 0.02879 | Inf | 0 | 1 | 1 | protein amidation |
| GO:0019102 | 0.02879 | Inf | 0 | 1 | 1 | male somatic sex determination |
| GO:0019483 | 0.02879 | Inf | 0 | 1 | 1 | beta-alanine biosynthetic process |
| GO:0019484 | 0.02879 | Inf | 0 | 1 | 1 | beta-alanine catabolic process |
| GO:0030451 | 0.02879 | Inf | 0 | 1 | 1 | regulation of complement activation, alternative pathway |
| GO:0030704 | 0.02879 | Inf | 0 | 1 | 1 | vitelline membrane formation |
| GO:0032848 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of cellular pH reduction |
| GO:0033396 | 0.02879 | Inf | 0 | 1 | 1 | beta-alanine biosynthetic process via 3-ureidopropionate |
| GO:0035378 | 0.02879 | Inf | 0 | 1 | 1 | carbon dioxide transmembrane transport |
| GO:0035499 | 0.02879 | Inf | 0 | 1 | 1 | carnosine biosynthetic process |
| GO:0035602 | 0.02879 | Inf | 0 | 1 | 1 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow |
| GO:0035603 | 0.02879 | Inf | 0 | 1 | 1 | fibroblast growth factor receptor signaling pathway involved in hemopoiesis |
| GO:0035604 | 0.02879 | Inf | 0 | 1 | 1 | fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow |
| GO:0035645 | 0.02879 | Inf | 0 | 1 | 1 | enteric smooth muscle cell differentiation |
| GO:0035921 | 0.02879 | Inf | 0 | 1 | 1 | desmosome disassembly |
| GO:0036290 | 0.02879 | Inf | 0 | 1 | 1 | protein trans-autophosphorylation |
| GO:0036517 | 0.02879 | Inf | 0 | 1 | 1 | chemoattraction of serotonergic neuron axon |
| GO:0038133 | 0.02879 | Inf | 0 | 1 | 1 | ERBB2-ERBB3 signaling pathway |
| GO:0038167 | 0.02879 | Inf | 0 | 1 | 1 | epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity |
| GO:0038168 | 0.02879 | Inf | 0 | 1 | 1 | epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade |
| GO:0038172 | 0.02879 | Inf | 0 | 1 | 1 | interleukin-33-mediated signaling pathway |
| GO:0042665 | 0.02879 | Inf | 0 | 1 | 1 | regulation of ectodermal cell fate specification |
| GO:0042666 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of ectodermal cell fate specification |
| GO:0042883 | 0.02879 | Inf | 0 | 1 | 1 | cysteine transport |
| GO:0043322 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of natural killer cell degranulation |
| GO:0043375 | 0.02879 | Inf | 0 | 1 | 1 | CD8-positive, alpha-beta T cell lineage commitment |
| GO:0043990 | 0.02879 | Inf | 0 | 1 | 1 | histone H2A-S1 phosphorylation |
| GO:0044722 | 0.02879 | Inf | 0 | 1 | 1 | renal phosphate excretion |
| GO:0045081 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of interleukin-10 biosynthetic process |
| GO:0045175 | 0.02879 | Inf | 0 | 1 | 1 | basal protein localization |
| GO:0045957 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of complement activation, alternative pathway |
| GO:0045959 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of complement activation, classical pathway |
| GO:0046398 | 0.02879 | Inf | 0 | 1 | 1 | UDP-glucuronate metabolic process |
| GO:0046722 | 0.02879 | Inf | 0 | 1 | 1 | lactic acid secretion |
| GO:0048074 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of eye pigmentation |
| GO:0048086 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of developmental pigmentation |
| GO:0050653 | 0.02879 | Inf | 0 | 1 | 1 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process |
| GO:0050894 | 0.02879 | Inf | 0 | 1 | 1 | determination of affect |
| GO:0051039 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of transcription involved in meiotic cell cycle |
| GO:0051042 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of calcium-independent cell-cell adhesion |
| GO:0051638 | 0.02879 | Inf | 0 | 1 | 1 | barbed-end actin filament uncapping |
| GO:0060212 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of nuclear-transcribed mRNA poly(A) tail shortening |
| GO:0060365 | 0.02879 | Inf | 0 | 1 | 1 | coronal suture morphogenesis |
| GO:0060514 | 0.02879 | Inf | 0 | 1 | 1 | prostate induction |
| GO:0060515 | 0.02879 | Inf | 0 | 1 | 1 | prostate field specification |
| GO:0060520 | 0.02879 | Inf | 0 | 1 | 1 | activation of prostate induction by androgen receptor signaling pathway |
| GO:0060804 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of Wnt signaling pathway by BMP signaling pathway |
| GO:0060843 | 0.02879 | Inf | 0 | 1 | 1 | venous endothelial cell differentiation |
| GO:0061011 | 0.02879 | Inf | 0 | 1 | 1 | hepatic duct development |
| GO:0061163 | 0.02879 | Inf | 0 | 1 | 1 | endoplasmic reticulum polarization |
| GO:0061301 | 0.02879 | Inf | 0 | 1 | 1 | cerebellum vasculature morphogenesis |
| GO:0061573 | 0.02879 | Inf | 0 | 1 | 1 | actin filament bundle retrograde transport |
| GO:0061682 | 0.02879 | Inf | 0 | 1 | 1 | seminal vesicle morphogenesis |
| GO:0061885 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of mini excitatory postsynaptic potential |
| GO:0061986 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of transcription by glucose |
| GO:0061987 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of transcription from RNA polymerase II promoter by glucose |
| GO:0070054 | 0.02879 | Inf | 0 | 1 | 1 | mRNA splicing, via endonucleolytic cleavage and ligation |
| GO:0070367 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of hepatocyte differentiation |
| GO:0070543 | 0.02879 | Inf | 0 | 1 | 1 | response to linoleic acid |
| GO:0072019 | 0.02879 | Inf | 0 | 1 | 1 | proximal convoluted tubule development |
| GO:0072020 | 0.02879 | Inf | 0 | 1 | 1 | proximal straight tubule development |
| GO:0072022 | 0.02879 | Inf | 0 | 1 | 1 | descending thin limb development |
| GO:0072024 | 0.02879 | Inf | 0 | 1 | 1 | macula densa development |
| GO:0072032 | 0.02879 | Inf | 0 | 1 | 1 | proximal convoluted tubule segment 2 development |
| GO:0072206 | 0.02879 | Inf | 0 | 1 | 1 | metanephric juxtaglomerular apparatus development |
| GO:0072220 | 0.02879 | Inf | 0 | 1 | 1 | metanephric descending thin limb development |
| GO:0072227 | 0.02879 | Inf | 0 | 1 | 1 | metanephric macula densa development |
| GO:0072229 | 0.02879 | Inf | 0 | 1 | 1 | metanephric proximal convoluted tubule development |
| GO:0072230 | 0.02879 | Inf | 0 | 1 | 1 | metanephric proximal straight tubule development |
| GO:0072232 | 0.02879 | Inf | 0 | 1 | 1 | metanephric proximal convoluted tubule segment 2 development |
| GO:0072237 | 0.02879 | Inf | 0 | 1 | 1 | metanephric proximal tubule development |
| GO:0072560 | 0.02879 | Inf | 0 | 1 | 1 | type B pancreatic cell maturation |
| GO:0072702 | 0.02879 | Inf | 0 | 1 | 1 | response to methyl methanesulfonate |
| GO:0072703 | 0.02879 | Inf | 0 | 1 | 1 | cellular response to methyl methanesulfonate |
| GO:0085018 | 0.02879 | Inf | 0 | 1 | 1 | maintenance of symbiont-containing vacuole by host |
| GO:0086100 | 0.02879 | Inf | 0 | 1 | 1 | endothelin receptor signaling pathway |
| GO:0090095 | 0.02879 | Inf | 0 | 1 | 1 | regulation of metanephric cap mesenchymal cell proliferation |
| GO:0090096 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of metanephric cap mesenchymal cell proliferation |
| GO:0097241 | 0.02879 | Inf | 0 | 1 | 1 | hematopoietic stem cell migration to bone marrow |
| GO:0097291 | 0.02879 | Inf | 0 | 1 | 1 | renal phosphate ion absorption |
| GO:0097403 | 0.02879 | Inf | 0 | 1 | 1 | cellular response to raffinose |
| GO:0097640 | 0.02879 | Inf | 0 | 1 | 1 | L-ornithine import across plasma membrane |
| GO:0100001 | 0.02879 | Inf | 0 | 1 | 1 | regulation of skeletal muscle contraction by action potential |
| GO:0106088 | 0.02879 | Inf | 0 | 1 | 1 | regulation of cell adhesion involved in sprouting angiogenesis |
| GO:0106089 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of cell adhesion involved in sprouting angiogenesis |
| GO:0110026 | 0.02879 | Inf | 0 | 1 | 1 | regulation of DNA strand resection involved in replication fork processing |
| GO:0110113 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of lipid transporter activity |
| GO:0120077 | 0.02879 | Inf | 0 | 1 | 1 | angiogenic sprout fusion |
| GO:0120078 | 0.02879 | Inf | 0 | 1 | 1 | cell adhesion involved in sprouting angiogenesis |
| GO:0140075 | 0.02879 | Inf | 0 | 1 | 1 | regulation of lipoprotein transport |
| GO:0140077 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of lipoprotein transport |
| GO:0150024 | 0.02879 | Inf | 0 | 1 | 1 | oxidised low-density lipoprotein particle clearance |
| GO:0150070 | 0.02879 | Inf | 0 | 1 | 1 | regulation of arginase activity |
| GO:0150072 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of arginase activity |
| GO:0150073 | 0.02879 | Inf | 0 | 1 | 1 | regulation of protein-glutamine gamma-glutamyltransferase activity |
| GO:0150074 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of protein-glutamine gamma-glutamyltransferase activity |
| GO:1900152 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
| GO:1900161 | 0.02879 | Inf | 0 | 1 | 1 | regulation of phospholipid scramblase activity |
| GO:1900163 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of phospholipid scramblase activity |
| GO:1900276 | 0.02879 | Inf | 0 | 1 | 1 | regulation of proteinase activated receptor activity |
| GO:1900387 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter |
| GO:1900737 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway |
| GO:1901297 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment |
| GO:1901545 | 0.02879 | Inf | 0 | 1 | 1 | response to raffinose |
| GO:1901627 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of postsynaptic membrane organization |
| GO:1902178 | 0.02879 | Inf | 0 | 1 | 1 | fibroblast growth factor receptor apoptotic signaling pathway |
| GO:1903048 | 0.02879 | Inf | 0 | 1 | 1 | regulation of acetylcholine-gated cation channel activity |
| GO:1903165 | 0.02879 | Inf | 0 | 1 | 1 | response to polycyclic arene |
| GO:1903166 | 0.02879 | Inf | 0 | 1 | 1 | cellular response to polycyclic arene |
| GO:1903402 | 0.02879 | Inf | 0 | 1 | 1 | regulation of renal phosphate excretion |
| GO:1903403 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of renal phosphate excretion |
| GO:1903450 | 0.02879 | Inf | 0 | 1 | 1 | regulation of G1 to G0 transition |
| GO:1903452 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of G1 to G0 transition |
| GO:1903597 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of gap junction assembly |
| GO:1903697 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of microvillus assembly |
| GO:1903701 | 0.02879 | Inf | 0 | 1 | 1 | substantia propria of cornea development |
| GO:1903720 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of I-kappaB phosphorylation |
| GO:1903744 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of anterograde synaptic vesicle transport |
| GO:1903803 | 0.02879 | Inf | 0 | 1 | 1 | L-glutamine import across plasma membrane |
| GO:1903910 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of receptor clustering |
| GO:1904005 | 0.02879 | Inf | 0 | 1 | 1 | regulation of phospholipase D activity |
| GO:1904006 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of phospholipase D activity |
| GO:1904205 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of skeletal muscle hypertrophy |
| GO:1904394 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of skeletal muscle acetylcholine-gated channel clustering |
| GO:1904441 | 0.02879 | Inf | 0 | 1 | 1 | regulation of thyroid gland epithelial cell proliferation |
| GO:1904442 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of thyroid gland epithelial cell proliferation |
| GO:1904675 | 0.02879 | Inf | 0 | 1 | 1 | regulation of somatic stem cell division |
| GO:1904677 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of somatic stem cell division |
| GO:1904681 | 0.02879 | Inf | 0 | 1 | 1 | response to 3-methylcholanthrene |
| GO:1904682 | 0.02879 | Inf | 0 | 1 | 1 | cellular response to 3-methylcholanthrene |
| GO:1904837 | 0.02879 | Inf | 0 | 1 | 1 | beta-catenin-TCF complex assembly |
| GO:1904863 | 0.02879 | Inf | 0 | 1 | 1 | regulation of beta-catenin-TCF complex assembly |
| GO:1904864 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of beta-catenin-TCF complex assembly |
| GO:1904934 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of cell proliferation in midbrain |
| GO:1904935 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of cell proliferation in midbrain |
| GO:1905068 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of canonical Wnt signaling pathway involved in heart development |
| GO:1990256 | 0.02879 | Inf | 0 | 1 | 1 | signal clustering |
| GO:1990579 | 0.02879 | Inf | 0 | 1 | 1 | peptidyl-serine trans-autophosphorylation |
| GO:1990771 | 0.02879 | Inf | 0 | 1 | 1 | clathrin-dependent extracellular exosome endocytosis |
| GO:1990789 | 0.02879 | Inf | 0 | 1 | 1 | thyroid gland epithelial cell proliferation |
| GO:1990790 | 0.02879 | Inf | 0 | 1 | 1 | response to glial cell derived neurotrophic factor |
| GO:1990792 | 0.02879 | Inf | 0 | 1 | 1 | cellular response to glial cell derived neurotrophic factor |
| GO:2000101 | 0.02879 | Inf | 0 | 1 | 1 | regulation of mammary stem cell proliferation |
| GO:2000103 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of mammary stem cell proliferation |
| GO:2000230 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of pancreatic stellate cell proliferation |
| GO:2000446 | 0.02879 | Inf | 0 | 1 | 1 | regulation of macrophage migration inhibitory factor signaling pathway |
| GO:2000577 | 0.02879 | Inf | 0 | 1 | 1 | regulation of ATP-dependent microtubule motor activity, minus-end-directed |
| GO:2000578 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of ATP-dependent microtubule motor activity, minus-end-directed |
| GO:2000752 | 0.02879 | Inf | 0 | 1 | 1 | regulation of glucosylceramide catabolic process |
| GO:2000753 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of glucosylceramide catabolic process |
| GO:2000754 | 0.02879 | Inf | 0 | 1 | 1 | regulation of sphingomyelin catabolic process |
| GO:2000755 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of sphingomyelin catabolic process |
| GO:2000970 | 0.02879 | Inf | 0 | 1 | 1 | regulation of detection of glucose |
| GO:2000971 | 0.02879 | Inf | 0 | 1 | 1 | negative regulation of detection of glucose |
| GO:2001031 | 0.02879 | Inf | 0 | 1 | 1 | positive regulation of cellular glucuronidation |
| GO:0002694 | 0.02918 | 1.51914 | 18 | 27 | 635 | regulation of leukocyte activation |
| GO:0042306 | 0.02931 | 2.71433 | 2 | 6 | 81 | regulation of protein import into nucleus |
| GO:0048663 | 0.02931 | 2.71433 | 2 | 6 | 81 | neuron fate commitment |
| GO:1901888 | 0.02931 | 2.71433 | 2 | 6 | 81 | regulation of cell junction assembly |
| GO:0002698 | 0.02945 | 2.30283 | 4 | 8 | 126 | negative regulation of immune effector process |
| GO:0035148 | 0.02953 | 2.07317 | 5 | 10 | 174 | tube formation |
| GO:0021696 | 0.02972 | 3.66316 | 1 | 4 | 41 | cerebellar cortex morphogenesis |
| GO:1901381 | 0.02972 | 3.66316 | 1 | 4 | 41 | positive regulation of potassium ion transmembrane transport |
| GO:0002792 | 0.02984 | 2.16915 | 4 | 9 | 150 | negative regulation of peptide secretion |
| GO:0032944 | 0.03033 | 1.91712 | 6 | 12 | 225 | regulation of mononuclear cell proliferation |
| GO:0062009 | 0.03067 | 4.83677 | 1 | 3 | 24 | secondary palate development |
| GO:0072576 | 0.03067 | 4.83677 | 1 | 3 | 24 | liver morphogenesis |
| GO:0090280 | 0.03067 | 4.83677 | 1 | 3 | 24 | positive regulation of calcium ion import |
| GO:1901739 | 0.03067 | 4.83677 | 1 | 3 | 24 | regulation of myoblast fusion |
| GO:1905809 | 0.03067 | 4.83677 | 1 | 3 | 24 | negative regulation of synapse organization |
| GO:0022600 | 0.03070 | 2.44979 | 3 | 7 | 104 | digestive system process |
| GO:0030316 | 0.03070 | 2.44979 | 3 | 7 | 104 | osteoclast differentiation |
| GO:0032414 | 0.03070 | 2.44979 | 3 | 7 | 104 | positive regulation of ion transmembrane transporter activity |
| GO:0015833 | 0.03071 | 1.30447 | 51 | 64 | 1757 | peptide transport |
| GO:0030162 | 0.03077 | 1.48798 | 20 | 29 | 696 | regulation of proteolysis |
| GO:0051899 | 0.03089 | 2.67849 | 2 | 6 | 82 | membrane depolarization |
| GO:2001057 | 0.03089 | 2.67849 | 2 | 6 | 82 | reactive nitrogen species metabolic process |
| GO:2001238 | 0.03089 | 3.02738 | 2 | 5 | 61 | positive regulation of extrinsic apoptotic signaling pathway |
| GO:0007264 | 0.03093 | 1.60391 | 13 | 21 | 468 | small GTPase mediated signal transduction |
| GO:0031400 | 0.03173 | 1.54735 | 16 | 24 | 554 | negative regulation of protein modification process |
| GO:0046822 | 0.03193 | 2.26425 | 4 | 8 | 128 | regulation of nucleocytoplasmic transport |
| GO:0002934 | 0.03195 | 8.45652 | 0 | 2 | 10 | desmosome organization |
| GO:0003129 | 0.03195 | 8.45652 | 0 | 2 | 10 | heart induction |
| GO:0003211 | 0.03195 | 8.45652 | 0 | 2 | 10 | cardiac ventricle formation |
| GO:0010459 | 0.03195 | 8.45652 | 0 | 2 | 10 | negative regulation of heart rate |
| GO:0010612 | 0.03195 | 8.45652 | 0 | 2 | 10 | regulation of cardiac muscle adaptation |
| GO:0032342 | 0.03195 | 8.45652 | 0 | 2 | 10 | aldosterone biosynthetic process |
| GO:0032354 | 0.03195 | 8.45652 | 0 | 2 | 10 | response to follicle-stimulating hormone |
| GO:0035907 | 0.03195 | 8.45652 | 0 | 2 | 10 | dorsal aorta development |
| GO:0040009 | 0.03195 | 8.45652 | 0 | 2 | 10 | regulation of growth rate |
| GO:0043497 | 0.03195 | 8.45652 | 0 | 2 | 10 | regulation of protein heterodimerization activity |
| GO:0045176 | 0.03195 | 8.45652 | 0 | 2 | 10 | apical protein localization |
| GO:0045607 | 0.03195 | 8.45652 | 0 | 2 | 10 | regulation of inner ear auditory receptor cell differentiation |
| GO:0045631 | 0.03195 | 8.45652 | 0 | 2 | 10 | regulation of mechanoreceptor differentiation |
| GO:0051971 | 0.03195 | 8.45652 | 0 | 2 | 10 | positive regulation of transmission of nerve impulse |
| GO:0060379 | 0.03195 | 8.45652 | 0 | 2 | 10 | cardiac muscle cell myoblast differentiation |
| GO:0060710 | 0.03195 | 8.45652 | 0 | 2 | 10 | chorio-allantoic fusion |
| GO:0060982 | 0.03195 | 8.45652 | 0 | 2 | 10 | coronary artery morphogenesis |
| GO:0072203 | 0.03195 | 8.45652 | 0 | 2 | 10 | cell proliferation involved in metanephros development |
| GO:0090281 | 0.03195 | 8.45652 | 0 | 2 | 10 | negative regulation of calcium ion import |
| GO:0098908 | 0.03195 | 8.45652 | 0 | 2 | 10 | regulation of neuronal action potential |
| GO:1900103 | 0.03195 | 8.45652 | 0 | 2 | 10 | positive regulation of endoplasmic reticulum unfolded protein response |
| GO:1901142 | 0.03195 | 8.45652 | 0 | 2 | 10 | insulin metabolic process |
| GO:1902513 | 0.03195 | 8.45652 | 0 | 2 | 10 | regulation of organelle transport along microtubule |
| GO:1903365 | 0.03195 | 8.45652 | 0 | 2 | 10 | regulation of fear response |
| GO:1904396 | 0.03195 | 8.45652 | 0 | 2 | 10 | regulation of neuromuscular junction development |
| GO:2000402 | 0.03195 | 8.45652 | 0 | 2 | 10 | negative regulation of lymphocyte migration |
| GO:2000574 | 0.03195 | 8.45652 | 0 | 2 | 10 | regulation of microtubule motor activity |
| GO:2000807 | 0.03195 | 8.45652 | 0 | 2 | 10 | regulation of synaptic vesicle clustering |
| GO:2000822 | 0.03195 | 8.45652 | 0 | 2 | 10 | regulation of behavioral fear response |
| GO:2000980 | 0.03195 | 8.45652 | 0 | 2 | 10 | regulation of inner ear receptor cell differentiation |
| GO:0071706 | 0.03210 | 2.13862 | 4 | 9 | 152 | tumor necrosis factor superfamily cytokine production |
| GO:0030048 | 0.03211 | 2.42469 | 3 | 7 | 105 | actin filament-based movement |
| GO:0032091 | 0.03211 | 2.42469 | 3 | 7 | 105 | negative regulation of protein binding |
| GO:0010883 | 0.03213 | 3.56660 | 1 | 4 | 42 | regulation of lipid storage |
| GO:0032814 | 0.03213 | 3.56660 | 1 | 4 | 42 | regulation of natural killer cell activation |
| GO:0043616 | 0.03213 | 3.56660 | 1 | 4 | 42 | keratinocyte proliferation |
| GO:0050704 | 0.03213 | 3.56660 | 1 | 4 | 42 | regulation of interleukin-1 secretion |
| GO:0050730 | 0.03228 | 1.84381 | 7 | 13 | 253 | regulation of peptidyl-tyrosine phosphorylation |
| GO:0008652 | 0.03283 | 2.97413 | 2 | 5 | 62 | cellular amino acid biosynthetic process |
| GO:0021695 | 0.03283 | 2.97413 | 2 | 5 | 62 | cerebellar cortex development |
| GO:0060042 | 0.03283 | 2.97413 | 2 | 5 | 62 | retina morphogenesis in camera-type eye |
| GO:0031100 | 0.03413 | 4.61671 | 1 | 3 | 25 | animal organ regeneration |
| GO:0035809 | 0.03413 | 4.61671 | 1 | 3 | 25 | regulation of urine volume |
| GO:0044550 | 0.03413 | 4.61671 | 1 | 3 | 25 | secondary metabolite biosynthetic process |
| GO:0046823 | 0.03413 | 4.61671 | 1 | 3 | 25 | negative regulation of nucleocytoplasmic transport |
| GO:0060004 | 0.03413 | 4.61671 | 1 | 3 | 25 | reflex |
| GO:0061213 | 0.03413 | 4.61671 | 1 | 3 | 25 | positive regulation of mesonephros development |
| GO:0071425 | 0.03413 | 4.61671 | 1 | 3 | 25 | hematopoietic stem cell proliferation |
| GO:0072012 | 0.03413 | 4.61671 | 1 | 3 | 25 | glomerulus vasculature development |
| GO:0099010 | 0.03413 | 4.61671 | 1 | 3 | 25 | modification of postsynaptic structure |
| GO:0120033 | 0.03413 | 4.61671 | 1 | 3 | 25 | negative regulation of plasma membrane bounded cell projection assembly |
| GO:1902230 | 0.03413 | 4.61671 | 1 | 3 | 25 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:1904646 | 0.03413 | 4.61671 | 1 | 3 | 25 | cellular response to amyloid-beta |
| GO:0070252 | 0.03420 | 2.60958 | 2 | 6 | 84 | actin-mediated cell contraction |
| GO:0070509 | 0.03420 | 2.60958 | 2 | 6 | 84 | calcium ion import |
| GO:0006633 | 0.03455 | 2.22693 | 4 | 8 | 130 | fatty acid biosynthetic process |
| GO:0030512 | 0.03485 | 2.92273 | 2 | 5 | 63 | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO:0044843 | 0.03487 | 2.01139 | 5 | 10 | 179 | cell cycle G1/S phase transition |
| GO:0051480 | 0.03554 | 1.66984 | 10 | 17 | 364 | regulation of cytosolic calcium ion concentration |
| GO:0009913 | 0.03572 | 1.92818 | 6 | 11 | 205 | epidermal cell differentiation |
| GO:0032984 | 0.03572 | 1.92818 | 6 | 11 | 205 | protein-containing complex disassembly |
| GO:0060538 | 0.03572 | 1.92818 | 6 | 11 | 205 | skeletal muscle organ development |
| GO:0002690 | 0.03594 | 2.57644 | 2 | 6 | 85 | positive regulation of leukocyte chemotaxis |
| GO:0045766 | 0.03601 | 1.99946 | 5 | 10 | 180 | positive regulation of angiogenesis |
| GO:0046649 | 0.03659 | 1.42676 | 24 | 33 | 825 | lymphocyte activation |
| GO:0042886 | 0.03667 | 1.28964 | 51 | 64 | 1775 | amide transport |
| GO:0010952 | 0.03697 | 2.08006 | 4 | 9 | 156 | positive regulation of peptidase activity |
| GO:0022409 | 0.03704 | 1.85554 | 7 | 12 | 232 | positive regulation of cell-cell adhesion |
| GO:0001523 | 0.03727 | 3.38797 | 1 | 4 | 44 | retinoid metabolic process |
| GO:0032873 | 0.03727 | 3.38797 | 1 | 4 | 44 | negative regulation of stress-activated MAPK cascade |
| GO:0040018 | 0.03727 | 3.38797 | 1 | 4 | 44 | positive regulation of multicellular organism growth |
| GO:0070303 | 0.03727 | 3.38797 | 1 | 4 | 44 | negative regulation of stress-activated protein kinase signaling cascade |
| GO:0090184 | 0.03727 | 3.38797 | 1 | 4 | 44 | positive regulation of kidney development |
| GO:0006112 | 0.03773 | 2.54412 | 2 | 6 | 86 | energy reserve metabolic process |
| GO:0007009 | 0.03773 | 2.54412 | 2 | 6 | 86 | plasma membrane organization |
| GO:0032612 | 0.03773 | 2.54412 | 2 | 6 | 86 | interleukin-1 production |
| GO:1904589 | 0.03773 | 2.54412 | 2 | 6 | 86 | regulation of protein import |
| GO:0009713 | 0.03778 | 4.41579 | 1 | 3 | 26 | catechol-containing compound biosynthetic process |
| GO:0032528 | 0.03778 | 4.41579 | 1 | 3 | 26 | microvillus organization |
| GO:0035929 | 0.03778 | 4.41579 | 1 | 3 | 26 | steroid hormone secretion |
| GO:0042423 | 0.03778 | 4.41579 | 1 | 3 | 26 | catecholamine biosynthetic process |
| GO:0045742 | 0.03778 | 4.41579 | 1 | 3 | 26 | positive regulation of epidermal growth factor receptor signaling pathway |
| GO:0060219 | 0.03778 | 4.41579 | 1 | 3 | 26 | camera-type eye photoreceptor cell differentiation |
| GO:0060716 | 0.03778 | 4.41579 | 1 | 3 | 26 | labyrinthine layer blood vessel development |
| GO:0061437 | 0.03778 | 4.41579 | 1 | 3 | 26 | renal system vasculature development |
| GO:0061440 | 0.03778 | 4.41579 | 1 | 3 | 26 | kidney vasculature development |
| GO:0090025 | 0.03778 | 4.41579 | 1 | 3 | 26 | regulation of monocyte chemotaxis |
| GO:0090189 | 0.03778 | 4.41579 | 1 | 3 | 26 | regulation of branching involved in ureteric bud morphogenesis |
| GO:2000311 | 0.03778 | 4.41579 | 1 | 3 | 26 | regulation of AMPA receptor activity |
| GO:2001171 | 0.03778 | 4.41579 | 1 | 3 | 26 | positive regulation of ATP biosynthetic process |
| GO:0042100 | 0.03818 | 2.32919 | 3 | 7 | 109 | B cell proliferation |
| GO:0002138 | 0.03831 | 7.51658 | 0 | 2 | 11 | retinoic acid biosynthetic process |
| GO:0006072 | 0.03831 | 7.51658 | 0 | 2 | 11 | glycerol-3-phosphate metabolic process |
| GO:0006705 | 0.03831 | 7.51658 | 0 | 2 | 11 | mineralocorticoid biosynthetic process |
| GO:0010739 | 0.03831 | 7.51658 | 0 | 2 | 11 | positive regulation of protein kinase A signaling |
| GO:0010744 | 0.03831 | 7.51658 | 0 | 2 | 11 | positive regulation of macrophage derived foam cell differentiation |
| GO:0016102 | 0.03831 | 7.51658 | 0 | 2 | 11 | diterpenoid biosynthetic process |
| GO:0032341 | 0.03831 | 7.51658 | 0 | 2 | 11 | aldosterone metabolic process |
| GO:0033603 | 0.03831 | 7.51658 | 0 | 2 | 11 | positive regulation of dopamine secretion |
| GO:0035457 | 0.03831 | 7.51658 | 0 | 2 | 11 | cellular response to interferon-alpha |
| GO:0035630 | 0.03831 | 7.51658 | 0 | 2 | 11 | bone mineralization involved in bone maturation |
| GO:0042048 | 0.03831 | 7.51658 | 0 | 2 | 11 | olfactory behavior |
| GO:0042983 | 0.03831 | 7.51658 | 0 | 2 | 11 | amyloid precursor protein biosynthetic process |
| GO:0042984 | 0.03831 | 7.51658 | 0 | 2 | 11 | regulation of amyloid precursor protein biosynthetic process |
| GO:0043619 | 0.03831 | 7.51658 | 0 | 2 | 11 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress |
| GO:0044557 | 0.03831 | 7.51658 | 0 | 2 | 11 | relaxation of smooth muscle |
| GO:0045161 | 0.03831 | 7.51658 | 0 | 2 | 11 | neuronal ion channel clustering |
| GO:0045924 | 0.03831 | 7.51658 | 0 | 2 | 11 | regulation of female receptivity |
| GO:0046532 | 0.03831 | 7.51658 | 0 | 2 | 11 | regulation of photoreceptor cell differentiation |
| GO:0060013 | 0.03831 | 7.51658 | 0 | 2 | 11 | righting reflex |
| GO:0060405 | 0.03831 | 7.51658 | 0 | 2 | 11 | regulation of penile erection |
| GO:0060693 | 0.03831 | 7.51658 | 0 | 2 | 11 | regulation of branching involved in salivary gland morphogenesis |
| GO:0060768 | 0.03831 | 7.51658 | 0 | 2 | 11 | regulation of epithelial cell proliferation involved in prostate gland development |
| GO:0060900 | 0.03831 | 7.51658 | 0 | 2 | 11 | embryonic camera-type eye formation |
| GO:0071340 | 0.03831 | 7.51658 | 0 | 2 | 11 | skeletal muscle acetylcholine-gated channel clustering |
| GO:0072102 | 0.03831 | 7.51658 | 0 | 2 | 11 | glomerulus morphogenesis |
| GO:0098722 | 0.03831 | 7.51658 | 0 | 2 | 11 | asymmetric stem cell division |
| GO:1901678 | 0.03831 | 7.51658 | 0 | 2 | 11 | iron coordination entity transport |
| GO:0098656 | 0.03837 | 1.97604 | 5 | 10 | 182 | anion transmembrane transport |
| GO:0048872 | 0.03840 | 1.71418 | 9 | 15 | 313 | homeostasis of number of cells |
| GO:0043624 | 0.03874 | 2.17319 | 4 | 8 | 133 | cellular protein complex disassembly |
| GO:0003143 | 0.03911 | 2.82505 | 2 | 5 | 65 | embryonic heart tube morphogenesis |
| GO:0046626 | 0.03911 | 2.82505 | 2 | 5 | 65 | regulation of insulin receptor signaling pathway |
| GO:0060997 | 0.03911 | 2.82505 | 2 | 5 | 65 | dendritic spine morphogenesis |
| GO:0061371 | 0.03911 | 2.82505 | 2 | 5 | 65 | determination of heart left/right asymmetry |
| GO:1903845 | 0.03911 | 2.82505 | 2 | 5 | 65 | negative regulation of cellular response to transforming growth factor beta stimulus |
| GO:0072507 | 0.03933 | 1.54187 | 15 | 22 | 509 | divalent inorganic cation homeostasis |
| GO:0021954 | 0.03959 | 2.51260 | 3 | 6 | 87 | central nervous system neuron development |
| GO:0060759 | 0.03981 | 2.30647 | 3 | 7 | 110 | regulation of response to cytokine stimulus |
| GO:0030003 | 0.03987 | 1.48315 | 18 | 26 | 625 | cellular cation homeostasis |
| GO:0019228 | 0.04001 | 3.30519 | 1 | 4 | 45 | neuronal action potential |
| GO:0030890 | 0.04001 | 3.30519 | 1 | 4 | 45 | positive regulation of B cell proliferation |
| GO:0032732 | 0.04001 | 3.30519 | 1 | 4 | 45 | positive regulation of interleukin-1 production |
| GO:0043029 | 0.04001 | 3.30519 | 1 | 4 | 45 | T cell homeostasis |
| GO:0048010 | 0.04001 | 3.30519 | 1 | 4 | 45 | vascular endothelial growth factor receptor signaling pathway |
| GO:0071470 | 0.04001 | 3.30519 | 1 | 4 | 45 | cellular response to osmotic stress |
| GO:1903018 | 0.04001 | 3.30519 | 1 | 4 | 45 | regulation of glycoprotein metabolic process |
| GO:0097305 | 0.04017 | 1.88889 | 6 | 11 | 209 | response to alcohol |
| GO:0055088 | 0.04020 | 2.15585 | 4 | 8 | 134 | lipid homeostasis |
| GO:0046777 | 0.04022 | 1.83033 | 7 | 12 | 235 | protein autophosphorylation |
| GO:0031669 | 0.04084 | 1.95315 | 5 | 10 | 184 | cellular response to nutrient levels |
| GO:0032623 | 0.04136 | 2.77861 | 2 | 5 | 66 | interleukin-2 production |
| GO:1903036 | 0.04136 | 2.77861 | 2 | 5 | 66 | positive regulation of response to wounding |
| GO:0001952 | 0.04148 | 2.28419 | 3 | 7 | 111 | regulation of cell-matrix adhesion |
| GO:0042113 | 0.04150 | 1.61029 | 11 | 18 | 399 | B cell activation |
| GO:0002068 | 0.04162 | 4.23161 | 1 | 3 | 27 | glandular epithelial cell development |
| GO:0003338 | 0.04162 | 4.23161 | 1 | 3 | 27 | metanephros morphogenesis |
| GO:0021533 | 0.04162 | 4.23161 | 1 | 3 | 27 | cell differentiation in hindbrain |
| GO:0030878 | 0.04162 | 4.23161 | 1 | 3 | 27 | thyroid gland development |
| GO:0036003 | 0.04162 | 4.23161 | 1 | 3 | 27 | positive regulation of transcription from RNA polymerase II promoter in response to stress |
| GO:0045822 | 0.04162 | 4.23161 | 1 | 3 | 27 | negative regulation of heart contraction |
| GO:0060143 | 0.04162 | 4.23161 | 1 | 3 | 27 | positive regulation of syncytium formation by plasma membrane fusion |
| GO:0071549 | 0.04162 | 4.23161 | 1 | 3 | 27 | cellular response to dexamethasone stimulus |
| GO:1904645 | 0.04162 | 4.23161 | 1 | 3 | 27 | response to amyloid-beta |
| GO:0071333 | 0.04171 | 2.13878 | 4 | 8 | 135 | cellular response to glucose stimulus |
| GO:0072503 | 0.04188 | 1.54737 | 14 | 21 | 484 | cellular divalent inorganic cation homeostasis |
| GO:0072175 | 0.04233 | 2.02459 | 5 | 9 | 160 | epithelial tube formation |
| GO:0031668 | 0.04254 | 1.86983 | 6 | 11 | 211 | cellular response to extracellular stimulus |
| GO:0001504 | 0.04286 | 3.22635 | 1 | 4 | 46 | neurotransmitter uptake |
| GO:0016101 | 0.04286 | 3.22635 | 1 | 4 | 46 | diterpenoid metabolic process |
| GO:0030520 | 0.04286 | 3.22635 | 1 | 4 | 46 | intracellular estrogen receptor signaling pathway |
| GO:0033120 | 0.04286 | 3.22635 | 1 | 4 | 46 | positive regulation of RNA splicing |
| GO:0048536 | 0.04286 | 3.22635 | 1 | 4 | 46 | spleen development |
| GO:0120193 | 0.04286 | 3.22635 | 1 | 4 | 46 | tight junction organization |
| GO:0008286 | 0.04320 | 2.26234 | 3 | 7 | 112 | insulin receptor signaling pathway |
| GO:0042472 | 0.04320 | 2.26234 | 3 | 7 | 112 | inner ear morphogenesis |
| GO:0050921 | 0.04325 | 2.12197 | 4 | 8 | 136 | positive regulation of chemotaxis |
| GO:0022402 | 0.04347 | 1.35429 | 31 | 41 | 1079 | cell cycle process |
| GO:0032370 | 0.04368 | 2.73368 | 2 | 5 | 67 | positive regulation of lipid transport |
| GO:1904888 | 0.04368 | 2.73368 | 2 | 5 | 67 | cranial skeletal system development |
| GO:0031644 | 0.04375 | 2.01118 | 5 | 9 | 161 | regulation of neurological system process |
| GO:0032103 | 0.04423 | 1.71392 | 8 | 14 | 292 | positive regulation of response to external stimulus |
| GO:0071331 | 0.04483 | 2.10543 | 4 | 8 | 137 | cellular response to hexose stimulus |
| GO:1903828 | 0.04496 | 2.24089 | 3 | 7 | 113 | negative regulation of cellular protein localization |
| GO:0003183 | 0.04512 | 6.76462 | 0 | 2 | 12 | mitral valve morphogenesis |
| GO:0003207 | 0.04512 | 6.76462 | 0 | 2 | 12 | cardiac chamber formation |
| GO:0006020 | 0.04512 | 6.76462 | 0 | 2 | 12 | inositol metabolic process |
| GO:0007440 | 0.04512 | 6.76462 | 0 | 2 | 12 | foregut morphogenesis |
| GO:0008212 | 0.04512 | 6.76462 | 0 | 2 | 12 | mineralocorticoid metabolic process |
| GO:0010889 | 0.04512 | 6.76462 | 0 | 2 | 12 | regulation of sequestering of triglyceride |
| GO:0014745 | 0.04512 | 6.76462 | 0 | 2 | 12 | negative regulation of muscle adaptation |
| GO:0014842 | 0.04512 | 6.76462 | 0 | 2 | 12 | regulation of skeletal muscle satellite cell proliferation |
| GO:0030836 | 0.04512 | 6.76462 | 0 | 2 | 12 | positive regulation of actin filament depolymerization |
| GO:0034309 | 0.04512 | 6.76462 | 0 | 2 | 12 | primary alcohol biosynthetic process |
| GO:0034350 | 0.04512 | 6.76462 | 0 | 2 | 12 | regulation of glial cell apoptotic process |
| GO:0045945 | 0.04512 | 6.76462 | 0 | 2 | 12 | positive regulation of transcription by RNA polymerase III |
| GO:0048733 | 0.04512 | 6.76462 | 0 | 2 | 12 | sebaceous gland development |
| GO:0051280 | 0.04512 | 6.76462 | 0 | 2 | 12 | negative regulation of release of sequestered calcium ion into cytosol |
| GO:0052646 | 0.04512 | 6.76462 | 0 | 2 | 12 | alditol phosphate metabolic process |
| GO:0060033 | 0.04512 | 6.76462 | 0 | 2 | 12 | anatomical structure regression |
| GO:0060068 | 0.04512 | 6.76462 | 0 | 2 | 12 | vagina development |
| GO:0060430 | 0.04512 | 6.76462 | 0 | 2 | 12 | lung saccule development |
| GO:0060767 | 0.04512 | 6.76462 | 0 | 2 | 12 | epithelial cell proliferation involved in prostate gland development |
| GO:0070970 | 0.04512 | 6.76462 | 0 | 2 | 12 | interleukin-2 secretion |
| GO:0072176 | 0.04512 | 6.76462 | 0 | 2 | 12 | nephric duct development |
| GO:0072697 | 0.04512 | 6.76462 | 0 | 2 | 12 | protein localization to cell cortex |
| GO:0090193 | 0.04512 | 6.76462 | 0 | 2 | 12 | positive regulation of glomerulus development |
| GO:0090494 | 0.04512 | 6.76462 | 0 | 2 | 12 | dopamine uptake |
| GO:2000009 | 0.04512 | 6.76462 | 0 | 2 | 12 | negative regulation of protein localization to cell surface |
| GO:2000047 | 0.04512 | 6.76462 | 0 | 2 | 12 | regulation of cell-cell adhesion mediated by cadherin |
| GO:0032755 | 0.04548 | 2.42254 | 3 | 6 | 90 | positive regulation of interleukin-6 production |
| GO:0043535 | 0.04548 | 2.42254 | 3 | 6 | 90 | regulation of blood vessel endothelial cell migration |
| GO:0005979 | 0.04564 | 4.06216 | 1 | 3 | 28 | regulation of glycogen biosynthetic process |
| GO:0006929 | 0.04564 | 4.06216 | 1 | 3 | 28 | substrate-dependent cell migration |
| GO:0010962 | 0.04564 | 4.06216 | 1 | 3 | 28 | regulation of glucan biosynthetic process |
| GO:0030511 | 0.04564 | 4.06216 | 1 | 3 | 28 | positive regulation of transforming growth factor beta receptor signaling pathway |
| GO:0032816 | 0.04564 | 4.06216 | 1 | 3 | 28 | positive regulation of natural killer cell activation |
| GO:0043552 | 0.04564 | 4.06216 | 1 | 3 | 28 | positive regulation of phosphatidylinositol 3-kinase activity |
| GO:0045663 | 0.04564 | 4.06216 | 1 | 3 | 28 | positive regulation of myoblast differentiation |
| GO:0045671 | 0.04564 | 4.06216 | 1 | 3 | 28 | negative regulation of osteoclast differentiation |
| GO:0045724 | 0.04564 | 4.06216 | 1 | 3 | 28 | positive regulation of cilium assembly |
| GO:0048596 | 0.04564 | 4.06216 | 1 | 3 | 28 | embryonic camera-type eye morphogenesis |
| GO:0060037 | 0.04564 | 4.06216 | 1 | 3 | 28 | pharyngeal system development |
| GO:0060384 | 0.04564 | 4.06216 | 1 | 3 | 28 | innervation |
| GO:0061217 | 0.04564 | 4.06216 | 1 | 3 | 28 | regulation of mesonephros development |
| GO:0061298 | 0.04564 | 4.06216 | 1 | 3 | 28 | retina vasculature development in camera-type eye |
| GO:1903846 | 0.04564 | 4.06216 | 1 | 3 | 28 | positive regulation of cellular response to transforming growth factor beta stimulus |
| GO:0001960 | 0.04582 | 3.15118 | 1 | 4 | 47 | negative regulation of cytokine-mediated signaling pathway |
| GO:0001990 | 0.04582 | 3.15118 | 1 | 4 | 47 | regulation of systemic arterial blood pressure by hormone |
| GO:0014009 | 0.04582 | 3.15118 | 1 | 4 | 47 | glial cell proliferation |
| GO:0038066 | 0.04582 | 3.15118 | 1 | 4 | 47 | p38MAPK cascade |
| GO:0043470 | 0.04582 | 3.15118 | 1 | 4 | 47 | regulation of carbohydrate catabolic process |
| GO:0045010 | 0.04582 | 3.15118 | 1 | 4 | 47 | actin nucleation |
| GO:1904036 | 0.04582 | 3.15118 | 1 | 4 | 47 | negative regulation of epithelial cell apoptotic process |
| GO:0019915 | 0.04608 | 2.69017 | 2 | 5 | 68 | lipid storage |
| GO:0050728 | 0.04645 | 2.08914 | 4 | 8 | 138 | negative regulation of inflammatory response |
| GO:0071326 | 0.04645 | 2.08914 | 4 | 8 | 138 | cellular response to monosaccharide stimulus |
| GO:0006816 | 0.04675 | 1.58490 | 12 | 18 | 405 | calcium ion transport |
| GO:2000278 | 0.04677 | 2.21985 | 3 | 7 | 114 | regulation of DNA biosynthetic process |
| GO:0010466 | 0.04713 | 1.78190 | 7 | 12 | 241 | negative regulation of peptidase activity |
| GO:0007268 | 0.04749 | 1.39211 | 24 | 33 | 844 | chemical synaptic transmission |
| GO:0098916 | 0.04749 | 1.39211 | 24 | 33 | 844 | anterograde trans-synaptic signaling |
| GO:0010660 | 0.04756 | 2.39393 | 3 | 6 | 91 | regulation of muscle cell apoptotic process |
| GO:0051495 | 0.04756 | 1.83284 | 6 | 11 | 215 | positive regulation of cytoskeleton organization |
| GO:0015031 | 0.04796 | 1.27371 | 49 | 61 | 1709 | protein transport |
| GO:0009755 | 0.04819 | 1.97199 | 5 | 9 | 164 | hormone-mediated signaling pathway |
| GO:0097164 | 0.04819 | 1.97199 | 5 | 9 | 164 | ammonium ion metabolic process |
| GO:0001818 | 0.04835 | 1.77407 | 7 | 12 | 242 | negative regulation of cytokine production |
| GO:0048146 | 0.04855 | 2.64801 | 2 | 5 | 69 | positive regulation of fibroblast proliferation |
| GO:0097120 | 0.04855 | 2.64801 | 2 | 5 | 69 | receptor localization to synapse |
| GO:0043280 | 0.04862 | 2.19920 | 3 | 7 | 115 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0071241 | 0.04887 | 1.82382 | 6 | 11 | 216 | cellular response to inorganic substance |
| GO:0021915 | 0.04889 | 1.88754 | 5 | 10 | 190 | neural tube development |
| GO:0032330 | 0.04890 | 3.07943 | 1 | 4 | 48 | regulation of chondrocyte differentiation |
| GO:0042755 | 0.04890 | 3.07943 | 1 | 4 | 48 | eating behavior |
| GO:0046189 | 0.04890 | 3.07943 | 1 | 4 | 48 | phenol-containing compound biosynthetic process |
| GO:0061005 | 0.04890 | 3.07943 | 1 | 4 | 48 | cell differentiation involved in kidney development |
| GO:2001239 | 0.04890 | 3.07943 | 1 | 4 | 48 | regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0001704 | 0.04970 | 2.36599 | 3 | 6 | 92 | formation of primary germ layer |
| GO:0000082 | 0.04973 | 1.95927 | 5 | 9 | 165 | G1/S transition of mitotic cell cycle |
| GO:0050709 | 0.04979 | 2.05731 | 4 | 8 | 140 | negative regulation of protein secretion |
| GO:0002691 | 0.04986 | 3.90575 | 1 | 3 | 29 | regulation of cellular extravasation |
| GO:2000191 | 0.04986 | 3.90575 | 1 | 3 | 29 | regulation of fatty acid transport |